id	sid	tid	token	lemma	pos
cuesj-183	1	1	tx_1	tx_1	PROPN
cuesj-183	1	2	:	:	PUNCT
cuesj-183	1	3	abs	ab	NOUN
cuesj-183	1	4	~	~	PUNCT
cuesj-183	1	5	at	at	ADP
cuesj-183	1	6	/	/	SYM
cuesj-183	1	7	tx_2	tx_2	PROPN
cuesj-183	1	8	:	:	PUNCT
cuesj-183	1	9	abs	ab	VERB
cuesj-183	1	10	~	~	PUNCT
cuesj-183	1	11	at	at	ADP
cuesj-183	1	12	45	45	NUM
cuesj-183	1	13	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-183	1	14	cuesj	cuesj	NOUN
cuesj-183	1	15	2020	2020	NUM
cuesj-183	1	16	,	,	PUNCT
cuesj-183	1	17	4	4	NUM
cuesj-183	1	18	(	(	PUNCT
cuesj-183	1	19	1	1	NUM
cuesj-183	1	20	):	):	PUNCT
cuesj-183	1	21	45	45	NUM
cuesj-183	1	22	-	-	SYM
cuesj-183	1	23	51	51	NUM
cuesj-183	1	24	research	research	NOUN
cuesj-183	1	25	article	article	NOUN
cuesj-183	1	26	prevalence	prevalence	NOUN
cuesj-183	1	27	and	and	CCONJ
cuesj-183	1	28	characterization	characterization	NOUN
cuesj-183	1	29	of	of	ADP
cuesj-183	1	30	hepatitis	hepatitis	PROPN
cuesj-183	1	31	b	b	PROPN
cuesj-183	1	32	and	and	CCONJ
cuesj-183	1	33	hepatitis	hepatitis	PROPN
cuesj-183	1	34	c	c	PROPN
cuesj-183	1	35	infection	infection	NOUN
cuesj-183	1	36	among	among	ADP
cuesj-183	1	37	blood	blood	NOUN
cuesj-183	1	38	donors	donor	NOUN
cuesj-183	1	39	in	in	ADP
cuesj-183	1	40	erbil	erbil	PROPN
cuesj-183	1	41	goran	goran	PROPN
cuesj-183	1	42	n.	n.	PROPN
cuesj-183	1	43	saleh	saleh	PROPN
cuesj-183	1	44	,	,	PUNCT
cuesj-183	1	45	chato	chato	PROPN
cuesj-183	1	46	a.	a.	PROPN
cuesj-183	1	47	taher	taher	PROPN
cuesj-183	1	48	*	*	PROPN
cuesj-183	1	49	department	department	PROPN
cuesj-183	1	50	of	of	ADP
cuesj-183	1	51	basic	basic	ADJ
cuesj-183	1	52	science	science	NOUN
cuesj-183	1	53	,	,	PUNCT
cuesj-183	1	54	microbiology	microbiology	NOUN
cuesj-183	1	55	unit	unit	NOUN
cuesj-183	1	56	,	,	PUNCT
cuesj-183	1	57	college	college	NOUN
cuesj-183	1	58	of	of	ADP
cuesj-183	1	59	medicine	medicine	NOUN
cuesj-183	1	60	,	,	PUNCT
cuesj-183	1	61	hawler	hawler	PROPN
cuesj-183	1	62	medical	medical	PROPN
cuesj-183	1	63	university	university	PROPN
cuesj-183	1	64	,	,	PUNCT
cuesj-183	1	65	erbil	erbil	PROPN
cuesj-183	1	66	,	,	PUNCT
cuesj-183	1	67	kurdistan	kurdistan	PROPN
cuesj-183	1	68	region	region	NOUN
cuesj-183	1	69	,	,	PUNCT
cuesj-183	1	70	iraq	iraq	PROPN
cuesj-183	1	71	abstract	abstract	ADJ
cuesj-183	1	72	blood	blood	NOUN
cuesj-183	1	73	transmitting	transmit	VERB
cuesj-183	1	74	infectious	infectious	ADJ
cuesj-183	1	75	disease	disease	NOUN
cuesj-183	1	76	still	still	ADV
cuesj-183	1	77	remains	remain	VERB
cuesj-183	1	78	a	a	DET
cuesj-183	1	79	considerable	considerable	ADJ
cuesj-183	1	80	global	global	ADJ
cuesj-183	1	81	health	health	NOUN
cuesj-183	1	82	problem	problem	NOUN
cuesj-183	1	83	.	.	PUNCT
cuesj-183	2	1	hepatitis	hepatitis	PROPN
cuesj-183	2	2	b	b	PROPN
cuesj-183	2	3	virus	virus	NOUN
cuesj-183	2	4	(	(	PUNCT
cuesj-183	2	5	hbv	hbv	NOUN
cuesj-183	2	6	)	)	PUNCT
cuesj-183	2	7	and	and	CCONJ
cuesj-183	2	8	hepatitis	hepatitis	PROPN
cuesj-183	2	9	c	c	PROPN
cuesj-183	2	10	virus	virus	NOUN
cuesj-183	2	11	(	(	PUNCT
cuesj-183	2	12	hcv	hcv	PROPN
cuesj-183	2	13	)	)	PUNCT
cuesj-183	2	14	are	be	AUX
cuesj-183	2	15	two	two	NUM
cuesj-183	2	16	of	of	ADP
cuesj-183	2	17	the	the	DET
cuesj-183	2	18	most	most	ADV
cuesj-183	2	19	commonly	commonly	ADV
cuesj-183	2	20	transmitted	transmit	VERB
cuesj-183	2	21	infectious	infectious	ADJ
cuesj-183	2	22	agents	agent	NOUN
cuesj-183	2	23	.	.	PUNCT
cuesj-183	3	1	this	this	DET
cuesj-183	3	2	prospective	prospective	ADJ
cuesj-183	3	3	cross	cross	ADJ
cuesj-183	3	4	-	-	ADJ
cuesj-183	3	5	sectional	sectional	ADJ
cuesj-183	3	6	study	study	NOUN
cuesj-183	3	7	was	be	AUX
cuesj-183	3	8	conducted	conduct	VERB
cuesj-183	3	9	between	between	ADP
cuesj-183	3	10	december	december	PROPN
cuesj-183	3	11	,	,	PUNCT
cuesj-183	3	12	2017	2017	NUM
cuesj-183	3	13	,	,	PUNCT
cuesj-183	3	14	and	and	CCONJ
cuesj-183	3	15	february	february	PROPN
cuesj-183	3	16	,	,	PUNCT
cuesj-183	3	17	2018	2018	NUM
cuesj-183	3	18	,	,	PUNCT
cuesj-183	3	19	at	at	ADP
cuesj-183	3	20	the	the	DET
cuesj-183	3	21	directorate	directorate	NOUN
cuesj-183	3	22	of	of	ADP
cuesj-183	3	23	blood	blood	NOUN
cuesj-183	3	24	bank	bank	NOUN
cuesj-183	3	25	in	in	ADP
cuesj-183	3	26	erbil	erbil	PROPN
cuesj-183	3	27	province	province	PROPN
cuesj-183	3	28	,	,	PUNCT
cuesj-183	3	29	northern	northern	ADJ
cuesj-183	3	30	iraq	iraq	PROPN
cuesj-183	3	31	.	.	PUNCT
cuesj-183	4	1	during	during	ADP
cuesj-183	4	2	that	that	DET
cuesj-183	4	3	period	period	NOUN
cuesj-183	4	4	,	,	PUNCT
cuesj-183	4	5	a	a	DET
cuesj-183	4	6	total	total	NOUN
cuesj-183	4	7	of	of	ADP
cuesj-183	4	8	6173	6173	NUM
cuesj-183	4	9	blood	blood	NOUN
cuesj-183	4	10	donors	donor	NOUN
cuesj-183	4	11	donated	donate	VERB
cuesj-183	4	12	blood	blood	NOUN
cuesj-183	4	13	;	;	PUNCT
cuesj-183	4	14	all	all	DET
cuesj-183	4	15	blood	blood	NOUN
cuesj-183	4	16	donors	donor	NOUN
cuesj-183	4	17	were	be	AUX
cuesj-183	4	18	asked	ask	VERB
cuesj-183	4	19	a	a	DET
cuesj-183	4	20	series	series	NOUN
cuesj-183	4	21	of	of	ADP
cuesj-183	4	22	questions	question	NOUN
cuesj-183	4	23	through	through	ADP
cuesj-183	4	24	a	a	DET
cuesj-183	4	25	structured	structured	ADJ
cuesj-183	4	26	questionnaire	questionnaire	NOUN
cuesj-183	4	27	designed	design	VERB
cuesj-183	4	28	for	for	ADP
cuesj-183	4	29	such	such	ADJ
cuesj-183	4	30	purpose	purpose	NOUN
cuesj-183	4	31	.	.	PUNCT
cuesj-183	5	1	these	these	DET
cuesj-183	5	2	patients	patient	NOUN
cuesj-183	5	3	were	be	AUX
cuesj-183	5	4	serologically	serologically	ADV
cuesj-183	5	5	examined	examine	VERB
cuesj-183	5	6	for	for	ADP
cuesj-183	5	7	hbv	hbv	NOUN
cuesj-183	5	8	and	and	CCONJ
cuesj-183	5	9	hcv	hcv	NOUN
cuesj-183	5	10	.	.	PUNCT
cuesj-183	6	1	positive	positive	ADJ
cuesj-183	6	2	blood	blood	NOUN
cuesj-183	6	3	samples	sample	NOUN
cuesj-183	6	4	were	be	AUX
cuesj-183	6	5	further	far	ADV
cuesj-183	6	6	analyzed	analyze	VERB
cuesj-183	6	7	serologically	serologically	ADV
cuesj-183	6	8	and	and	CCONJ
cuesj-183	6	9	confirmed	confirm	VERB
cuesj-183	6	10	by	by	ADP
cuesj-183	6	11	real	real	ADJ
cuesj-183	6	12	-	-	PUNCT
cuesj-183	6	13	time	time	NOUN
cuesj-183	6	14	polymerase	polymerase	NOUN
cuesj-183	6	15	chain	chain	NOUN
cuesj-183	6	16	reaction	reaction	NOUN
cuesj-183	6	17	(	(	PUNCT
cuesj-183	6	18	rt	rt	NOUN
cuesj-183	6	19	-	-	PUNCT
cuesj-183	6	20	pcr	pcr	NOUN
cuesj-183	6	21	)	)	PUNCT
cuesj-183	6	22	.	.	PUNCT
cuesj-183	7	1	among	among	ADP
cuesj-183	7	2	6173	6173	NUM
cuesj-183	7	3	blood	blood	NOUN
cuesj-183	7	4	donors	donor	NOUN
cuesj-183	7	5	who	who	PRON
cuesj-183	7	6	were	be	AUX
cuesj-183	7	7	investigated	investigate	VERB
cuesj-183	7	8	for	for	ADP
cuesj-183	7	9	hbv	hbv	NOUN
cuesj-183	7	10	,	,	PUNCT
cuesj-183	7	11	7	7	NUM
cuesj-183	7	12	 	 	SPACE
cuesj-183	7	13	(	(	PUNCT
cuesj-183	7	14	0.11	0.11	NUM
cuesj-183	7	15	%	%	NOUN
cuesj-183	7	16	)	)	PUNCT
cuesj-183	7	17	and	and	CCONJ
cuesj-183	7	18	98	98	NUM
cuesj-183	7	19	 	 	SPACE
cuesj-183	7	20	(	(	PUNCT
cuesj-183	7	21	1.6	1.6	NUM
cuesj-183	7	22	%	%	NOUN
cuesj-183	7	23	)	)	PUNCT
cuesj-183	7	24	were	be	AUX
cuesj-183	7	25	positive	positive	ADJ
cuesj-183	7	26	for	for	ADP
cuesj-183	7	27	hepatitis	hepatitis	PROPN
cuesj-183	7	28	b	b	PROPN
cuesj-183	7	29	surface	surface	NOUN
cuesj-183	7	30	antigen	antigen	NOUN
cuesj-183	7	31	(	(	PUNCT
cuesj-183	7	32	hbs	hbs	PROPN
cuesj-183	7	33	-	-	PUNCT
cuesj-183	7	34	ag	ag	PROPN
cuesj-183	7	35	)	)	PUNCT
cuesj-183	7	36	and	and	CCONJ
cuesj-183	7	37	hepatitis	hepatitis	PROPN
cuesj-183	7	38	b	b	PROPN
cuesj-183	7	39	core	core	NOUN
cuesj-183	7	40	antibody	antibody	NOUN
cuesj-183	7	41	(	(	PUNCT
cuesj-183	7	42	hbc	hbc	PROPN
cuesj-183	7	43	-	-	PUNCT
cuesj-183	7	44	ab	ab	NOUN
cuesj-183	7	45	)	)	PUNCT
cuesj-183	7	46	,	,	PUNCT
cuesj-183	7	47	respectively	respectively	ADV
cuesj-183	7	48	,	,	PUNCT
cuesj-183	7	49	whereas	whereas	SCONJ
cuesj-183	7	50	during	during	ADP
cuesj-183	7	51	screening	screen	VERB
cuesj-183	7	52	for	for	ADP
cuesj-183	7	53	hcv	hcv	PROPN
cuesj-183	7	54	,	,	PUNCT
cuesj-183	7	55	4	4	NUM
cuesj-183	7	56	 	 	SPACE
cuesj-183	7	57	(	(	PUNCT
cuesj-183	7	58	0.06	0.06	NUM
cuesj-183	7	59	%	%	NOUN
cuesj-183	7	60	)	)	PUNCT
cuesj-183	7	61	were	be	AUX
cuesj-183	7	62	positive	positive	ADJ
cuesj-183	7	63	for	for	ADP
cuesj-183	7	64	hcv	hcv	PROPN
cuesj-183	7	65	-	-	PUNCT
cuesj-183	7	66	ab	ab	PROPN
cuesj-183	7	67	.	.	PUNCT
cuesj-183	7	68	coinfection	coinfection	NOUN
cuesj-183	7	69	(	(	PUNCT
cuesj-183	7	70	dual	dual	ADJ
cuesj-183	7	71	infection	infection	NOUN
cuesj-183	7	72	(	(	PUNCT
cuesj-183	7	73	hbv	hbv	NOUN
cuesj-183	7	74	and	and	CCONJ
cuesj-183	7	75	hcv	hcv	NOUN
cuesj-183	7	76	)	)	PUNCT
cuesj-183	7	77	was	be	AUX
cuesj-183	7	78	positive	positive	ADJ
cuesj-183	7	79	in	in	ADP
cuesj-183	7	80	1	1	NUM
cuesj-183	7	81	 	 	SPACE
cuesj-183	7	82	patient	patient	NOUN
cuesj-183	7	83	(	(	PUNCT
cuesj-183	7	84	0.01	0.01	NUM
cuesj-183	7	85	%	%	NOUN
cuesj-183	7	86	)	)	PUNCT
cuesj-183	7	87	.	.	PUNCT
cuesj-183	8	1	among	among	ADP
cuesj-183	8	2	98	98	NUM
cuesj-183	8	3	reactive	reactive	ADJ
cuesj-183	8	4	samples	sample	NOUN
cuesj-183	8	5	,	,	PUNCT
cuesj-183	8	6	75.5	75.5	NUM
cuesj-183	8	7	%	%	NOUN
cuesj-183	8	8	were	be	AUX
cuesj-183	8	9	positive	positive	ADJ
cuesj-183	8	10	for	for	ADP
cuesj-183	8	11	hbs	hbs	ADJ
cuesj-183	8	12	antibody	antibody	NOUN
cuesj-183	8	13	(	(	PUNCT
cuesj-183	8	14	hbs	hbs	PROPN
cuesj-183	8	15	-	-	PUNCT
cuesj-183	8	16	ab	ab	PROPN
cuesj-183	8	17	)	)	PUNCT
cuesj-183	8	18	,	,	PUNCT
cuesj-183	8	19	the	the	DET
cuesj-183	8	20	remaining	remain	VERB
cuesj-183	8	21	24	24	NUM
cuesj-183	8	22	 	 	SPACE
cuesj-183	8	23	samples	sample	NOUN
cuesj-183	8	24	(	(	PUNCT
cuesj-183	8	25	24.5	24.5	NUM
cuesj-183	8	26	%	%	NOUN
cuesj-183	8	27	)	)	PUNCT
cuesj-183	8	28	were	be	AUX
cuesj-183	8	29	regarded	regard	VERB
cuesj-183	8	30	as	as	ADP
cuesj-183	8	31	occult	occult	NOUN
cuesj-183	8	32	hepatitis	hepatitis	PROPN
cuesj-183	8	33	b	b	PROPN
cuesj-183	8	34	infection	infection	NOUN
cuesj-183	8	35	(	(	PUNCT
cuesj-183	8	36	obi	obi	PROPN
cuesj-183	8	37	)	)	PUNCT
cuesj-183	8	38	,	,	PUNCT
cuesj-183	8	39	since	since	SCONJ
cuesj-183	8	40	they	they	PRON
cuesj-183	8	41	were	be	AUX
cuesj-183	8	42	positive	positive	ADJ
cuesj-183	8	43	for	for	ADP
cuesj-183	8	44	hbc	hbc	NOUN
cuesj-183	8	45	-	-	PUNCT
cuesj-183	8	46	ab	ab	NOUN
cuesj-183	8	47	,	,	PUNCT
cuesj-183	8	48	whereas	whereas	SCONJ
cuesj-183	8	49	negative	negative	ADJ
cuesj-183	8	50	both	both	PRON
cuesj-183	8	51	for	for	ADP
cuesj-183	8	52	hbs	hbs	PROPN
cuesj-183	8	53	-	-	PUNCT
cuesj-183	8	54	ag	ag	PROPN
cuesj-183	8	55	and	and	CCONJ
cuesj-183	8	56	hbs	hbs	PROPN
cuesj-183	8	57	-	-	PUNCT
cuesj-183	8	58	ab	ab	PROPN
cuesj-183	8	59	.	.	PUNCT
cuesj-183	9	1	the	the	DET
cuesj-183	9	2	diagnosis	diagnosis	NOUN
cuesj-183	9	3	of	of	ADP
cuesj-183	9	4	obi	obi	PROPN
cuesj-183	9	5	could	could	AUX
cuesj-183	9	6	be	be	AUX
cuesj-183	9	7	confirmed	confirm	VERB
cuesj-183	9	8	by	by	ADP
cuesj-183	9	9	rt	rt	PROPN
cuesj-183	9	10	-	-	PUNCT
cuesj-183	9	11	pcr	pcr	PROPN
cuesj-183	9	12	in	in	ADP
cuesj-183	9	13	8	8	NUM
cuesj-183	9	14	 	 	SPACE
cuesj-183	9	15	samples	sample	NOUN
cuesj-183	9	16	,	,	PUNCT
cuesj-183	9	17	33	33	NUM
cuesj-183	9	18	%	%	NOUN
cuesj-183	9	19	of	of	ADP
cuesj-183	9	20	samples	sample	NOUN
cuesj-183	9	21	.	.	PUNCT
cuesj-183	10	1	the	the	DET
cuesj-183	10	2	overall	overall	ADJ
cuesj-183	10	3	incidence	incidence	NOUN
cuesj-183	10	4	of	of	ADP
cuesj-183	10	5	hbv	hbv	NOUN
cuesj-183	10	6	and	and	CCONJ
cuesj-183	10	7	hcv	hcv	PROPN
cuesj-183	10	8	among	among	ADP
cuesj-183	10	9	examined	examine	VERB
cuesj-183	10	10	blood	blood	NOUN
cuesj-183	10	11	donors	donor	NOUN
cuesj-183	10	12	was	be	AUX
cuesj-183	10	13	0.5	0.5	NUM
cuesj-183	10	14	%	%	NOUN
cuesj-183	10	15	,	,	PUNCT
cuesj-183	10	16	and	and	CCONJ
cuesj-183	10	17	0.06	0.06	NUM
cuesj-183	10	18	%	%	NOUN
cuesj-183	10	19	,	,	PUNCT
cuesj-183	10	20	respectively	respectively	ADV
cuesj-183	10	21	.	.	PUNCT
cuesj-183	11	1	amidst	amidst	ADP
cuesj-183	11	2	that	that	DET
cuesj-183	11	3	incidence	incidence	NOUN
cuesj-183	11	4	,	,	PUNCT
cuesj-183	11	5	0.39	0.39	NUM
cuesj-183	11	6	%	%	NOUN
cuesj-183	11	7	were	be	AUX
cuesj-183	11	8	diagnosed	diagnose	VERB
cuesj-183	11	9	as	as	ADP
cuesj-183	11	10	obi	obi	PROPN
cuesj-183	11	11	.	.	PUNCT
cuesj-183	11	12	to	to	PART
cuesj-183	11	13	prevent	prevent	VERB
cuesj-183	11	14	viral	viral	ADJ
cuesj-183	11	15	transmission	transmission	NOUN
cuesj-183	11	16	through	through	ADP
cuesj-183	11	17	blood	blood	NOUN
cuesj-183	11	18	transfusion	transfusion	NOUN
cuesj-183	11	19	is	be	AUX
cuesj-183	11	20	needed	need	VERB
cuesj-183	11	21	to	to	PART
cuesj-183	11	22	combine	combine	VERB
cuesj-183	11	23	a	a	DET
cuesj-183	11	24	different	different	ADJ
cuesj-183	11	25	and	and	CCONJ
cuesj-183	11	26	sensitive	sensitive	ADJ
cuesj-183	11	27	method	method	NOUN
cuesj-183	11	28	for	for	ADP
cuesj-183	11	29	hbv	hbv	NOUN
cuesj-183	11	30	detection	detection	NOUN
cuesj-183	11	31	as	as	ADV
cuesj-183	11	32	well	well	ADV
cuesj-183	11	33	as	as	ADP
cuesj-183	11	34	evolve	evolve	VERB
cuesj-183	11	35	tests	test	NOUN
cuesj-183	11	36	that	that	PRON
cuesj-183	11	37	have	have	VERB
cuesj-183	11	38	high	high	ADJ
cuesj-183	11	39	sensitivity	sensitivity	NOUN
cuesj-183	11	40	and	and	CCONJ
cuesj-183	11	41	specificity	specificity	NOUN
cuesj-183	11	42	for	for	ADP
cuesj-183	11	43	serological	serological	ADJ
cuesj-183	11	44	markers	marker	NOUN
cuesj-183	11	45	.	.	PUNCT
cuesj-183	12	1	moreover	moreover	ADV
cuesj-183	12	2	,	,	PUNCT
cuesj-183	12	3	a	a	DET
cuesj-183	12	4	molecular	molecular	ADJ
cuesj-183	12	5	tool	tool	NOUN
cuesj-183	12	6	that	that	PRON
cuesj-183	12	7	is	be	AUX
cuesj-183	12	8	sensitive	sensitive	ADJ
cuesj-183	12	9	enough	enough	ADV
cuesj-183	12	10	to	to	PART
cuesj-183	12	11	detect	detect	VERB
cuesj-183	12	12	very	very	ADV
cuesj-183	12	13	low	low	ADJ
cuesj-183	12	14	copies	copy	NOUN
cuesj-183	12	15	of	of	ADP
cuesj-183	12	16	viral	viral	ADJ
cuesj-183	12	17	dna	dna	NOUN
cuesj-183	12	18	must	must	AUX
cuesj-183	12	19	also	also	ADV
cuesj-183	12	20	be	be	AUX
cuesj-183	12	21	developed	develop	VERB
cuesj-183	12	22	.	.	PUNCT
cuesj-183	13	1	keywords	keyword	NOUN
cuesj-183	13	2	:	:	PUNCT
cuesj-183	13	3	blood	blood	NOUN
cuesj-183	13	4	donors	donor	NOUN
cuesj-183	13	5	,	,	PUNCT
cuesj-183	13	6	hepatitis	hepatitis	PROPN
cuesj-183	13	7	b	b	PROPN
cuesj-183	13	8	surface	surface	NOUN
cuesj-183	13	9	antigen	antigen	ADV
cuesj-183	13	10	,	,	PUNCT
cuesj-183	13	11	hepatitis	hepatitis	PROPN
cuesj-183	13	12	b	b	PROPN
cuesj-183	13	13	surface	surface	NOUN
cuesj-183	13	14	antibody	antibody	NOUN
cuesj-183	13	15	,	,	PUNCT
cuesj-183	13	16	hepatitis	hepatitis	NOUN
cuesj-183	13	17	b	b	PROPN
cuesj-183	13	18	,	,	PUNCT
cuesj-183	13	19	hepatitis	hepatitis	PROPN
cuesj-183	13	20	c	c	NOUN
cuesj-183	13	21	introduction	introduction	NOUN
cuesj-183	13	22	infections	infection	NOUN
cuesj-183	13	23	with	with	ADP
cuesj-183	13	24	hepatitis	hepatitis	PROPN
cuesj-183	13	25	b	b	PROPN
cuesj-183	13	26	virus	virus	NOUN
cuesj-183	13	27	(	(	PUNCT
cuesj-183	13	28	hbv	hbv	NOUN
cuesj-183	13	29	)	)	PUNCT
cuesj-183	13	30	and	and	CCONJ
cuesj-183	13	31	hepatitis	hepatitis	PROPN
cuesj-183	13	32	c	c	PROPN
cuesj-183	13	33	viruses	virus	NOUN
cuesj-183	13	34	(	(	PUNCT
cuesj-183	13	35	hcv	hcv	NOUN
cuesj-183	13	36	)	)	PUNCT
cuesj-183	13	37	are	be	AUX
cuesj-183	13	38	major	major	ADJ
cuesj-183	13	39	global	global	ADJ
cuesj-183	13	40	health	health	NOUN
cuesj-183	13	41	problems	problem	NOUN
cuesj-183	13	42	worldwide	worldwide	ADV
cuesj-183	13	43	:	:	PUNCT
cuesj-183	13	44	it	it	PRON
cuesj-183	13	45	is	be	AUX
cuesj-183	13	46	predictable	predictable	ADJ
cuesj-183	13	47	that	that	SCONJ
cuesj-183	13	48	about	about	ADV
cuesj-183	13	49	350	350	NUM
cuesj-183	13	50	million	million	NUM
cuesj-183	13	51	persons	person	NOUN
cuesj-183	13	52	are	be	AUX
cuesj-183	13	53	chronically	chronically	ADV
cuesj-183	13	54	infected	infect	VERB
cuesj-183	13	55	with	with	ADP
cuesj-183	13	56	hbv	hbv	NOUN
cuesj-183	13	57	,	,	PUNCT
cuesj-183	13	58	and	and	CCONJ
cuesj-183	13	59	nearly	nearly	ADV
cuesj-183	13	60	200	200	NUM
cuesj-183	13	61	million	million	NUM
cuesj-183	13	62	people	people	NOUN
cuesj-183	13	63	are	be	AUX
cuesj-183	13	64	infected	infect	VERB
cuesj-183	13	65	with	with	ADP
cuesj-183	13	66	hcv	hcv	PROPN
cuesj-183	13	67	worldwide	worldwide	ADV
cuesj-183	13	68	.	.	PUNCT
cuesj-183	14	1	both	both	DET
cuesj-183	14	2	hepatitis	hepatitis	PROPN
cuesj-183	14	3	b	b	PROPN
cuesj-183	14	4	and	and	CCONJ
cuesj-183	14	5	hepatitis	hepatitis	PROPN
cuesj-183	14	6	c	c	PROPN
cuesj-183	14	7	are	be	AUX
cuesj-183	14	8	among	among	ADP
cuesj-183	14	9	common	common	ADJ
cuesj-183	14	10	infectious	infectious	ADJ
cuesj-183	14	11	liver	liver	NOUN
cuesj-183	14	12	diseases	disease	NOUN
cuesj-183	14	13	worldwide.[1	worldwide.[1	ADJ
cuesj-183	14	14	]	]	X
cuesj-183	14	15	viral	viral	ADJ
cuesj-183	14	16	hepatitis	hepatitis	NOUN
cuesj-183	14	17	is	be	AUX
cuesj-183	14	18	a	a	DET
cuesj-183	14	19	systemic	systemic	ADJ
cuesj-183	14	20	disease	disease	NOUN
cuesj-183	14	21	primarily	primarily	ADV
cuesj-183	14	22	affecting	affect	VERB
cuesj-183	14	23	the	the	DET
cuesj-183	14	24	liver	liver	NOUN
cuesj-183	14	25	,	,	PUNCT
cuesj-183	14	26	which	which	PRON
cuesj-183	14	27	induces	induce	VERB
cuesj-183	14	28	acute	acute	ADJ
cuesj-183	14	29	inflammation	inflammation	NOUN
cuesj-183	14	30	of	of	ADP
cuesj-183	14	31	the	the	DET
cuesj-183	14	32	liver	liver	NOUN
cuesj-183	14	33	,	,	PUNCT
cuesj-183	14	34	resulting	result	VERB
cuesj-183	14	35	in	in	ADP
cuesj-183	14	36	a	a	DET
cuesj-183	14	37	clinical	clinical	ADJ
cuesj-183	14	38	illness	illness	NOUN
cuesj-183	14	39	characterized	characterize	VERB
cuesj-183	14	40	by	by	ADP
cuesj-183	14	41	fever	fever	NOUN
cuesj-183	14	42	,	,	PUNCT
cuesj-183	14	43	gastrointestinal	gastrointestinal	ADJ
cuesj-183	14	44	symptoms	symptom	NOUN
cuesj-183	14	45	such	such	ADJ
cuesj-183	14	46	as	as	ADP
cuesj-183	14	47	nausea	nausea	NOUN
cuesj-183	14	48	,	,	PUNCT
cuesj-183	14	49	vomiting	vomiting	NOUN
cuesj-183	14	50	,	,	PUNCT
cuesj-183	14	51	and	and	CCONJ
cuesj-183	14	52	jaundice	jaundice	NOUN
cuesj-183	14	53	.	.	PUNCT
cuesj-183	15	1	regardless	regardless	ADV
cuesj-183	15	2	of	of	ADP
cuesj-183	15	3	the	the	DET
cuesj-183	15	4	virus	virus	NOUN
cuesj-183	15	5	type	type	NOUN
cuesj-183	15	6	,	,	PUNCT
cuesj-183	15	7	identical	identical	ADJ
cuesj-183	15	8	histopathologic	histopathologic	ADJ
cuesj-183	15	9	lesions	lesion	NOUN
cuesj-183	15	10	are	be	AUX
cuesj-183	15	11	observed	observe	VERB
cuesj-183	15	12	in	in	ADP
cuesj-183	15	13	the	the	DET
cuesj-183	15	14	liver	liver	NOUN
cuesj-183	15	15	during	during	ADP
cuesj-183	15	16	acute	acute	NOUN
cuesj-183	15	17	disease.[2	disease.[2	NOUN
cuesj-183	15	18	]	]	PUNCT
cuesj-183	15	19	both	both	CCONJ
cuesj-183	15	20	hbv	hbv	NOUN
cuesj-183	15	21	and	and	CCONJ
cuesj-183	15	22	hcv	hcv	NOUN
cuesj-183	15	23	infections	infection	NOUN
cuesj-183	15	24	are	be	AUX
cuesj-183	15	25	known	know	VERB
cuesj-183	15	26	for	for	ADP
cuesj-183	15	27	their	their	PRON
cuesj-183	15	28	parenteral	parenteral	ADJ
cuesj-183	15	29	transmission	transmission	NOUN
cuesj-183	15	30	;	;	PUNCT
cuesj-183	15	31	therefore	therefore	ADV
cuesj-183	15	32	,	,	PUNCT
cuesj-183	15	33	blood	blood	NOUN
cuesj-183	15	34	transfusion	transfusion	NOUN
cuesj-183	15	35	is	be	AUX
cuesj-183	15	36	a	a	DET
cuesj-183	15	37	potential	potential	ADJ
cuesj-183	15	38	route	route	NOUN
cuesj-183	15	39	of	of	ADP
cuesj-183	15	40	transmission.[3,4	transmission.[3,4	NOUN
cuesj-183	15	41	]	]	X
cuesj-183	15	42	the	the	DET
cuesj-183	15	43	risk	risk	NOUN
cuesj-183	15	44	of	of	ADP
cuesj-183	15	45	infection	infection	NOUN
cuesj-183	15	46	with	with	ADP
cuesj-183	15	47	transfusion	transfusion	NOUN
cuesj-183	15	48	-	-	PUNCT
cuesj-183	15	49	transmitted	transmit	VERB
cuesj-183	15	50	viruses	virus	NOUN
cuesj-183	15	51	has	have	AUX
cuesj-183	15	52	been	be	AUX
cuesj-183	15	53	reduced	reduce	VERB
cuesj-183	15	54	remarkably	remarkably	ADV
cuesj-183	15	55	since	since	SCONJ
cuesj-183	15	56	the	the	DET
cuesj-183	15	57	introduction	introduction	NOUN
cuesj-183	15	58	of	of	ADP
cuesj-183	15	59	serological	serological	ADJ
cuesj-183	15	60	screening	screening	NOUN
cuesj-183	15	61	;	;	PUNCT
cuesj-183	15	62	on	on	ADP
cuesj-183	15	63	the	the	DET
cuesj-183	15	64	other	other	ADJ
cuesj-183	15	65	hand	hand	NOUN
cuesj-183	15	66	,	,	PUNCT
cuesj-183	15	67	a	a	DET
cuesj-183	15	68	zero	zero	NUM
cuesj-183	15	69	-	-	PUNCT
cuesj-183	15	70	risk	risk	NOUN
cuesj-183	15	71	blood	blood	NOUN
cuesj-183	15	72	supply	supply	NOUN
cuesj-183	15	73	remains	remain	VERB
cuesj-183	15	74	the	the	DET
cuesj-183	15	75	ideal	ideal	ADJ
cuesj-183	15	76	aim.[5	aim.[5	NOUN
cuesj-183	15	77	]	]	X
cuesj-183	15	78	the	the	DET
cuesj-183	15	79	risk	risk	NOUN
cuesj-183	15	80	of	of	ADP
cuesj-183	15	81	transfusion	transfusion	NOUN
cuesj-183	15	82	-	-	PUNCT
cuesj-183	15	83	transmitted	transmit	VERB
cuesj-183	15	84	hbv	hbv	NOUN
cuesj-183	15	85	infection	infection	NOUN
cuesj-183	15	86	has	have	AUX
cuesj-183	15	87	been	be	AUX
cuesj-183	15	88	reduced	reduce	VERB
cuesj-183	15	89	by	by	ADP
cuesj-183	15	90	screening	screen	VERB
cuesj-183	15	91	all	all	DET
cuesj-183	15	92	blood	blood	NOUN
cuesj-183	15	93	donations	donation	NOUN
cuesj-183	15	94	for	for	ADP
cuesj-183	15	95	hepatitis	hepatitis	PROPN
cuesj-183	15	96	b	b	PROPN
cuesj-183	15	97	surface	surface	NOUN
cuesj-183	15	98	antigen	antigen	NOUN
cuesj-183	15	99	(	(	PUNCT
cuesj-183	15	100	hbs	hbs	PROPN
cuesj-183	15	101	-	-	PUNCT
cuesj-183	15	102	ag	ag	PROPN
cuesj-183	15	103	)	)	PUNCT
cuesj-183	15	104	since	since	SCONJ
cuesj-183	15	105	1970	1970	NUM
cuesj-183	15	106	,	,	PUNCT
cuesj-183	15	107	screening	screen	VERB
cuesj-183	15	108	for	for	ADP
cuesj-183	15	109	hbs	hbs	PROPN
cuesj-183	15	110	-	-	PUNCT
cuesj-183	15	111	ag	ag	PROPN
cuesj-183	15	112	is	be	AUX
cuesj-183	15	113	still	still	ADV
cuesj-183	15	114	regarded	regard	VERB
cuesj-183	15	115	as	as	ADP
cuesj-183	15	116	an	an	DET
cuesj-183	15	117	important	important	ADJ
cuesj-183	15	118	tool	tool	NOUN
cuesj-183	15	119	for	for	ADP
cuesj-183	15	120	blood	blood	NOUN
cuesj-183	15	121	screening	screening	NOUN
cuesj-183	15	122	by	by	ADP
cuesj-183	15	123	the	the	DET
cuesj-183	15	124	world	world	PROPN
cuesj-183	15	125	health	health	PROPN
cuesj-183	15	126	organization	organization	NOUN
cuesj-183	15	127	(	(	PUNCT
cuesj-183	15	128	who).[6	who).[6	PROPN
cuesj-183	15	129	]	]	X
cuesj-183	15	130	it	it	PRON
cuesj-183	15	131	was	be	AUX
cuesj-183	15	132	accepted	accept	VERB
cuesj-183	15	133	that	that	SCONJ
cuesj-183	15	134	the	the	DET
cuesj-183	15	135	disappearance	disappearance	NOUN
cuesj-183	15	136	of	of	ADP
cuesj-183	15	137	hbs	hbs	PROPN
cuesj-183	15	138	-	-	PUNCT
cuesj-183	15	139	ag	ag	PROPN
cuesj-183	15	140	indicates	indicate	VERB
cuesj-183	15	141	the	the	DET
cuesj-183	15	142	clearance	clearance	NOUN
cuesj-183	15	143	of	of	ADP
cuesj-183	15	144	hbv	hbv	NOUN
cuesj-183	15	145	.	.	PUNCT
cuesj-183	16	1	meanwhile	meanwhile	ADV
cuesj-183	16	2	,	,	PUNCT
cuesj-183	16	3	many	many	ADJ
cuesj-183	16	4	reports	report	NOUN
cuesj-183	16	5	pointed	point	VERB
cuesj-183	16	6	to	to	ADP
cuesj-183	16	7	the	the	DET
cuesj-183	16	8	occurrence	occurrence	NOUN
cuesj-183	16	9	of	of	ADP
cuesj-183	16	10	post	post	ADJ
cuesj-183	16	11	-	-	ADJ
cuesj-183	16	12	transfusion	transfusion	ADJ
cuesj-183	16	13	hepatitis	hepatitis	PROPN
cuesj-183	16	14	b	b	PROPN
cuesj-183	16	15	despite	despite	SCONJ
cuesj-183	16	16	the	the	DET
cuesj-183	16	17	screening	screening	NOUN
cuesj-183	16	18	for	for	ADP
cuesj-183	16	19	hbs	hbs	PROPN
cuesj-183	16	20	-	-	PUNCT
cuesj-183	16	21	ag	ag	PROPN
cuesj-183	16	22	,	,	PUNCT
cuesj-183	16	23	necessitating	necessitate	VERB
cuesj-183	16	24	the	the	DET
cuesj-183	16	25	use	use	NOUN
cuesj-183	16	26	of	of	ADP
cuesj-183	16	27	other	other	ADJ
cuesj-183	16	28	markers	marker	NOUN
cuesj-183	16	29	for	for	ADP
cuesj-183	16	30	viral	viral	ADJ
cuesj-183	16	31	screening	screening	NOUN
cuesj-183	16	32	.	.	PUNCT
cuesj-183	17	1	for	for	ADP
cuesj-183	17	2	this	this	PRON
cuesj-183	17	3	,	,	PUNCT
cuesj-183	17	4	screening	screen	VERB
cuesj-183	17	5	for	for	ADP
cuesj-183	17	6	hbc	hbc	PROPN
cuesj-183	17	7	-	-	PUNCT
cuesj-183	17	8	ab	ab	PROPN
cuesj-183	17	9	was	be	AUX
cuesj-183	17	10	recommended	recommend	VERB
cuesj-183	17	11	by	by	ADP
cuesj-183	17	12	the	the	DET
cuesj-183	17	13	german	german	ADJ
cuesj-183	17	14	advisory	advisory	ADJ
cuesj-183	17	15	committee	committee	NOUN
cuesj-183	17	16	blood	blood	NOUN
cuesj-183	17	17	in	in	ADP
cuesj-183	17	18	march	march	PROPN
cuesj-183	17	19	2005	2005	NUM
cuesj-183	17	20	,	,	PUNCT
cuesj-183	17	21	especially	especially	ADV
cuesj-183	17	22	for	for	ADP
cuesj-183	17	23	areas	area	NOUN
cuesj-183	17	24	with	with	ADP
cuesj-183	17	25	low	low	ADJ
cuesj-183	17	26	hbv	hbv	NOUN
cuesj-183	17	27	prevalence.[7,8	prevalence.[7,8	NOUN
cuesj-183	17	28	]	]	PUNCT
cuesj-183	17	29	recently	recently	ADV
cuesj-183	17	30	in	in	ADP
cuesj-183	17	31	the	the	DET
cuesj-183	17	32	major	major	ADJ
cuesj-183	17	33	blood	blood	NOUN
cuesj-183	17	34	bank	bank	NOUN
cuesj-183	17	35	of	of	ADP
cuesj-183	17	36	erbil	erbil	PROPN
cuesj-183	17	37	,	,	PUNCT
cuesj-183	17	38	hbc	hbc	PROPN
cuesj-183	17	39	-	-	PUNCT
cuesj-183	17	40	ab	ab	PROPN
cuesj-183	17	41	screening	screening	NOUN
cuesj-183	17	42	has	have	AUX
cuesj-183	17	43	also	also	ADV
cuesj-183	17	44	been	be	AUX
cuesj-183	17	45	performed	perform	VERB
cuesj-183	17	46	for	for	ADP
cuesj-183	17	47	all	all	DET
cuesj-183	17	48	blood	blood	NOUN
cuesj-183	17	49	donors	donor	NOUN
cuesj-183	17	50	.	.	PUNCT
cuesj-183	18	1	the	the	DET
cuesj-183	18	2	donated	donate	VERB
cuesj-183	18	3	blood	blood	NOUN
cuesj-183	18	4	with	with	ADP
cuesj-183	18	5	negative	negative	ADJ
cuesj-183	18	6	hbs	hbs	PROPN
cuesj-183	18	7	-	-	PUNCT
cuesj-183	18	8	ag	ag	PROPN
cuesj-183	18	9	but	but	CCONJ
cuesj-183	18	10	positive	positive	ADJ
cuesj-183	18	11	hbc	hbc	PROPN
cuesj-183	18	12	-	-	PUNCT
cuesj-183	18	13	ab	ab	PROPN
cuesj-183	18	14	will	will	AUX
cuesj-183	18	15	be	be	AUX
cuesj-183	18	16	corresponding	corresponding	ADJ
cuesj-183	18	17	author	author	NOUN
cuesj-183	18	18	:	:	PUNCT
cuesj-183	18	19	chato	chato	PROPN
cuesj-183	18	20	a.	a.	PROPN
cuesj-183	18	21	taher	taher	PROPN
cuesj-183	18	22	,	,	PUNCT
cuesj-183	18	23	department	department	NOUN
cuesj-183	18	24	of	of	ADP
cuesj-183	18	25	basic	basic	ADJ
cuesj-183	18	26	science	science	NOUN
cuesj-183	18	27	,	,	PUNCT
cuesj-183	18	28	microbiology	microbiology	NOUN
cuesj-183	18	29	unit	unit	NOUN
cuesj-183	18	30	,	,	PUNCT
cuesj-183	18	31	college	college	NOUN
cuesj-183	18	32	of	of	ADP
cuesj-183	18	33	medicine	medicine	NOUN
cuesj-183	18	34	,	,	PUNCT
cuesj-183	18	35	hawler	hawler	PROPN
cuesj-183	18	36	medical	medical	PROPN
cuesj-183	18	37	university	university	PROPN
cuesj-183	18	38	,	,	PUNCT
cuesj-183	18	39	erbil	erbil	PROPN
cuesj-183	18	40	,	,	PUNCT
cuesj-183	18	41	kurdistan	kurdistan	PROPN
cuesj-183	18	42	region	region	NOUN
cuesj-183	18	43	,	,	PUNCT
cuesj-183	18	44	iraq	iraq	PROPN
cuesj-183	18	45	.	.	PUNCT
cuesj-183	19	1	e	e	X
cuesj-183	19	2	-	-	NOUN
cuesj-183	19	3	mail	mail	NOUN
cuesj-183	19	4	:	:	PUNCT
cuesj-183	19	5	chato.taher@gmail.com	chato.taher@gmail.com	X
cuesj-183	19	6	received	receive	VERB
cuesj-183	19	7	:	:	PUNCT
cuesj-183	19	8	apr	apr	NOUN
cuesj-183	19	9	16	16	NUM
cuesj-183	19	10	,	,	PUNCT
cuesj-183	19	11	2019	2019	NUM
cuesj-183	19	12	accepted	accept	VERB
cuesj-183	19	13	:	:	PUNCT
cuesj-183	19	14	apr	apr	NOUN
cuesj-183	19	15	27	27	NUM
cuesj-183	19	16	,	,	PUNCT
cuesj-183	19	17	2019	2019	NUM
cuesj-183	19	18	published	publish	VERB
cuesj-183	19	19	:	:	PUNCT
cuesj-183	19	20	jan	jan	PROPN
cuesj-183	19	21	20	20	NUM
cuesj-183	19	22	,	,	PUNCT
cuesj-183	19	23	2020	2020	NUM
cuesj-183	19	24	doi	doi	NOUN
cuesj-183	19	25	:	:	PUNCT
cuesj-183	19	26	10.24086	10.24086	NUM
cuesj-183	19	27	/	/	SYM
cuesj-183	19	28	cuesj.v4n1y2020.pp45	cuesj.v4n1y2020.pp45	PROPN
cuesj-183	19	29	-	-	SYM
cuesj-183	19	30	51	51	NUM
cuesj-183	19	31	copyright	copyright	NOUN
cuesj-183	19	32	©	©	PROPN
cuesj-183	19	33	2020	2020	NUM
cuesj-183	19	34	goran	goran	PROPN
cuesj-183	19	35	n.	n.	PROPN
cuesj-183	19	36	saleh	saleh	PROPN
cuesj-183	19	37	,	,	PUNCT
cuesj-183	19	38	chato	chato	PROPN
cuesj-183	19	39	a.	a.	PROPN
cuesj-183	19	40	taher	taher	PROPN
cuesj-183	19	41	.	.	PUNCT
cuesj-183	20	1	this	this	PRON
cuesj-183	20	2	is	be	AUX
cuesj-183	20	3	an	an	DET
cuesj-183	20	4	open	open	ADJ
cuesj-183	20	5	-	-	PUNCT
cuesj-183	20	6	access	access	NOUN
cuesj-183	20	7	article	article	NOUN
cuesj-183	20	8	distributed	distribute	VERB
cuesj-183	20	9	under	under	ADP
cuesj-183	20	10	the	the	DET
cuesj-183	20	11	creative	creative	ADJ
cuesj-183	20	12	commons	common	NOUN
cuesj-183	20	13	attribution	attribution	NOUN
cuesj-183	20	14	license	license	NOUN
cuesj-183	20	15	.	.	PUNCT
cuesj-183	21	1	cihan	cihan	VERB
cuesj-183	21	2	university	university	NOUN
cuesj-183	21	3	-	-	PUNCT
cuesj-183	21	4	erbil	erbil	PROPN
cuesj-183	21	5	scientific	scientific	ADJ
cuesj-183	21	6	journal	journal	NOUN
cuesj-183	21	7	(	(	PUNCT
cuesj-183	21	8	cuesj	cuesj	PROPN
cuesj-183	21	9	)	)	PUNCT
cuesj-183	21	10	https://creativecommons.org/licenses/by-nc-nd/4.0/	https://creativecommons.org/licenses/by-nc-nd/4.0/	PROPN
cuesj-183	21	11	saleh	saleh	NOUN
cuesj-183	21	12	and	and	CCONJ
cuesj-183	21	13	taher	taher	PROPN
cuesj-183	21	14	:	:	PUNCT
cuesj-183	21	15	prevalence	prevalence	NOUN
cuesj-183	21	16	of	of	ADP
cuesj-183	21	17	hepatitis	hepatitis	PROPN
cuesj-183	21	18	b	b	PROPN
cuesj-183	21	19	and	and	CCONJ
cuesj-183	21	20	hepatitis	hepatitis	PROPN
cuesj-183	21	21	c	c	NOUN
cuesj-183	21	22	infection	infection	NOUN
cuesj-183	21	23	in	in	ADP
cuesj-183	21	24	erbil	erbil	PROPN
cuesj-183	21	25	46	46	NUM
cuesj-183	21	26	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-183	21	27	cuesj	cuesj	NOUN
cuesj-183	21	28	2020	2020	NUM
cuesj-183	21	29	,	,	PUNCT
cuesj-183	21	30	4	4	NUM
cuesj-183	21	31	(	(	PUNCT
cuesj-183	21	32	1	1	NUM
cuesj-183	21	33	):	):	PUNCT
cuesj-183	21	34	45	45	NUM
cuesj-183	21	35	-	-	SYM
cuesj-183	21	36	51	51	NUM
cuesj-183	21	37	discarded	discard	VERB
cuesj-183	21	38	,	,	PUNCT
cuesj-183	21	39	these	these	DET
cuesj-183	21	40	groups	group	NOUN
cuesj-183	21	41	of	of	ADP
cuesj-183	21	42	blood	blood	NOUN
cuesj-183	21	43	donors	donor	NOUN
cuesj-183	21	44	are	be	AUX
cuesj-183	21	45	either	either	ADV
cuesj-183	21	46	infected	infected	ADJ
cuesj-183	21	47	but	but	CCONJ
cuesj-183	21	48	have	have	AUX
cuesj-183	21	49	been	be	AUX
cuesj-183	21	50	cured	cure	VERB
cuesj-183	21	51	of	of	ADP
cuesj-183	21	52	the	the	DET
cuesj-183	21	53	diseases	disease	NOUN
cuesj-183	21	54	,	,	PUNCT
cuesj-183	21	55	or	or	CCONJ
cuesj-183	21	56	else	else	ADV
cuesj-183	21	57	the	the	DET
cuesj-183	21	58	donor	donor	NOUN
cuesj-183	21	59	is	be	AUX
cuesj-183	21	60	still	still	ADV
cuesj-183	21	61	infected	infect	VERB
cuesj-183	21	62	with	with	ADP
cuesj-183	21	63	hbv	hbv	NOUN
cuesj-183	21	64	that	that	PRON
cuesj-183	21	65	can	can	AUX
cuesj-183	21	66	be	be	AUX
cuesj-183	21	67	further	far	ADV
cuesj-183	21	68	confirmed	confirm	VERB
cuesj-183	21	69	and	and	CCONJ
cuesj-183	21	70	need	need	VERB
cuesj-183	21	71	to	to	PART
cuesj-183	21	72	be	be	AUX
cuesj-183	21	73	further	far	ADV
cuesj-183	21	74	analyzed	analyze	VERB
cuesj-183	21	75	both	both	CCONJ
cuesj-183	21	76	serologically	serologically	ADV
cuesj-183	21	77	and	and	CCONJ
cuesj-183	21	78	by	by	ADP
cuesj-183	21	79	molecular	molecular	ADJ
cuesj-183	21	80	detection	detection	NOUN
cuesj-183	21	81	using	use	VERB
cuesj-183	21	82	polymerase	polymerase	NOUN
cuesj-183	21	83	chain	chain	NOUN
cuesj-183	21	84	reaction	reaction	NOUN
cuesj-183	21	85	(	(	PUNCT
cuesj-183	21	86	pcr).[9	pcr).[9	X
cuesj-183	21	87	]	]	PUNCT
cuesj-183	21	88	the	the	DET
cuesj-183	21	89	blood	blood	NOUN
cuesj-183	21	90	donors	donor	NOUN
cuesj-183	21	91	with	with	ADP
cuesj-183	21	92	hbs	hbs	PROPN
cuesj-183	21	93	-	-	PUNCT
cuesj-183	21	94	ag	ag	PROPN
cuesj-183	21	95	negative	negative	ADJ
cuesj-183	21	96	serology	serology	NOUN
cuesj-183	21	97	,	,	PUNCT
cuesj-183	21	98	hbc	hbc	NOUN
cuesj-183	21	99	-	-	PUNCT
cuesj-183	21	100	abs	ab	NOUN
cuesj-183	21	101	positive	positive	ADJ
cuesj-183	21	102	or	or	CCONJ
cuesj-183	21	103	negative	negative	ADJ
cuesj-183	21	104	and	and	CCONJ
cuesj-183	21	105	the	the	DET
cuesj-183	21	106	presence	presence	NOUN
cuesj-183	21	107	of	of	ADP
cuesj-183	21	108	viral	viral	ADJ
cuesj-183	21	109	dna	dna	NOUN
cuesj-183	21	110	by	by	ADP
cuesj-183	21	111	pcr	pcr	PROPN
cuesj-183	21	112	are	be	AUX
cuesj-183	21	113	known	know	VERB
cuesj-183	21	114	as	as	ADP
cuesj-183	21	115	occult	occult	NOUN
cuesj-183	21	116	hbv	hbv	NOUN
cuesj-183	21	117	infected	infect	VERB
cuesj-183	21	118	occult	occult	NOUN
cuesj-183	21	119	hepatitis	hepatitis	PROPN
cuesj-183	21	120	b	b	PROPN
cuesj-183	21	121	infection	infection	NOUN
cuesj-183	21	122	(	(	PUNCT
cuesj-183	21	123	obi	obi	PROPN
cuesj-183	21	124	)	)	PUNCT
cuesj-183	21	125	.	.	PUNCT
cuesj-183	22	1	obi	obi	PROPN
cuesj-183	22	2	is	be	AUX
cuesj-183	22	3	a	a	DET
cuesj-183	22	4	risky	risky	ADJ
cuesj-183	22	5	group	group	NOUN
cuesj-183	22	6	playing	play	VERB
cuesj-183	22	7	an	an	DET
cuesj-183	22	8	important	important	ADJ
cuesj-183	22	9	role	role	NOUN
cuesj-183	22	10	in	in	ADP
cuesj-183	22	11	hepatitis	hepatitis	PROPN
cuesj-183	22	12	virus	virus	NOUN
cuesj-183	22	13	transmission	transmission	NOUN
cuesj-183	22	14	by	by	ADP
cuesj-183	22	15	blood	blood	NOUN
cuesj-183	22	16	transfusion.[10	transfusion.[10	NUM
cuesj-183	22	17	]	]	PUNCT
cuesj-183	22	18	regarding	regard	VERB
cuesj-183	22	19	the	the	DET
cuesj-183	22	20	hbv	hbv	NOUN
cuesj-183	22	21	prevalence	prevalence	NOUN
cuesj-183	22	22	in	in	ADP
cuesj-183	22	23	the	the	DET
cuesj-183	22	24	world	world	NOUN
cuesj-183	22	25	could	could	AUX
cuesj-183	22	26	be	be	AUX
cuesj-183	22	27	divided	divide	VERB
cuesj-183	22	28	into	into	ADP
cuesj-183	22	29	three	three	NUM
cuesj-183	22	30	areas	area	NOUN
cuesj-183	22	31	where	where	SCONJ
cuesj-183	22	32	the	the	DET
cuesj-183	22	33	prevalence	prevalence	NOUN
cuesj-183	22	34	of	of	ADP
cuesj-183	22	35	chronic	chronic	ADJ
cuesj-183	22	36	hbv	hbv	NOUN
cuesj-183	22	37	infection	infection	NOUN
cuesj-183	22	38	is	be	AUX
cuesj-183	22	39	high	high	ADJ
cuesj-183	22	40	(	(	PUNCT
cuesj-183	22	41	>	>	SYM
cuesj-183	22	42	8	8	NUM
cuesj-183	22	43	%	%	NOUN
cuesj-183	22	44	)	)	PUNCT
cuesj-183	22	45	,	,	PUNCT
cuesj-183	22	46	intermediate	intermediate	ADJ
cuesj-183	22	47	(	(	PUNCT
cuesj-183	22	48	between	between	ADP
cuesj-183	22	49	2	2	NUM
cuesj-183	22	50	and	and	CCONJ
cuesj-183	22	51	8	8	NUM
cuesj-183	22	52	%	%	NOUN
cuesj-183	22	53	)	)	PUNCT
cuesj-183	22	54	,	,	PUNCT
cuesj-183	22	55	and	and	CCONJ
cuesj-183	22	56	low	low	ADJ
cuesj-183	22	57	(	(	PUNCT
cuesj-183	22	58	<	<	X
cuesj-183	22	59	2%).[11	2%).[11	NUM
cuesj-183	22	60	]	]	PUNCT
cuesj-183	22	61	infection	infection	NOUN
cuesj-183	22	62	with	with	ADP
cuesj-183	22	63	hepatitis	hepatitis	PROPN
cuesj-183	22	64	b	b	PROPN
cuesj-183	22	65	and	and	CCONJ
cuesj-183	22	66	c	c	PROPN
cuesj-183	22	67	is	be	AUX
cuesj-183	22	68	regarded	regard	VERB
cuesj-183	22	69	as	as	ADP
cuesj-183	22	70	a	a	DET
cuesj-183	22	71	major	major	ADJ
cuesj-183	22	72	cause	cause	NOUN
cuesj-183	22	73	of	of	ADP
cuesj-183	22	74	liver	liver	NOUN
cuesj-183	22	75	cirrhosis	cirrhosis	NOUN
cuesj-183	22	76	and	and	CCONJ
cuesj-183	22	77	hepatocellular	hepatocellular	ADJ
cuesj-183	22	78	carcinoma	carcinoma	NOUN
cuesj-183	22	79	.	.	PUNCT
cuesj-183	23	1	the	the	PRON
cuesj-183	23	2	who	who	PRON
cuesj-183	23	3	estimates	estimate	VERB
cuesj-183	23	4	that	that	SCONJ
cuesj-183	23	5	57	57	NUM
cuesj-183	23	6	%	%	NOUN
cuesj-183	23	7	of	of	ADP
cuesj-183	23	8	cases	case	NOUN
cuesj-183	23	9	of	of	ADP
cuesj-183	23	10	liver	liver	NOUN
cuesj-183	23	11	cirrhosis	cirrhosis	NOUN
cuesj-183	23	12	and	and	CCONJ
cuesj-183	23	13	78	78	NUM
cuesj-183	23	14	%	%	NOUN
cuesj-183	23	15	of	of	ADP
cuesj-183	23	16	primary	primary	ADJ
cuesj-183	23	17	liver	liver	NOUN
cuesj-183	23	18	carcinomas	carcinoma	NOUN
cuesj-183	23	19	result	result	VERB
cuesj-183	23	20	from	from	ADP
cuesj-183	23	21	a	a	DET
cuesj-183	23	22	hepatitis	hepatitis	NOUN
cuesj-183	23	23	b	b	PROPN
cuesj-183	23	24	or	or	CCONJ
cuesj-183	23	25	c	c	PROPN
cuesj-183	23	26	virus.[12	virus.[12	NOUN
cuesj-183	23	27	]	]	PUNCT
cuesj-183	23	28	approximately	approximately	ADV
cuesj-183	23	29	70%–80	70%–80	NUM
cuesj-183	23	30	%	%	NOUN
cuesj-183	23	31	of	of	ADP
cuesj-183	23	32	hcv	hcv	NOUN
cuesj-183	23	33	-	-	PUNCT
cuesj-183	23	34	infected	infect	VERB
cuesj-183	23	35	patients	patient	NOUN
cuesj-183	23	36	fail	fail	VERB
cuesj-183	23	37	to	to	PART
cuesj-183	23	38	clear	clear	VERB
cuesj-183	23	39	the	the	DET
cuesj-183	23	40	virus	virus	NOUN
cuesj-183	23	41	and	and	CCONJ
cuesj-183	23	42	develop	develop	VERB
cuesj-183	23	43	chronic	chronic	ADJ
cuesj-183	23	44	hcv	hcv	NOUN
cuesj-183	23	45	infection	infection	NOUN
cuesj-183	23	46	,	,	PUNCT
cuesj-183	23	47	which	which	PRON
cuesj-183	23	48	is	be	AUX
cuesj-183	23	49	a	a	DET
cuesj-183	23	50	risk	risk	NOUN
cuesj-183	23	51	factor	factor	NOUN
cuesj-183	23	52	for	for	ADP
cuesj-183	23	53	liver	liver	NOUN
cuesj-183	23	54	diseases	disease	NOUN
cuesj-183	23	55	such	such	ADJ
cuesj-183	23	56	as	as	ADP
cuesj-183	23	57	fibrosis	fibrosis	NOUN
cuesj-183	23	58	,	,	PUNCT
cuesj-183	23	59	cirrhosis	cirrhosis	NOUN
cuesj-183	23	60	,	,	PUNCT
cuesj-183	23	61	and	and	CCONJ
cuesj-183	23	62	hepatocellular	hepatocellular	ADJ
cuesj-183	23	63	carcinoma.[13,14	carcinoma.[13,14	NOUN
cuesj-183	23	64	]	]	X
cuesj-183	23	65	several	several	ADJ
cuesj-183	23	66	studies	study	NOUN
cuesj-183	23	67	have	have	AUX
cuesj-183	23	68	recorded	record	VERB
cuesj-183	23	69	the	the	DET
cuesj-183	23	70	prevalence	prevalence	NOUN
cuesj-183	23	71	of	of	ADP
cuesj-183	23	72	hbv	hbv	NOUN
cuesj-183	23	73	and	and	CCONJ
cuesj-183	23	74	hcv	hcv	NOUN
cuesj-183	23	75	infection	infection	NOUN
cuesj-183	23	76	in	in	ADP
cuesj-183	23	77	blood	blood	NOUN
cuesj-183	23	78	donors	donor	NOUN
cuesj-183	23	79	of	of	ADP
cuesj-183	23	80	different	different	ADJ
cuesj-183	23	81	iraqi	iraqi	ADJ
cuesj-183	23	82	cities.[15	cities.[15	NOUN
cuesj-183	23	83	-	-	SYM
cuesj-183	23	84	17	17	NUM
cuesj-183	23	85	]	]	PUNCT
cuesj-183	23	86	according	accord	VERB
cuesj-183	23	87	to	to	ADP
cuesj-183	23	88	the	the	DET
cuesj-183	23	89	studies	study	NOUN
cuesj-183	23	90	that	that	PRON
cuesj-183	23	91	have	have	AUX
cuesj-183	23	92	been	be	AUX
cuesj-183	23	93	conducted	conduct	VERB
cuesj-183	23	94	in	in	ADP
cuesj-183	23	95	the	the	DET
cuesj-183	23	96	past	past	ADJ
cuesj-183	23	97	years	year	NOUN
cuesj-183	23	98	investigating	investigate	VERB
cuesj-183	23	99	the	the	DET
cuesj-183	23	100	seroprevalence	seroprevalence	NOUN
cuesj-183	23	101	of	of	ADP
cuesj-183	23	102	hepatitis	hepatitis	PROPN
cuesj-183	23	103	b	b	PROPN
cuesj-183	23	104	and	and	CCONJ
cuesj-183	23	105	hepatitis	hepatitis	PROPN
cuesj-183	23	106	c	c	PROPN
cuesj-183	23	107	,	,	PUNCT
cuesj-183	23	108	the	the	DET
cuesj-183	23	109	prevalence	prevalence	NOUN
cuesj-183	23	110	rate	rate	NOUN
cuesj-183	23	111	in	in	ADP
cuesj-183	23	112	our	our	PRON
cuesj-183	23	113	region	region	NOUN
cuesj-183	23	114	is	be	AUX
cuesj-183	23	115	low	low	ADJ
cuesj-183	23	116	which	which	PRON
cuesj-183	23	117	is	be	AUX
cuesj-183	23	118	<	<	X
cuesj-183	23	119	2%.[18,19	2%.[18,19	NUM
cuesj-183	23	120	]	]	X
cuesj-183	23	121	lack	lack	NOUN
cuesj-183	23	122	of	of	ADP
cuesj-183	23	123	documentary	documentary	NOUN
cuesj-183	23	124	data	datum	NOUN
cuesj-183	23	125	in	in	ADP
cuesj-183	23	126	erbil	erbil	PROPN
cuesj-183	23	127	governments	government	NOUN
cuesj-183	23	128	and	and	CCONJ
cuesj-183	23	129	immigration	immigration	NOUN
cuesj-183	23	130	of	of	ADP
cuesj-183	23	131	a	a	DET
cuesj-183	23	132	significant	significant	ADJ
cuesj-183	23	133	number	number	NOUN
cuesj-183	23	134	of	of	ADP
cuesj-183	23	135	refugees	refugee	NOUN
cuesj-183	23	136	from	from	ADP
cuesj-183	23	137	a	a	DET
cuesj-183	23	138	neighboring	neighbor	VERB
cuesj-183	23	139	country	country	NOUN
cuesj-183	23	140	to	to	ADP
cuesj-183	23	141	kurdistan	kurdistan	PROPN
cuesj-183	23	142	region	region	NOUN
cuesj-183	23	143	,	,	PUNCT
cuesj-183	23	144	as	as	ADV
cuesj-183	23	145	well	well	ADV
cuesj-183	23	146	as	as	ADP
cuesj-183	23	147	foreign	foreign	ADJ
cuesj-183	23	148	tourists	tourist	NOUN
cuesj-183	23	149	and	and	CCONJ
cuesj-183	23	150	the	the	DET
cuesj-183	23	151	traveling	traveling	NOUN
cuesj-183	23	152	of	of	ADP
cuesj-183	23	153	kurdish	kurdish	ADJ
cuesj-183	23	154	peoples	people	NOUN
cuesj-183	23	155	to	to	ADP
cuesj-183	23	156	other	other	ADJ
cuesj-183	23	157	countries	country	NOUN
cuesj-183	23	158	,	,	PUNCT
cuesj-183	23	159	necessitate	necessitate	ADJ
cuesj-183	23	160	updated	update	VERB
cuesj-183	23	161	research	research	NOUN
cuesj-183	23	162	on	on	ADP
cuesj-183	23	163	seroprevalence	seroprevalence	NOUN
cuesj-183	23	164	of	of	ADP
cuesj-183	23	165	infectious	infectious	ADJ
cuesj-183	23	166	agents	agent	NOUN
cuesj-183	23	167	(	(	PUNCT
cuesj-183	23	168	hbv	hbv	NOUN
cuesj-183	23	169	and	and	CCONJ
cuesj-183	23	170	hcv	hcv	NOUN
cuesj-183	23	171	)	)	PUNCT
cuesj-183	23	172	among	among	ADP
cuesj-183	23	173	blood	blood	NOUN
cuesj-183	23	174	donors	donor	NOUN
cuesj-183	23	175	.	.	PUNCT
cuesj-183	24	1	nonetheless	nonetheless	ADV
cuesj-183	24	2	,	,	PUNCT
cuesj-183	24	3	the	the	DET
cuesj-183	24	4	hbv	hbv	NOUN
cuesj-183	24	5	vaccine	vaccine	NOUN
cuesj-183	24	6	was	be	AUX
cuesj-183	24	7	added	add	VERB
cuesj-183	24	8	to	to	ADP
cuesj-183	24	9	the	the	DET
cuesj-183	24	10	expanded	expand	VERB
cuesj-183	24	11	program	program	NOUN
cuesj-183	24	12	of	of	ADP
cuesj-183	24	13	vaccination	vaccination	NOUN
cuesj-183	24	14	in	in	ADP
cuesj-183	24	15	early	early	ADJ
cuesj-183	24	16	2000.[20	2000.[20	NUM
cuesj-183	24	17	]	]	PUNCT
cuesj-183	24	18	there	there	PRON
cuesj-183	24	19	was	be	VERB
cuesj-183	24	20	an	an	DET
cuesj-183	24	21	absence	absence	NOUN
cuesj-183	24	22	of	of	ADP
cuesj-183	24	23	data	datum	NOUN
cuesj-183	24	24	on	on	ADP
cuesj-183	24	25	the	the	DET
cuesj-183	24	26	success	success	NOUN
cuesj-183	24	27	of	of	ADP
cuesj-183	24	28	the	the	DET
cuesj-183	24	29	vaccination	vaccination	NOUN
cuesj-183	24	30	program	program	NOUN
cuesj-183	24	31	;	;	PUNCT
cuesj-183	24	32	therefore	therefore	ADV
cuesj-183	24	33	,	,	PUNCT
cuesj-183	24	34	we	we	PRON
cuesj-183	24	35	thought	think	VERB
cuesj-183	24	36	of	of	ADP
cuesj-183	24	37	evaluating	evaluate	VERB
cuesj-183	24	38	the	the	DET
cuesj-183	24	39	antibody	antibody	NOUN
cuesj-183	24	40	for	for	ADP
cuesj-183	24	41	these	these	DET
cuesj-183	24	42	viruses	virus	NOUN
cuesj-183	24	43	in	in	ADP
cuesj-183	24	44	the	the	DET
cuesj-183	24	45	blood	blood	NOUN
cuesj-183	24	46	which	which	PRON
cuesj-183	24	47	offer	offer	VERB
cuesj-183	24	48	an	an	DET
cuesj-183	24	49	idea	idea	NOUN
cuesj-183	24	50	of	of	ADP
cuesj-183	24	51	the	the	DET
cuesj-183	24	52	level	level	NOUN
cuesj-183	24	53	of	of	ADP
cuesj-183	24	54	protection	protection	NOUN
cuesj-183	24	55	against	against	ADP
cuesj-183	24	56	these	these	DET
cuesj-183	24	57	infectious	infectious	ADJ
cuesj-183	24	58	agents	agent	NOUN
cuesj-183	24	59	.	.	PUNCT
cuesj-183	25	1	this	this	DET
cuesj-183	25	2	study	study	NOUN
cuesj-183	25	3	was	be	AUX
cuesj-183	25	4	conducted	conduct	VERB
cuesj-183	25	5	to	to	PART
cuesj-183	25	6	find	find	VERB
cuesj-183	25	7	out	out	ADP
cuesj-183	25	8	the	the	DET
cuesj-183	25	9	incidence	incidence	NOUN
cuesj-183	25	10	of	of	ADP
cuesj-183	25	11	hbv	hbv	NOUN
cuesj-183	25	12	and	and	CCONJ
cuesj-183	25	13	hcv	hcv	PROPN
cuesj-183	25	14	among	among	ADP
cuesj-183	25	15	blood	blood	NOUN
cuesj-183	25	16	donors	donor	NOUN
cuesj-183	25	17	in	in	ADP
cuesj-183	25	18	erbil	erbil	PROPN
cuesj-183	25	19	community	community	NOUN
cuesj-183	25	20	.	.	PUNCT
cuesj-183	26	1	besides	besides	SCONJ
cuesj-183	26	2	this	this	PRON
cuesj-183	26	3	,	,	PUNCT
cuesj-183	26	4	we	we	PRON
cuesj-183	26	5	further	far	ADV
cuesj-183	26	6	characterized	characterize	VERB
cuesj-183	26	7	the	the	DET
cuesj-183	26	8	hbv	hbv	NOUN
cuesj-183	26	9	infected	infect	VERB
cuesj-183	26	10	individuals	individual	NOUN
cuesj-183	26	11	along	along	ADP
cuesj-183	26	12	with	with	ADP
cuesj-183	26	13	the	the	DET
cuesj-183	26	14	screening	screening	NOUN
cuesj-183	26	15	for	for	ADP
cuesj-183	26	16	hbs	hbs	PROPN
cuesj-183	26	17	-	-	PUNCT
cuesj-183	26	18	ab	ab	PROPN
cuesj-183	26	19	,	,	PUNCT
cuesj-183	26	20	evaluating	evaluate	VERB
cuesj-183	26	21	the	the	DET
cuesj-183	26	22	level	level	NOUN
cuesj-183	26	23	of	of	ADP
cuesj-183	26	24	protection	protection	NOUN
cuesj-183	26	25	against	against	ADP
cuesj-183	26	26	hbv	hbv	NOUN
cuesj-183	26	27	infection	infection	NOUN
cuesj-183	26	28	among	among	ADP
cuesj-183	26	29	our	our	PRON
cuesj-183	26	30	community	community	NOUN
cuesj-183	26	31	.	.	PUNCT
cuesj-183	27	1	materials	material	NOUN
cuesj-183	27	2	and	and	CCONJ
cuesj-183	27	3	methods	method	NOUN
cuesj-183	27	4	study	study	VERB
cuesj-183	27	5	population	population	NOUN
cuesj-183	27	6	and	and	CCONJ
cuesj-183	27	7	sampling	sample	VERB
cuesj-183	27	8	this	this	PRON
cuesj-183	27	9	is	be	AUX
cuesj-183	27	10	a	a	DET
cuesj-183	27	11	prospective	prospective	ADJ
cuesj-183	27	12	and	and	CCONJ
cuesj-183	27	13	cross	cross	ADJ
cuesj-183	27	14	-	-	ADJ
cuesj-183	27	15	sectional	sectional	ADJ
cuesj-183	27	16	study	study	NOUN
cuesj-183	27	17	investigating	investigate	VERB
cuesj-183	27	18	hbv	hbv	NOUN
cuesj-183	27	19	and	and	CCONJ
cuesj-183	27	20	hcv	hcv	VERB
cuesj-183	27	21	among	among	ADP
cuesj-183	27	22	blood	blood	NOUN
cuesj-183	27	23	donors	donor	NOUN
cuesj-183	27	24	who	who	PRON
cuesj-183	27	25	donated	donate	VERB
cuesj-183	27	26	blood	blood	NOUN
cuesj-183	27	27	in	in	ADP
cuesj-183	27	28	the	the	DET
cuesj-183	27	29	directorate	directorate	NOUN
cuesj-183	27	30	of	of	ADP
cuesj-183	27	31	blood	blood	NOUN
cuesj-183	27	32	bank	bank	NOUN
cuesj-183	27	33	-	-	PUNCT
cuesj-183	27	34	erbil	erbil	PROPN
cuesj-183	27	35	,	,	PUNCT
cuesj-183	27	36	iraq	iraq	PROPN
cuesj-183	27	37	.	.	PUNCT
cuesj-183	28	1	all	all	DET
cuesj-183	28	2	volunteers	volunteer	NOUN
cuesj-183	28	3	who	who	PRON
cuesj-183	28	4	visited	visit	VERB
cuesj-183	28	5	the	the	DET
cuesj-183	28	6	blood	blood	NOUN
cuesj-183	28	7	bank	bank	NOUN
cuesj-183	28	8	to	to	PART
cuesj-183	28	9	donate	donate	VERB
cuesj-183	28	10	blood	blood	NOUN
cuesj-183	28	11	from	from	ADP
cuesj-183	28	12	december	december	PROPN
cuesj-183	28	13	2017	2017	NUM
cuesj-183	28	14	to	to	ADP
cuesj-183	28	15	february	february	PROPN
cuesj-183	28	16	2018	2018	NUM
cuesj-183	28	17	were	be	AUX
cuesj-183	28	18	included	include	VERB
cuesj-183	28	19	in	in	ADP
cuesj-183	28	20	the	the	DET
cuesj-183	28	21	study	study	NOUN
cuesj-183	28	22	:	:	PUNCT
cuesj-183	28	23	blood	blood	NOUN
cuesj-183	28	24	donors	donor	NOUN
cuesj-183	28	25	were	be	AUX
cuesj-183	28	26	selected	select	VERB
cuesj-183	28	27	after	after	ADP
cuesj-183	28	28	an	an	DET
cuesj-183	28	29	interview	interview	NOUN
cuesj-183	28	30	through	through	ADP
cuesj-183	28	31	a	a	DET
cuesj-183	28	32	structured	structured	ADJ
cuesj-183	28	33	questionnaire	questionnaire	NOUN
cuesj-183	28	34	designed	design	VERB
cuesj-183	28	35	for	for	ADP
cuesj-183	28	36	such	such	ADJ
cuesj-183	28	37	purpose	purpose	NOUN
cuesj-183	28	38	.	.	PUNCT
cuesj-183	29	1	blood	blood	NOUN
cuesj-183	29	2	donors	donor	NOUN
cuesj-183	29	3	with	with	ADP
cuesj-183	29	4	low	low	ADJ
cuesj-183	29	5	or	or	CCONJ
cuesj-183	29	6	high	high	ADJ
cuesj-183	29	7	hemoglobin	hemoglobin	NOUN
cuesj-183	29	8	concentration	concentration	NOUN
cuesj-183	29	9	,	,	PUNCT
cuesj-183	29	10	high	high	ADJ
cuesj-183	29	11	body	body	NOUN
cuesj-183	29	12	temperature	temperature	NOUN
cuesj-183	29	13	,	,	PUNCT
cuesj-183	29	14	having	have	VERB
cuesj-183	29	15	any	any	DET
cuesj-183	29	16	disease	disease	NOUN
cuesj-183	29	17	,	,	PUNCT
cuesj-183	29	18	weight	weight	NOUN
cuesj-183	29	19	<	<	X
cuesj-183	29	20	50	50	NUM
cuesj-183	29	21	kg	kg	NOUN
cuesj-183	29	22	,	,	PUNCT
cuesj-183	29	23	cupping	cup	VERB
cuesj-183	29	24	in	in	ADP
cuesj-183	29	25	past	past	ADJ
cuesj-183	29	26	6	6	NUM
cuesj-183	29	27	months	month	NOUN
cuesj-183	29	28	,	,	PUNCT
cuesj-183	29	29	operation	operation	NOUN
cuesj-183	29	30	in	in	ADP
cuesj-183	29	31	the	the	DET
cuesj-183	29	32	last	last	ADJ
cuesj-183	29	33	year	year	NOUN
cuesj-183	29	34	,	,	PUNCT
cuesj-183	29	35	drinking	drink	VERB
cuesj-183	29	36	alcohol	alcohol	NOUN
cuesj-183	29	37	,	,	PUNCT
cuesj-183	29	38	uncontrolled	uncontrolled	ADJ
cuesj-183	29	39	blood	blood	NOUN
cuesj-183	29	40	pressure	pressure	NOUN
cuesj-183	29	41	,	,	PUNCT
cuesj-183	29	42	history	history	NOUN
cuesj-183	29	43	of	of	ADP
cuesj-183	29	44	taking	take	VERB
cuesj-183	29	45	any	any	DET
cuesj-183	29	46	drugs	drug	NOUN
cuesj-183	29	47	,	,	PUNCT
cuesj-183	29	48	fever	fever	NOUN
cuesj-183	29	49	,	,	PUNCT
cuesj-183	29	50	and	and	CCONJ
cuesj-183	29	51	having	have	VERB
cuesj-183	29	52	tattoos	tattoo	NOUN
cuesj-183	29	53	on	on	ADP
cuesj-183	29	54	their	their	PRON
cuesj-183	29	55	body	body	NOUN
cuesj-183	29	56	were	be	AUX
cuesj-183	29	57	excluded	exclude	VERB
cuesj-183	29	58	in	in	ADP
cuesj-183	29	59	our	our	PRON
cuesj-183	29	60	study	study	NOUN
cuesj-183	29	61	.	.	PUNCT
cuesj-183	30	1	in	in	ADP
cuesj-183	30	2	total	total	ADJ
cuesj-183	30	3	,	,	PUNCT
cuesj-183	30	4	6173	6173	NUM
cuesj-183	30	5	participants	participant	NOUN
cuesj-183	30	6	donated	donate	VERB
cuesj-183	30	7	blood	blood	NOUN
cuesj-183	30	8	during	during	ADP
cuesj-183	30	9	the	the	DET
cuesj-183	30	10	specific	specific	ADJ
cuesj-183	30	11	time	time	NOUN
cuesj-183	30	12	and	and	CCONJ
cuesj-183	30	13	were	be	AUX
cuesj-183	30	14	screened	screen	VERB
cuesj-183	30	15	for	for	ADP
cuesj-183	30	16	hbv	hbv	NOUN
cuesj-183	30	17	and	and	CCONJ
cuesj-183	30	18	hcv	hcv	NOUN
cuesj-183	30	19	.	.	PUNCT
cuesj-183	31	1	among	among	ADP
cuesj-183	31	2	those	those	DET
cuesj-183	31	3	blood	blood	NOUN
cuesj-183	31	4	donors	donor	NOUN
cuesj-183	31	5	,	,	PUNCT
cuesj-183	31	6	109	109	NUM
cuesj-183	31	7	were	be	AUX
cuesj-183	31	8	reactive	reactive	ADJ
cuesj-183	31	9	for	for	ADP
cuesj-183	31	10	hbv	hbv	NOUN
cuesj-183	31	11	or	or	CCONJ
cuesj-183	31	12	hcv	hcv	NOUN
cuesj-183	31	13	.	.	PUNCT
cuesj-183	32	1	fifty	fifty	NUM
cuesj-183	32	2	healthy	healthy	ADJ
cuesj-183	32	3	individuals	individual	NOUN
cuesj-183	32	4	were	be	AUX
cuesj-183	32	5	also	also	ADV
cuesj-183	32	6	included	include	VERB
cuesj-183	32	7	in	in	ADP
cuesj-183	32	8	this	this	DET
cuesj-183	32	9	study	study	NOUN
cuesj-183	32	10	as	as	ADP
cuesj-183	32	11	a	a	DET
cuesj-183	32	12	control	control	NOUN
cuesj-183	32	13	group	group	NOUN
cuesj-183	32	14	.	.	PUNCT
cuesj-183	33	1	each	each	DET
cuesj-183	33	2	blood	blood	NOUN
cuesj-183	33	3	sample	sample	NOUN
cuesj-183	33	4	was	be	AUX
cuesj-183	33	5	collected	collect	VERB
cuesj-183	33	6	in	in	ADP
cuesj-183	33	7	a	a	DET
cuesj-183	33	8	5	5	NUM
cuesj-183	33	9	ml	ml	NOUN
cuesj-183	33	10	of	of	ADP
cuesj-183	33	11	a	a	DET
cuesj-183	33	12	sterile	sterile	ADJ
cuesj-183	33	13	tube	tube	NOUN
cuesj-183	33	14	,	,	PUNCT
cuesj-183	33	15	and	and	CCONJ
cuesj-183	33	16	then	then	ADV
cuesj-183	33	17	the	the	DET
cuesj-183	33	18	whole	whole	ADJ
cuesj-183	33	19	blood	blood	NOUN
cuesj-183	33	20	was	be	AUX
cuesj-183	33	21	centrifuged	centrifuge	VERB
cuesj-183	33	22	,	,	PUNCT
cuesj-183	33	23	plasma	plasma	NOUN
cuesj-183	33	24	was	be	AUX
cuesj-183	33	25	taken	take	VERB
cuesj-183	33	26	and	and	CCONJ
cuesj-183	33	27	stored	store	VERB
cuesj-183	33	28	at	at	ADP
cuesj-183	33	29	minus	minus	ADP
cuesj-183	33	30	20	20	NUM
cuesj-183	33	31	freezer	freezer	NOUN
cuesj-183	33	32	.	.	PUNCT
cuesj-183	34	1	the	the	DET
cuesj-183	34	2	study	study	NOUN
cuesj-183	34	3	was	be	AUX
cuesj-183	34	4	approved	approve	VERB
cuesj-183	34	5	by	by	ADP
cuesj-183	34	6	the	the	DET
cuesj-183	34	7	ethics	ethic	NOUN
cuesj-183	34	8	committee	committee	PROPN
cuesj-183	34	9	at	at	ADP
cuesj-183	34	10	the	the	DET
cuesj-183	34	11	hawler	hawler	PROPN
cuesj-183	34	12	medical	medical	PROPN
cuesj-183	34	13	university	university	PROPN
cuesj-183	34	14	,	,	PUNCT
cuesj-183	34	15	for	for	ADP
cuesj-183	34	16	dealing	deal	VERB
cuesj-183	34	17	with	with	ADP
cuesj-183	34	18	the	the	DET
cuesj-183	34	19	samples	sample	NOUN
cuesj-183	34	20	and	and	CCONJ
cuesj-183	34	21	participant	participant	ADJ
cuesj-183	34	22	information	information	NOUN
cuesj-183	34	23	and	and	CCONJ
cuesj-183	34	24	a	a	DET
cuesj-183	34	25	written	write	VERB
cuesj-183	34	26	informed	inform	VERB
cuesj-183	34	27	consent	consent	NOUN
cuesj-183	34	28	was	be	AUX
cuesj-183	34	29	obtained	obtain	VERB
cuesj-183	34	30	from	from	ADP
cuesj-183	34	31	each	each	DET
cuesj-183	34	32	blood	blood	NOUN
cuesj-183	34	33	donor	donor	NOUN
cuesj-183	34	34	for	for	ADP
cuesj-183	34	35	their	their	PRON
cuesj-183	34	36	participation	participation	NOUN
cuesj-183	34	37	in	in	ADP
cuesj-183	34	38	the	the	DET
cuesj-183	34	39	study	study	NOUN
cuesj-183	34	40	.	.	PUNCT
cuesj-183	35	1	detection	detection	NOUN
cuesj-183	35	2	of	of	ADP
cuesj-183	35	3	hbv	hbv	NOUN
cuesj-183	35	4	serological	serological	NOUN
cuesj-183	35	5	markers	marker	NOUN
cuesj-183	35	6	elisa	elisa	PROPN
cuesj-183	35	7	screening	screen	VERB
cuesj-183	35	8	test	test	NOUN
cuesj-183	35	9	for	for	ADP
cuesj-183	35	10	hbs	hbs	PROPN
cuesj-183	35	11	ag	ag	PROPN
cuesj-183	35	12	and	and	CCONJ
cuesj-183	35	13	anti	anti	ADJ
cuesj-183	35	14	-	-	ADJ
cuesj-183	35	15	hbc	hbc	ADJ
cuesj-183	35	16	monolisa	monolisa	NOUN
cuesj-183	35	17	™	™	VERB
cuesj-183	35	18	hbs	hbs	PROPN
cuesj-183	35	19	ag	ag	PROPN
cuesj-183	35	20	ultra	ultra	ADJ
cuesj-183	35	21	(	(	PUNCT
cuesj-183	35	22	bio	bio	NOUN
cuesj-183	35	23	-	-	PUNCT
cuesj-183	35	24	rad	rad	PROPN
cuesj-183	35	25	,	,	PUNCT
cuesj-183	35	26	france	france	PROPN
cuesj-183	35	27	)	)	PUNCT
cuesj-183	35	28	assay	assay	VERB
cuesj-183	35	29	is	be	AUX
cuesj-183	35	30	a	a	DET
cuesj-183	35	31	one	one	NUM
cuesj-183	35	32	-	-	PUNCT
cuesj-183	35	33	step	step	NOUN
cuesj-183	35	34	enzyme	enzyme	NOUN
cuesj-183	35	35	immunoassay	immunoassay	NOUN
cuesj-183	35	36	based	base	VERB
cuesj-183	35	37	on	on	ADP
cuesj-183	35	38	the	the	DET
cuesj-183	35	39	principle	principle	NOUN
cuesj-183	35	40	of	of	ADP
cuesj-183	35	41	the	the	DET
cuesj-183	35	42	“	"	PUNCT
cuesj-183	35	43	sandwich	sandwich	NOUN
cuesj-183	35	44	”	"	PUNCT
cuesj-183	35	45	type	type	NOUN
cuesj-183	35	46	using	use	VERB
cuesj-183	35	47	monoclonal	monoclonal	NOUN
cuesj-183	35	48	antibodies	antibody	NOUN
cuesj-183	35	49	and	and	CCONJ
cuesj-183	35	50	polyclonal	polyclonal	ADJ
cuesj-183	35	51	antibodies	antibody	NOUN
cuesj-183	35	52	selected	select	VERB
cuesj-183	35	53	for	for	ADP
cuesj-183	35	54	their	their	PRON
cuesj-183	35	55	capability	capability	NOUN
cuesj-183	35	56	to	to	PART
cuesj-183	35	57	bind	bind	VERB
cuesj-183	35	58	themselves	themselves	PRON
cuesj-183	35	59	to	to	ADP
cuesj-183	35	60	the	the	DET
cuesj-183	35	61	numerous	numerous	ADJ
cuesj-183	35	62	subtypes	subtype	NOUN
cuesj-183	35	63	of	of	ADP
cuesj-183	35	64	hbs	hbs	PROPN
cuesj-183	35	65	ag.[21	ag.[21	NOUN
cuesj-183	35	66	]	]	PUNCT
cuesj-183	35	67	serologically	serologically	ADV
cuesj-183	35	68	,	,	PUNCT
cuesj-183	35	69	the	the	DET
cuesj-183	35	70	samples	sample	NOUN
cuesj-183	35	71	were	be	AUX
cuesj-183	35	72	rechecked	rechecke	VERB
cuesj-183	35	73	by	by	ADP
cuesj-183	35	74	elecsys	elecsys	PROPN
cuesj-183	35	75	hbs	hbs	PROPN
cuesj-183	35	76	ag	ag	PROPN
cuesj-183	35	77	ii	ii	PROPN
cuesj-183	35	78	by	by	ADP
cuesj-183	35	79	device	device	NOUN
cuesj-183	36	1	cobas	cobas	PROPN
cuesj-183	36	2	e411(roche	e411(roche	PROPN
cuesj-183	36	3	,	,	PUNCT
cuesj-183	36	4	germany	germany	PROPN
cuesj-183	36	5	)	)	PUNCT
cuesj-183	36	6	.	.	PUNCT
cuesj-183	37	1	the	the	DET
cuesj-183	37	2	elecsys	elecsys	PROPN
cuesj-183	37	3	hbsag	hbsag	PROPN
cuesj-183	37	4	ii	ii	PROPN
cuesj-183	37	5	assay	assay	NOUN
cuesj-183	37	6	uses	use	VERB
cuesj-183	37	7	monoclonal	monoclonal	NOUN
cuesj-183	37	8	and	and	CCONJ
cuesj-183	37	9	polyclonal	polyclonal	ADJ
cuesj-183	37	10	anti	anti	ADJ
cuesj-183	37	11	-	-	ADJ
cuesj-183	37	12	hbs	hbs	ADJ
cuesj-183	37	13	antibodies	antibody	NOUN
cuesj-183	37	14	(	(	PUNCT
cuesj-183	37	15	mouse	mouse	NOUN
cuesj-183	37	16	and	and	CCONJ
cuesj-183	37	17	sheep	sheep	NOUN
cuesj-183	37	18	)	)	PUNCT
cuesj-183	37	19	for	for	ADP
cuesj-183	37	20	the	the	DET
cuesj-183	37	21	hbsag	hbsag	ADJ
cuesj-183	37	22	determination	determination	NOUN
cuesj-183	37	23	.	.	PUNCT
cuesj-183	38	1	monolisa	monolisa	NOUN
cuesj-183	38	2	™	™	VERB
cuesj-183	38	3	anti	anti	ADJ
cuesj-183	38	4	-	-	ADJ
cuesj-183	38	5	hbc	hbc	ADJ
cuesj-183	38	6	plus	plus	CCONJ
cuesj-183	38	7	(	(	PUNCT
cuesj-183	38	8	bio	bio	NOUN
cuesj-183	38	9	-	-	PROPN
cuesj-183	38	10	rad	rad	PROPN
cuesj-183	38	11	,	,	PUNCT
cuesj-183	38	12	france	france	PROPN
cuesj-183	38	13	)	)	PUNCT
cuesj-183	38	14	is	be	AUX
cuesj-183	38	15	an	an	DET
cuesj-183	38	16	enzyme	enzyme	NOUN
cuesj-183	38	17	immunoassay	immunoassay	NOUN
cuesj-183	38	18	(	(	PUNCT
cuesj-183	38	19	indirect	indirect	ADJ
cuesj-183	38	20	elisa	elisa	NOUN
cuesj-183	38	21	type	type	NOUN
cuesj-183	38	22	)	)	PUNCT
cuesj-183	38	23	for	for	ADP
cuesj-183	38	24	the	the	DET
cuesj-183	38	25	simultaneous	simultaneous	ADJ
cuesj-183	38	26	finding	finding	NOUN
cuesj-183	38	27	of	of	ADP
cuesj-183	38	28	total	total	ADJ
cuesj-183	38	29	antibodies	antibody	NOUN
cuesj-183	39	1	to	to	PART
cuesj-183	39	2	hbv	hbv	VERB
cuesj-183	39	3	core.[22	core.[22	PROPN
cuesj-183	39	4	]	]	PUNCT
cuesj-183	39	5	chemiluminescent	chemiluminescent	PROPN
cuesj-183	39	6	immunoassay	immunoassay	PROPN
cuesj-183	39	7	(	(	PUNCT
cuesj-183	39	8	clia	clia	PROPN
cuesj-183	39	9	)	)	PUNCT
cuesj-183	39	10	screening	screen	VERB
cuesj-183	39	11	test	test	NOUN
cuesj-183	39	12	for	for	ADP
cuesj-183	39	13	anti	anti	ADJ
cuesj-183	39	14	-	-	ADJ
cuesj-183	39	15	hbs	hbs	ADJ
cuesj-183	39	16	clia	clia	PROPN
cuesj-183	39	17	way	way	NOUN
cuesj-183	39	18	was	be	AUX
cuesj-183	39	19	used	use	VERB
cuesj-183	39	20	for	for	ADP
cuesj-183	39	21	detecting	detect	VERB
cuesj-183	39	22	antibody	antibody	NOUN
cuesj-183	39	23	of	of	ADP
cuesj-183	39	24	hbs	hbs	PROPN
cuesj-183	39	25	by	by	ADP
cuesj-183	39	26	the	the	DET
cuesj-183	39	27	liaison	liaison	NOUN
cuesj-183	39	28	xl	xl	PROPN
cuesj-183	39	29	(	(	PUNCT
cuesj-183	39	30	diasorin	diasorin	PROPN
cuesj-183	39	31	,	,	PUNCT
cuesj-183	39	32	italy	italy	PROPN
cuesj-183	39	33	)	)	PUNCT
cuesj-183	39	34	.	.	PUNCT
cuesj-183	40	1	amid	amid	ADP
cuesj-183	40	2	numerous	numerous	ADJ
cuesj-183	40	3	enzyme	enzyme	NOUN
cuesj-183	40	4	assays	assay	NOUN
cuesj-183	40	5	that	that	PRON
cuesj-183	40	6	give	give	VERB
cuesj-183	40	7	light	light	NOUN
cuesj-183	40	8	-	-	PUNCT
cuesj-183	40	9	emitting	emit	VERB
cuesj-183	40	10	reactions	reaction	NOUN
cuesj-183	40	11	,	,	PUNCT
cuesj-183	40	12	one	one	NUM
cuesj-183	40	13	of	of	ADP
cuesj-183	40	14	the	the	DET
cuesj-183	40	15	most	most	ADV
cuesj-183	40	16	successful	successful	ADJ
cuesj-183	40	17	tests	test	NOUN
cuesj-183	40	18	is	be	AUX
cuesj-183	40	19	the	the	DET
cuesj-183	40	20	improved	improved	ADJ
cuesj-183	40	21	clia	clia	PROPN
cuesj-183	40	22	regarding	regard	VERB
cuesj-183	40	23	a	a	DET
cuesj-183	40	24	horseradish	horseradish	ADJ
cuesj-183	40	25	peroxidase	peroxidase	NOUN
cuesj-183	40	26	labeled	label	VERB
cuesj-183	40	27	antibody	antibody	NOUN
cuesj-183	40	28	or	or	CCONJ
cuesj-183	40	29	antigen	antigen	NOUN
cuesj-183	40	30	and	and	CCONJ
cuesj-183	40	31	a	a	DET
cuesj-183	40	32	mixture	mixture	NOUN
cuesj-183	40	33	of	of	ADP
cuesj-183	40	34	the	the	DET
cuesj-183	40	35	chemiluminescent	chemiluminescent	NOUN
cuesj-183	40	36	substrate	substrate	NOUN
cuesj-183	40	37	,	,	PUNCT
cuesj-183	40	38	hydrogen	hydrogen	NOUN
cuesj-183	40	39	peroxide	peroxide	NOUN
cuesj-183	40	40	,	,	PUNCT
cuesj-183	40	41	and	and	CCONJ
cuesj-183	40	42	enhancers.[23	enhancers.[23	NOUN
cuesj-183	40	43	]	]	PUNCT
cuesj-183	40	44	detection	detection	NOUN
cuesj-183	40	45	of	of	ADP
cuesj-183	40	46	hcv	hcv	ADJ
cuesj-183	40	47	serological	serological	ADJ
cuesj-183	40	48	markers	marker	NOUN
cuesj-183	40	49	monolisa	monolisa	NOUN
cuesj-183	40	50	™	™	VERB
cuesj-183	40	51	anti	anti	ADJ
cuesj-183	40	52	-	-	ADJ
cuesj-183	40	53	hcv	hcv	ADJ
cuesj-183	40	54	plus	plus	CCONJ
cuesj-183	40	55	version	version	NOUN
cuesj-183	40	56	2	2	NUM
cuesj-183	40	57	or	or	CCONJ
cuesj-183	40	58	3	3	NUM
cuesj-183	40	59	(	(	PUNCT
cuesj-183	40	60	bio	bio	NOUN
cuesj-183	40	61	-	-	PROPN
cuesj-183	40	62	rad	rad	PROPN
cuesj-183	40	63	,	,	PUNCT
cuesj-183	40	64	france	france	PROPN
cuesj-183	40	65	)	)	PUNCT
cuesj-183	40	66	is	be	AUX
cuesj-183	40	67	an	an	DET
cuesj-183	40	68	indirect	indirect	ADJ
cuesj-183	40	69	qualitative	qualitative	ADJ
cuesj-183	40	70	enzyme	enzyme	NOUN
cuesj-183	40	71	immunoassay	immunoassay	NOUN
cuesj-183	40	72	for	for	ADP
cuesj-183	40	73	the	the	DET
cuesj-183	40	74	detection	detection	NOUN
cuesj-183	40	75	of	of	ADP
cuesj-183	40	76	infection	infection	NOUN
cuesj-183	40	77	by	by	ADP
cuesj-183	40	78	the	the	DET
cuesj-183	40	79	hcv	hcv	NOUN
cuesj-183	40	80	based	base	VERB
cuesj-183	40	81	on	on	ADP
cuesj-183	40	82	the	the	DET
cuesj-183	40	83	detection	detection	NOUN
cuesj-183	40	84	of	of	ADP
cuesj-183	40	85	anti	anti	ADJ
cuesj-183	40	86	-	-	ADJ
cuesj-183	40	87	hcv	hcv	ADJ
cuesj-183	40	88	antibodies	antibody	NOUN
cuesj-183	40	89	in	in	ADP
cuesj-183	40	90	serum	serum	NOUN
cuesj-183	40	91	or	or	CCONJ
cuesj-183	40	92	human	human	ADJ
cuesj-183	40	93	plasma.[24	plasma.[24	NOUN
cuesj-183	40	94	]	]	PUNCT
cuesj-183	40	95	detection	detection	NOUN
cuesj-183	40	96	of	of	ADP
cuesj-183	40	97	hbv	hbv	PROPN
cuesj-183	40	98	dna	dna	PROPN
cuesj-183	40	99	(	(	PUNCT
cuesj-183	40	100	pcr	pcr	PROPN
cuesj-183	40	101	)	)	PUNCT
cuesj-183	40	102	the	the	DET
cuesj-183	40	103	extraction	extraction	NOUN
cuesj-183	40	104	of	of	ADP
cuesj-183	40	105	hbv	hbv	NOUN
cuesj-183	40	106	dna	dna	PROPN
cuesj-183	40	107	is	be	AUX
cuesj-183	40	108	done	do	VERB
cuesj-183	40	109	by	by	ADP
cuesj-183	40	110	a	a	DET
cuesj-183	40	111	kit	kit	NOUN
cuesj-183	40	112	ez1	ez1	NOUN
cuesj-183	40	113	virus	virus	NOUN
cuesj-183	40	114	mini	mini	NOUN
cuesj-183	40	115	kit	kit	NOUN
cuesj-183	40	116	(	(	PUNCT
cuesj-183	40	117	v2.0	v2.0	X
cuesj-183	40	118	qiagen	qiagen	PROPN
cuesj-183	40	119	,	,	PUNCT
cuesj-183	40	120	germany	germany	PROPN
cuesj-183	40	121	)	)	PUNCT
cuesj-183	40	122	using	use	VERB
cuesj-183	40	123	the	the	DET
cuesj-183	40	124	ez1	ez1	NOUN
cuesj-183	40	125	advanced	advance	VERB
cuesj-183	40	126	xl	xl	PROPN
cuesj-183	40	127	device	device	NOUN
cuesj-183	40	128	(	(	PUNCT
cuesj-183	40	129	qiagen	qiagen	NOUN
cuesj-183	40	130	,	,	PUNCT
cuesj-183	40	131	germany).[25	germany).[25	PROPN
cuesj-183	40	132	]	]	PUNCT
cuesj-183	40	133	the	the	DET
cuesj-183	40	134	artus	artus	PROPN
cuesj-183	40	135	hbv	hbv	PROPN
cuesj-183	40	136	rg	rg	PROPN
cuesj-183	40	137	pcr	pcr	PROPN
cuesj-183	40	138	kit	kit	NOUN
cuesj-183	40	139	is	be	AUX
cuesj-183	40	140	used	use	VERB
cuesj-183	40	141	in	in	ADP
cuesj-183	40	142	the	the	DET
cuesj-183	40	143	automated	automate	VERB
cuesj-183	40	144	system	system	NOUN
cuesj-183	40	145	for	for	ADP
cuesj-183	40	146	the	the	DET
cuesj-183	40	147	detection	detection	NOUN
cuesj-183	40	148	of	of	ADP
cuesj-183	40	149	hbv	hbv	NOUN
cuesj-183	40	150	dna	dna	PROPN
cuesj-183	40	151	using	use	VERB
cuesj-183	40	152	the	the	DET
cuesj-183	40	153	pcr	pcr	NOUN
cuesj-183	40	154	on	on	ADP
cuesj-183	40	155	rotor	rotor	NOUN
cuesj-183	40	156	-	-	PUNCT
cuesj-183	40	157	gene	gene	NOUN
cuesj-183	40	158	q	q	NOUN
cuesj-183	40	159	(	(	PUNCT
cuesj-183	40	160	qiagen	qiagen	PROPN
cuesj-183	40	161	,	,	PUNCT
cuesj-183	40	162	germany).[26	germany).[26	PROPN
cuesj-183	40	163	]	]	X
cuesj-183	40	164	this	this	PRON
cuesj-183	40	165	is	be	AUX
cuesj-183	40	166	conducted	conduct	VERB
cuesj-183	40	167	for	for	ADP
cuesj-183	40	168	24	24	NUM
cuesj-183	40	169	samples	sample	NOUN
cuesj-183	40	170	that	that	PRON
cuesj-183	40	171	are	be	AUX
cuesj-183	40	172	negatives	negative	NOUN
cuesj-183	40	173	for	for	ADP
cuesj-183	40	174	anti	anti	ADJ
cuesj-183	40	175	-	-	ADJ
cuesj-183	40	176	hbs	hbs	ADJ
cuesj-183	40	177	and	and	CCONJ
cuesj-183	40	178	positives	positive	NOUN
cuesj-183	40	179	for	for	ADP
cuesj-183	40	180	antihbc	antihbc	PROPN
cuesj-183	40	181	igg	igg	PROPN
cuesj-183	40	182	,	,	PUNCT
cuesj-183	40	183	and	and	CCONJ
cuesj-183	40	184	six	six	NUM
cuesj-183	40	185	samples	sample	NOUN
cuesj-183	40	186	are	be	AUX
cuesj-183	40	187	used	use	VERB
cuesj-183	40	188	as	as	ADP
cuesj-183	40	189	a	a	DET
cuesj-183	40	190	negative	negative	ADJ
cuesj-183	40	191	control	control	NOUN
cuesj-183	40	192	.	.	PUNCT
cuesj-183	41	1	statistical	statistical	ADJ
cuesj-183	41	2	analysis	analysis	NOUN
cuesj-183	41	3	microsoft	microsoft	PROPN
cuesj-183	41	4	office	office	PROPN
cuesj-183	41	5	excel	excel	VERB
cuesj-183	41	6	and	and	CCONJ
cuesj-183	41	7	statistical	statistical	ADJ
cuesj-183	41	8	package	package	NOUN
cuesj-183	41	9	for	for	ADP
cuesj-183	41	10	the	the	DET
cuesj-183	41	11	social	social	ADJ
cuesj-183	41	12	sciences	sciences	PROPN
cuesj-183	41	13	(	(	PUNCT
cuesj-183	41	14	spss	spss	PROPN
cuesj-183	41	15	)	)	PUNCT
cuesj-183	41	16	are	be	AUX
cuesj-183	41	17	used	use	VERB
cuesj-183	41	18	for	for	ADP
cuesj-183	41	19	data	datum	NOUN
cuesj-183	41	20	entry	entry	NOUN
cuesj-183	41	21	and	and	CCONJ
cuesj-183	41	22	analysis	analysis	NOUN
cuesj-183	41	23	.	.	PUNCT
cuesj-183	42	1	results	result	NOUN
cuesj-183	42	2	among	among	ADP
cuesj-183	42	3	6173	6173	NUM
cuesj-183	42	4	participants	participant	NOUN
cuesj-183	42	5	,	,	PUNCT
cuesj-183	42	6	109	109	NUM
cuesj-183	42	7	were	be	AUX
cuesj-183	42	8	reactive	reactive	ADJ
cuesj-183	42	9	for	for	ADP
cuesj-183	42	10	hbv	hbv	NOUN
cuesj-183	42	11	and	and	CCONJ
cuesj-183	42	12	hcv	hcv	PROPN
cuesj-183	42	13	.	.	PUNCT
cuesj-183	43	1	fifty	fifty	NUM
cuesj-183	43	2	negative	negative	ADJ
cuesj-183	43	3	samples	sample	NOUN
cuesj-183	43	4	were	be	AUX
cuesj-183	43	5	also	also	ADV
cuesj-183	43	6	included	include	VERB
cuesj-183	43	7	in	in	ADP
cuesj-183	43	8	this	this	DET
cuesj-183	43	9	study	study	NOUN
cuesj-183	43	10	as	as	ADP
cuesj-183	43	11	a	a	DET
cuesj-183	43	12	control	control	NOUN
cuesj-183	43	13	group	group	NOUN
cuesj-183	43	14	for	for	ADP
cuesj-183	43	15	further	further	ADJ
cuesj-183	43	16	analysis	analysis	NOUN
cuesj-183	43	17	.	.	PUNCT
cuesj-183	44	1	among	among	ADP
cuesj-183	44	2	the	the	DET
cuesj-183	44	3	159	159	NUM
cuesj-183	44	4	participants	participant	NOUN
cuesj-183	44	5	saleh	saleh	VERB
cuesj-183	44	6	and	and	CCONJ
cuesj-183	44	7	taher	taher	PROPN
cuesj-183	44	8	:	:	PUNCT
cuesj-183	44	9	prevalence	prevalence	NOUN
cuesj-183	44	10	of	of	ADP
cuesj-183	44	11	hepatitis	hepatitis	PROPN
cuesj-183	44	12	b	b	PROPN
cuesj-183	44	13	and	and	CCONJ
cuesj-183	44	14	hepatitis	hepatitis	PROPN
cuesj-183	44	15	c	c	NOUN
cuesj-183	44	16	infection	infection	NOUN
cuesj-183	44	17	in	in	ADP
cuesj-183	44	18	erbil	erbil	PROPN
cuesj-183	44	19	47	47	NUM
cuesj-183	44	20	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-183	44	21	cuesj	cuesj	NOUN
cuesj-183	44	22	2020	2020	NUM
cuesj-183	44	23	,	,	PUNCT
cuesj-183	44	24	4	4	NUM
cuesj-183	44	25	(	(	PUNCT
cuesj-183	44	26	1	1	NUM
cuesj-183	44	27	):	):	PUNCT
cuesj-183	44	28	45	45	NUM
cuesj-183	44	29	-	-	SYM
cuesj-183	44	30	51	51	NUM
cuesj-183	44	31	who	who	PRON
cuesj-183	44	32	were	be	AUX
cuesj-183	44	33	included	include	VERB
cuesj-183	44	34	in	in	ADP
cuesj-183	44	35	this	this	DET
cuesj-183	44	36	study	study	NOUN
cuesj-183	44	37	as	as	ADP
cuesj-183	44	38	a	a	DET
cuesj-183	44	39	test	test	NOUN
cuesj-183	44	40	and	and	CCONJ
cuesj-183	44	41	control	control	NOUN
cuesj-183	44	42	group	group	NOUN
cuesj-183	44	43	,	,	PUNCT
cuesj-183	44	44	the	the	DET
cuesj-183	44	45	mean	mean	ADJ
cuesj-183	44	46	and	and	CCONJ
cuesj-183	44	47	standard	standard	ADJ
cuesj-183	44	48	deviation	deviation	NOUN
cuesj-183	44	49	in	in	ADP
cuesj-183	44	50	age	age	NOUN
cuesj-183	44	51	for	for	ADP
cuesj-183	44	52	the	the	DET
cuesj-183	44	53	control	control	NOUN
cuesj-183	44	54	group	group	NOUN
cuesj-183	44	55	was	be	AUX
cuesj-183	44	56	35.5	35.5	NUM
cuesj-183	44	57	±	±	NUM
cuesj-183	44	58	8.6	8.6	NUM
cuesj-183	44	59	and	and	CCONJ
cuesj-183	44	60	that	that	SCONJ
cuesj-183	44	61	for	for	ADP
cuesj-183	44	62	the	the	DET
cuesj-183	44	63	test	test	NOUN
cuesj-183	44	64	group	group	NOUN
cuesj-183	44	65	was	be	AUX
cuesj-183	44	66	40.9	40.9	NUM
cuesj-183	44	67	±	±	NUM
cuesj-183	44	68	12	12	NUM
cuesj-183	44	69	.	.	PUNCT
cuesj-183	45	1	the	the	DET
cuesj-183	45	2	ages	age	NOUN
cuesj-183	45	3	of	of	ADP
cuesj-183	45	4	blood	blood	NOUN
cuesj-183	45	5	donors	donor	NOUN
cuesj-183	45	6	both	both	PRON
cuesj-183	45	7	for	for	ADP
cuesj-183	45	8	test	test	NOUN
cuesj-183	45	9	and	and	CCONJ
cuesj-183	45	10	control	control	PROPN
cuesj-183	45	11	group	group	NOUN
cuesj-183	45	12	were	be	AUX
cuesj-183	45	13	grouped	group	VERB
cuesj-183	45	14	into	into	ADP
cuesj-183	45	15	six	six	NUM
cuesj-183	45	16	groups	group	NOUN
cuesj-183	45	17	[	[	X
cuesj-183	45	18	tables	table	NOUN
cuesj-183	45	19	1	1	NUM
cuesj-183	45	20	and	and	CCONJ
cuesj-183	45	21	2	2	NUM
cuesj-183	45	22	]	]	PUNCT
cuesj-183	45	23	.	.	PUNCT
cuesj-183	46	1	the	the	DET
cuesj-183	46	2	minimum	minimum	ADJ
cuesj-183	46	3	age	age	NOUN
cuesj-183	46	4	is	be	AUX
cuesj-183	46	5	19	19	NUM
cuesj-183	46	6	years	year	NOUN
cuesj-183	46	7	,	,	PUNCT
cuesj-183	46	8	and	and	CCONJ
cuesj-183	46	9	the	the	DET
cuesj-183	46	10	maximum	maximum	ADJ
cuesj-183	46	11	age	age	NOUN
cuesj-183	46	12	is	be	AUX
cuesj-183	46	13	73	73	NUM
cuesj-183	46	14	years	year	NOUN
cuesj-183	46	15	for	for	ADP
cuesj-183	46	16	the	the	DET
cuesj-183	46	17	test	test	NOUN
cuesj-183	46	18	group	group	NOUN
cuesj-183	46	19	and	and	CCONJ
cuesj-183	46	20	22	22	NUM
cuesj-183	46	21	and	and	CCONJ
cuesj-183	46	22	57	57	NUM
cuesj-183	46	23	years	year	NOUN
cuesj-183	46	24	for	for	ADP
cuesj-183	46	25	the	the	DET
cuesj-183	46	26	control	control	NOUN
cuesj-183	46	27	group	group	NOUN
cuesj-183	46	28	.	.	PUNCT
cuesj-183	47	1	prevalence	prevalence	NOUN
cuesj-183	47	2	of	of	ADP
cuesj-183	47	3	hepatitis	hepatitis	PROPN
cuesj-183	47	4	b	b	PROPN
cuesj-183	47	5	and	and	CCONJ
cuesj-183	47	6	hepatitis	hepatitis	PROPN
cuesj-183	47	7	c	c	PROPN
cuesj-183	47	8	serologically	serologically	ADV
cuesj-183	47	9	,	,	PUNCT
cuesj-183	47	10	based	base	VERB
cuesj-183	47	11	on	on	ADP
cuesj-183	47	12	detection	detection	NOUN
cuesj-183	47	13	of	of	ADP
cuesj-183	47	14	hbs	hbs	PROPN
cuesj-183	47	15	-	-	PUNCT
cuesj-183	47	16	ag	ag	PROPN
cuesj-183	47	17	,	,	PUNCT
cuesj-183	47	18	hbc	hbc	PROPN
cuesj-183	47	19	-	-	PUNCT
cuesj-183	47	20	ab	ab	NOUN
cuesj-183	47	21	,	,	PUNCT
cuesj-183	47	22	and	and	CCONJ
cuesj-183	47	23	hcv	hcv	PROPN
cuesj-183	47	24	-	-	PUNCT
cuesj-183	47	25	ab	ab	NOUN
cuesj-183	47	26	,	,	PUNCT
cuesj-183	47	27	we	we	PRON
cuesj-183	47	28	decided	decide	VERB
cuesj-183	47	29	whether	whether	SCONJ
cuesj-183	47	30	the	the	DET
cuesj-183	47	31	patient	patient	NOUN
cuesj-183	47	32	has	have	VERB
cuesj-183	47	33	hbv	hbv	NOUN
cuesj-183	47	34	or	or	CCONJ
cuesj-183	47	35	hcv	hcv	NOUN
cuesj-183	47	36	infection	infection	NOUN
cuesj-183	47	37	.	.	PUNCT
cuesj-183	48	1	these	these	DET
cuesj-183	48	2	tests	test	NOUN
cuesj-183	48	3	were	be	AUX
cuesj-183	48	4	carried	carry	VERB
cuesj-183	48	5	out	out	ADP
cuesj-183	48	6	for	for	ADP
cuesj-183	48	7	all	all	DET
cuesj-183	48	8	the	the	DET
cuesj-183	48	9	participants	participant	NOUN
cuesj-183	48	10	(	(	PUNCT
cuesj-183	48	11	6173	6173	NUM
cuesj-183	48	12	)	)	PUNCT
cuesj-183	48	13	.	.	PUNCT
cuesj-183	49	1	among	among	ADP
cuesj-183	49	2	all	all	DET
cuesj-183	49	3	examined	examine	VERB
cuesj-183	49	4	participants	participant	NOUN
cuesj-183	49	5	,	,	PUNCT
cuesj-183	49	6	only	only	ADV
cuesj-183	49	7	7	7	NUM
cuesj-183	49	8	patients	patient	NOUN
cuesj-183	49	9	were	be	AUX
cuesj-183	49	10	reactive	reactive	ADJ
cuesj-183	49	11	for	for	ADP
cuesj-183	49	12	hbs	hbs	PROPN
cuesj-183	49	13	-	-	PUNCT
cuesj-183	49	14	ag	ag	PROPN
cuesj-183	49	15	(	(	PUNCT
cuesj-183	49	16	0.11	0.11	NUM
cuesj-183	49	17	%	%	NOUN
cuesj-183	49	18	)	)	PUNCT
cuesj-183	49	19	,	,	PUNCT
cuesj-183	49	20	whereas	whereas	SCONJ
cuesj-183	49	21	98	98	NUM
cuesj-183	49	22	donors	donor	NOUN
cuesj-183	49	23	were	be	AUX
cuesj-183	49	24	reactive	reactive	ADJ
cuesj-183	49	25	for	for	ADP
cuesj-183	49	26	hbc	hbc	PROPN
cuesj-183	49	27	-	-	PUNCT
cuesj-183	49	28	ab	ab	PROPN
cuesj-183	49	29	(	(	PUNCT
cuesj-183	49	30	1.58	1.58	NUM
cuesj-183	49	31	%	%	NOUN
cuesj-183	49	32	)	)	PUNCT
cuesj-183	49	33	.	.	PUNCT
cuesj-183	50	1	regarding	regard	VERB
cuesj-183	50	2	hcv	hcv	NOUN
cuesj-183	50	3	infection	infection	NOUN
cuesj-183	50	4	only	only	ADV
cuesj-183	50	5	4	4	NUM
cuesj-183	50	6	patients	patient	NOUN
cuesj-183	50	7	were	be	AUX
cuesj-183	50	8	positive	positive	ADJ
cuesj-183	50	9	for	for	ADP
cuesj-183	50	10	antihcv	antihcv	PROPN
cuesj-183	50	11	ab	ab	PROPN
cuesj-183	50	12	(	(	PUNCT
cuesj-183	50	13	0.065	0.065	NUM
cuesj-183	50	14	%	%	NOUN
cuesj-183	50	15	)	)	PUNCT
cuesj-183	50	16	,	,	PUNCT
cuesj-183	50	17	as	as	SCONJ
cuesj-183	50	18	described	describe	VERB
cuesj-183	50	19	in	in	ADP
cuesj-183	50	20	figures	figure	NOUN
cuesj-183	50	21	1	1	NUM
cuesj-183	50	22	and	and	CCONJ
cuesj-183	50	23	2	2	NUM
cuesj-183	50	24	.	.	NOUN
cuesj-183	50	25	immune	immune	ADJ
cuesj-183	50	26	blood	blood	NOUN
cuesj-183	50	27	donors	donor	NOUN
cuesj-183	50	28	for	for	ADP
cuesj-183	50	29	hbv	hbv	NOUN
cuesj-183	50	30	infection	infection	NOUN
cuesj-183	50	31	among	among	ADP
cuesj-183	50	32	the	the	DET
cuesj-183	50	33	sero	sero	NOUN
cuesj-183	50	34	-	-	PUNCT
cuesj-183	50	35	reactive	reactive	NOUN
cuesj-183	50	36	blood	blood	NOUN
cuesj-183	50	37	donors	donor	NOUN
cuesj-183	50	38	for	for	ADP
cuesj-183	50	39	hbv	hbv	NOUN
cuesj-183	50	40	,	,	PUNCT
cuesj-183	50	41	we	we	PRON
cuesj-183	50	42	further	far	ADV
cuesj-183	50	43	characterize	characterize	VERB
cuesj-183	50	44	them	they	PRON
cuesj-183	50	45	through	through	ADP
cuesj-183	50	46	detection	detection	NOUN
cuesj-183	50	47	of	of	ADP
cuesj-183	50	48	antibody	antibody	NOUN
cuesj-183	50	49	against	against	ADP
cuesj-183	50	50	hbs	hbs	PROPN
cuesj-183	50	51	-	-	PUNCT
cuesj-183	50	52	ag	ag	PROPN
cuesj-183	50	53	(	(	PUNCT
cuesj-183	50	54	hbs	hbs	PROPN
cuesj-183	50	55	-	-	PUNCT
cuesj-183	50	56	ab	ab	PROPN
cuesj-183	50	57	)	)	PUNCT
cuesj-183	50	58	.	.	PUNCT
cuesj-183	51	1	should	should	AUX
cuesj-183	51	2	individuals	individual	NOUN
cuesj-183	51	3	of	of	ADP
cuesj-183	51	4	hbc	hbc	PROPN
cuesj-183	51	5	-	-	PUNCT
cuesj-183	51	6	ab	ab	PROPN
cuesj-183	51	7	positive	positive	ADJ
cuesj-183	51	8	blood	blood	NOUN
cuesj-183	51	9	have	have	VERB
cuesj-183	51	10	hbs	hbs	PROPN
cuesj-183	51	11	-	-	PUNCT
cuesj-183	51	12	ab	ab	PROPN
cuesj-183	51	13	in	in	ADP
cuesj-183	51	14	their	their	PRON
cuesj-183	51	15	blood	blood	NOUN
cuesj-183	51	16	,	,	PUNCT
cuesj-183	51	17	this	this	PRON
cuesj-183	51	18	indicates	indicate	VERB
cuesj-183	51	19	that	that	SCONJ
cuesj-183	51	20	these	these	DET
cuesj-183	51	21	participants	participant	NOUN
cuesj-183	51	22	are	be	AUX
cuesj-183	51	23	cured	cure	VERB
cuesj-183	51	24	of	of	ADP
cuesj-183	51	25	hbv	hbv	NOUN
cuesj-183	51	26	infection	infection	NOUN
cuesj-183	51	27	and	and	CCONJ
cuesj-183	51	28	means	mean	VERB
cuesj-183	51	29	that	that	SCONJ
cuesj-183	51	30	they	they	PRON
cuesj-183	51	31	have	have	VERB
cuesj-183	51	32	immunity	immunity	NOUN
cuesj-183	51	33	to	to	PART
cuesj-183	51	34	hbv	hbv	NOUN
cuesj-183	51	35	infection	infection	NOUN
cuesj-183	51	36	.	.	PUNCT
cuesj-183	52	1	among	among	ADP
cuesj-183	52	2	the	the	DET
cuesj-183	52	3	98	98	NUM
cuesj-183	52	4	sero	sero	ADJ
cuesj-183	52	5	-	-	PUNCT
cuesj-183	52	6	reactive	reactive	NOUN
cuesj-183	52	7	blood	blood	NOUN
cuesj-183	52	8	donors	donor	NOUN
cuesj-183	52	9	,	,	PUNCT
cuesj-183	52	10	74	74	NUM
cuesj-183	52	11	blood	blood	NOUN
cuesj-183	52	12	donors	donor	NOUN
cuesj-183	52	13	were	be	AUX
cuesj-183	52	14	positive	positive	ADJ
cuesj-183	52	15	for	for	SCONJ
cuesj-183	52	16	hbs	hbs	PROPN
cuesj-183	52	17	-	-	PUNCT
cuesj-183	52	18	ab	ab	PROPN
cuesj-183	52	19	(	(	PUNCT
cuesj-183	52	20	75.5	75.5	NUM
cuesj-183	52	21	%	%	NOUN
cuesj-183	52	22	)	)	PUNCT
cuesj-183	52	23	indicating	indicate	VERB
cuesj-183	52	24	that	that	SCONJ
cuesj-183	52	25	they	they	PRON
cuesj-183	52	26	are	be	AUX
cuesj-183	52	27	cured	cure	VERB
cuesj-183	52	28	of	of	ADP
cuesj-183	52	29	natural	natural	ADJ
cuesj-183	52	30	infection	infection	NOUN
cuesj-183	52	31	.	.	PUNCT
cuesj-183	53	1	we	we	PRON
cuesj-183	53	2	also	also	ADV
cuesj-183	53	3	examined	examine	VERB
cuesj-183	53	4	50	50	NUM
cuesj-183	53	5	healthy	healthy	ADJ
cuesj-183	53	6	volunteers	volunteer	NOUN
cuesj-183	53	7	that	that	PRON
cuesj-183	53	8	are	be	AUX
cuesj-183	53	9	free	free	ADJ
cuesj-183	53	10	from	from	ADP
cuesj-183	53	11	hbv	hbv	NOUN
cuesj-183	53	12	and	and	CCONJ
cuesj-183	53	13	hcv	hcv	NOUN
cuesj-183	53	14	infection	infection	NOUN
cuesj-183	53	15	,	,	PUNCT
cuesj-183	53	16	among	among	ADP
cuesj-183	53	17	them	they	PRON
cuesj-183	53	18	only	only	ADV
cuesj-183	53	19	4	4	NUM
cuesj-183	53	20	blood	blood	NOUN
cuesj-183	53	21	donors	donor	NOUN
cuesj-183	53	22	were	be	AUX
cuesj-183	53	23	positive	positive	ADJ
cuesj-183	53	24	for	for	ADP
cuesj-183	53	25	hbs	hbs	PROPN
cuesj-183	53	26	-	-	PUNCT
cuesj-183	53	27	ab	ab	PROPN
cuesj-183	53	28	,	,	PUNCT
cuesj-183	53	29	reflecting	reflect	VERB
cuesj-183	53	30	the	the	DET
cuesj-183	53	31	successful	successful	ADJ
cuesj-183	53	32	vaccination	vaccination	NOUN
cuesj-183	53	33	and	and	CCONJ
cuesj-183	53	34	protection	protection	NOUN
cuesj-183	53	35	against	against	ADP
cuesj-183	53	36	hbv	hbv	NOUN
cuesj-183	53	37	infection	infection	NOUN
cuesj-183	53	38	[	[	X
cuesj-183	53	39	table	table	NOUN
cuesj-183	53	40	3	3	NUM
cuesj-183	53	41	]	]	PUNCT
cuesj-183	53	42	.	.	PUNCT
cuesj-183	54	1	diagnosing	diagnose	VERB
cuesj-183	54	2	occult	occult	NOUN
cuesj-183	54	3	hbv	hbv	NOUN
cuesj-183	54	4	infection	infection	NOUN
cuesj-183	54	5	as	as	SCONJ
cuesj-183	54	6	we	we	PRON
cuesj-183	54	7	defined	define	VERB
cuesj-183	54	8	obi	obi	NOUN
cuesj-183	54	9	before	before	ADV
cuesj-183	54	10	,	,	PUNCT
cuesj-183	54	11	blood	blood	NOUN
cuesj-183	54	12	donors	donor	NOUN
cuesj-183	54	13	with	with	ADP
cuesj-183	54	14	hbs	hbs	PROPN
cuesj-183	54	15	-	-	PUNCT
cuesj-183	54	16	ag	ag	PROPN
cuesj-183	54	17	negative	negative	ADJ
cuesj-183	54	18	serology	serology	NOUN
cuesj-183	54	19	,	,	PUNCT
cuesj-183	54	20	hbc	hbc	NOUN
cuesj-183	54	21	-	-	PUNCT
cuesj-183	54	22	abs	ab	NOUN
cuesj-183	54	23	positive	positive	ADJ
cuesj-183	54	24	or	or	CCONJ
cuesj-183	54	25	negative	negative	ADJ
cuesj-183	54	26	,	,	PUNCT
cuesj-183	54	27	and	and	CCONJ
cuesj-183	54	28	the	the	DET
cuesj-183	54	29	presence	presence	NOUN
cuesj-183	54	30	of	of	ADP
cuesj-183	54	31	viral	viral	ADJ
cuesj-183	54	32	dna	dna	NOUN
cuesj-183	54	33	by	by	ADP
cuesj-183	54	34	pcr	pcr	PROPN
cuesj-183	54	35	are	be	AUX
cuesj-183	54	36	known	know	VERB
cuesj-183	54	37	as	as	ADP
cuesj-183	54	38	occult	occult	NOUN
cuesj-183	54	39	hbv	hbv	NOUN
cuesj-183	54	40	infection	infection	NOUN
cuesj-183	54	41	(	(	PUNCT
cuesj-183	54	42	obi	obi	PROPN
cuesj-183	54	43	)	)	PUNCT
cuesj-183	54	44	.	.	PUNCT
cuesj-183	55	1	blood	blood	NOUN
cuesj-183	55	2	donors	donor	NOUN
cuesj-183	55	3	with	with	ADP
cuesj-183	55	4	only	only	ADJ
cuesj-183	55	5	positive	positive	ADJ
cuesj-183	55	6	hbc	hbc	NOUN
cuesj-183	55	7	-	-	PUNCT
cuesj-183	55	8	ab	ab	NOUN
cuesj-183	55	9	in	in	ADP
cuesj-183	55	10	the	the	DET
cuesj-183	55	11	absence	absence	NOUN
cuesj-183	55	12	of	of	ADP
cuesj-183	55	13	hbs	hbs	PROPN
cuesj-183	55	14	-	-	PUNCT
cuesj-183	55	15	ag	ag	PROPN
cuesj-183	55	16	and	and	CCONJ
cuesj-183	55	17	hbs	hbs	PROPN
cuesj-183	55	18	-	-	PUNCT
cuesj-183	55	19	ab	ab	PROPN
cuesj-183	55	20	are	be	AUX
cuesj-183	55	21	regarded	regard	VERB
cuesj-183	55	22	as	as	ADP
cuesj-183	55	23	obi.[10	obi.[10	ADV
cuesj-183	55	24	]	]	PUNCT
cuesj-183	55	25	in	in	ADP
cuesj-183	55	26	our	our	PRON
cuesj-183	55	27	study	study	NOUN
cuesj-183	55	28	,	,	PUNCT
cuesj-183	55	29	we	we	PRON
cuesj-183	55	30	further	far	ADV
cuesj-183	55	31	characterize	characterize	VERB
cuesj-183	55	32	the	the	DET
cuesj-183	55	33	positive	positive	ADJ
cuesj-183	55	34	blood	blood	NOUN
cuesj-183	55	35	donors	donor	NOUN
cuesj-183	55	36	.	.	PUNCT
cuesj-183	56	1	among	among	ADP
cuesj-183	56	2	the	the	DET
cuesj-183	56	3	samples	sample	NOUN
cuesj-183	56	4	that	that	PRON
cuesj-183	56	5	are	be	AUX
cuesj-183	56	6	included	include	VERB
cuesj-183	56	7	in	in	ADP
cuesj-183	56	8	our	our	PRON
cuesj-183	56	9	study	study	NOUN
cuesj-183	56	10	,	,	PUNCT
cuesj-183	56	11	98	98	NUM
cuesj-183	56	12	samples	sample	NOUN
cuesj-183	56	13	were	be	AUX
cuesj-183	56	14	positive	positive	ADJ
cuesj-183	56	15	for	for	ADP
cuesj-183	56	16	hbc	hbc	NOUN
cuesj-183	56	17	-	-	PUNCT
cuesj-183	56	18	ab	ab	NOUN
cuesj-183	56	19	,	,	PUNCT
cuesj-183	56	20	from	from	ADP
cuesj-183	56	21	which	which	PRON
cuesj-183	56	22	24	24	NUM
cuesj-183	56	23	blood	blood	NOUN
cuesj-183	56	24	donors	donor	NOUN
cuesj-183	56	25	(	(	PUNCT
cuesj-183	56	26	24.5	24.5	NUM
cuesj-183	56	27	%	%	NOUN
cuesj-183	56	28	)	)	PUNCT
cuesj-183	56	29	were	be	AUX
cuesj-183	56	30	negative	negative	ADJ
cuesj-183	56	31	for	for	ADP
cuesj-183	56	32	hbs	hbs	PROPN
cuesj-183	56	33	-	-	PUNCT
cuesj-183	56	34	ag	ag	PROPN
cuesj-183	56	35	and	and	CCONJ
cuesj-183	56	36	hbs	hbs	PROPN
cuesj-183	56	37	-	-	PUNCT
cuesj-183	56	38	ab	ab	PROPN
cuesj-183	56	39	(	(	PUNCT
cuesj-183	56	40	hbc	hbc	PROPN
cuesj-183	56	41	-	-	PUNCT
cuesj-183	56	42	ab	ab	PROPN
cuesj-183	57	1	+	+	PROPN
cuesj-183	57	2	ve	ve	PROPN
cuesj-183	57	3	,	,	PUNCT
cuesj-183	57	4	hbs	hbs	PROPN
cuesj-183	57	5	-	-	PUNCT
cuesj-183	57	6	ag	ag	PROPN
cuesj-183	57	7	–	–	PUNCT
cuesj-183	57	8	ve	ve	VERB
cuesj-183	57	9	,	,	PUNCT
cuesj-183	57	10	and	and	CCONJ
cuesj-183	57	11	hbs	hbs	PROPN
cuesj-183	57	12	-	-	PUNCT
cuesj-183	57	13	ab	ab	PROPN
cuesj-183	57	14	–	–	PUNCT
cuesj-183	57	15	ve	ve	PROPN
cuesj-183	57	16	)	)	PUNCT
cuesj-183	57	17	,	,	PUNCT
cuesj-183	57	18	indicating	indicate	VERB
cuesj-183	57	19	that	that	SCONJ
cuesj-183	57	20	these	these	DET
cuesj-183	57	21	blood	blood	NOUN
cuesj-183	57	22	donors	donor	NOUN
cuesj-183	57	23	were	be	AUX
cuesj-183	57	24	defined	define	VERB
cuesj-183	57	25	as	as	ADP
cuesj-183	57	26	having	have	VERB
cuesj-183	57	27	occult	occult	NOUN
cuesj-183	57	28	hepatitis	hepatitis	NOUN
cuesj-183	57	29	virus	virus	NOUN
cuesj-183	57	30	infection	infection	NOUN
cuesj-183	57	31	[	[	X
cuesj-183	57	32	table	table	NOUN
cuesj-183	57	33	3	3	NUM
cuesj-183	57	34	]	]	PUNCT
cuesj-183	57	35	.	.	PUNCT
cuesj-183	58	1	these	these	DET
cuesj-183	58	2	24	24	NUM
cuesj-183	58	3	samples	sample	NOUN
cuesj-183	58	4	were	be	AUX
cuesj-183	58	5	further	far	ADV
cuesj-183	58	6	investigated	investigate	VERB
cuesj-183	58	7	for	for	ADP
cuesj-183	58	8	the	the	DET
cuesj-183	58	9	detection	detection	NOUN
cuesj-183	58	10	of	of	ADP
cuesj-183	58	11	hbv	hbv	NOUN
cuesj-183	58	12	dna	dna	PROPN
cuesj-183	58	13	[	[	X
cuesj-183	58	14	figure	figure	NOUN
cuesj-183	58	15	3	3	NUM
cuesj-183	58	16	]	]	PUNCT
cuesj-183	58	17	.	.	PUNCT
cuesj-183	59	1	hcv	hcv	NOUN
cuesj-183	59	2	incidence	incidence	NOUN
cuesj-183	59	3	and	and	CCONJ
cuesj-183	59	4	dual	dual	ADJ
cuesj-183	59	5	infection	infection	NOUN
cuesj-183	59	6	in	in	ADP
cuesj-183	59	7	this	this	DET
cuesj-183	59	8	study	study	NOUN
cuesj-183	59	9	,	,	PUNCT
cuesj-183	59	10	as	as	SCONJ
cuesj-183	59	11	we	we	PRON
cuesj-183	59	12	mentioned	mention	VERB
cuesj-183	59	13	above	above	ADV
cuesj-183	59	14	,	,	PUNCT
cuesj-183	59	15	besides	besides	SCONJ
cuesj-183	59	16	screening	screen	VERB
cuesj-183	59	17	for	for	ADP
cuesj-183	59	18	hbv	hbv	NOUN
cuesj-183	59	19	infection	infection	NOUN
cuesj-183	59	20	,	,	PUNCT
cuesj-183	59	21	screening	screen	VERB
cuesj-183	59	22	for	for	ADP
cuesj-183	59	23	hcv	hcv	PROPN
cuesj-183	59	24	was	be	AUX
cuesj-183	59	25	also	also	ADV
cuesj-183	59	26	done	do	VERB
cuesj-183	59	27	for	for	ADP
cuesj-183	59	28	these	these	DET
cuesj-183	59	29	participants	participant	NOUN
cuesj-183	59	30	.	.	PUNCT
cuesj-183	60	1	among	among	ADP
cuesj-183	60	2	6173	6173	NUM
cuesj-183	60	3	participants	participant	NOUN
cuesj-183	60	4	,	,	PUNCT
cuesj-183	60	5	only	only	ADV
cuesj-183	60	6	four	four	NUM
cuesj-183	60	7	blood	blood	NOUN
cuesj-183	60	8	donors	donor	NOUN
cuesj-183	60	9	were	be	AUX
cuesj-183	60	10	positive	positive	ADJ
cuesj-183	60	11	for	for	ADP
cuesj-183	60	12	hcv	hcv	PROPN
cuesj-183	60	13	-	-	PUNCT
cuesj-183	60	14	ab	ab	NOUN
cuesj-183	60	15	0.06	0.06	NUM
cuesj-183	60	16	%	%	NOUN
cuesj-183	60	17	.	.	PUNCT
cuesj-183	61	1	among	among	ADP
cuesj-183	61	2	hcv	hcv	NOUN
cuesj-183	61	3	reactive	reactive	ADJ
cuesj-183	61	4	donors	donor	NOUN
cuesj-183	61	5	,	,	PUNCT
cuesj-183	61	6	one	one	NUM
cuesj-183	61	7	individual	individual	NOUN
cuesj-183	61	8	was	be	AUX
cuesj-183	61	9	positive	positive	ADJ
cuesj-183	61	10	both	both	CCONJ
cuesj-183	61	11	for	for	ADP
cuesj-183	61	12	hbv	hbv	NOUN
cuesj-183	61	13	infection	infection	NOUN
cuesj-183	61	14	and	and	CCONJ
cuesj-183	61	15	hcv	hcv	NOUN
cuesj-183	61	16	infection	infection	NOUN
cuesj-183	61	17	,	,	PUNCT
cuesj-183	61	18	which	which	PRON
cuesj-183	61	19	means	mean	VERB
cuesj-183	61	20	that	that	SCONJ
cuesj-183	61	21	he	he	PRON
cuesj-183	61	22	has	have	VERB
cuesj-183	61	23	a	a	DET
cuesj-183	61	24	dual	dual	ADJ
cuesj-183	61	25	infection	infection	NOUN
cuesj-183	61	26	[	[	X
cuesj-183	61	27	table	table	NOUN
cuesj-183	61	28	4	4	NUM
cuesj-183	61	29	]	]	PUNCT
cuesj-183	61	30	.	.	PUNCT
cuesj-183	62	1	sero	sero	NOUN
cuesj-183	62	2	-	-	PUNCT
cuesj-183	62	3	status	status	NOUN
cuesj-183	62	4	in	in	ADP
cuesj-183	62	5	relation	relation	NOUN
cuesj-183	62	6	to	to	PART
cuesj-183	62	7	socio	socio	VERB
cuesj-183	62	8	-	-	ADJ
cuesj-183	62	9	demographic	demographic	ADJ
cuesj-183	62	10	characteristics	characteristic	NOUN
cuesj-183	62	11	among	among	ADP
cuesj-183	62	12	the	the	DET
cuesj-183	62	13	hbv	hbv	NOUN
cuesj-183	62	14	and	and	CCONJ
cuesj-183	62	15	hcv	hcv	VERB
cuesj-183	62	16	positive	positive	ADJ
cuesj-183	62	17	blood	blood	NOUN
cuesj-183	62	18	donors	donor	NOUN
cuesj-183	62	19	,	,	PUNCT
cuesj-183	62	20	the	the	DET
cuesj-183	62	21	highest	high	ADJ
cuesj-183	62	22	frequency	frequency	NOUN
cuesj-183	62	23	of	of	ADP
cuesj-183	62	24	38	38	NUM
cuesj-183	62	25	(	(	PUNCT
cuesj-183	62	26	35	35	NUM
cuesj-183	62	27	%	%	NOUN
cuesj-183	62	28	)	)	PUNCT
cuesj-183	62	29	was	be	AUX
cuesj-183	62	30	found	find	VERB
cuesj-183	62	31	among	among	ADP
cuesj-183	62	32	those	those	PRON
cuesj-183	62	33	aged	age	VERB
cuesj-183	62	34	between	between	ADP
cuesj-183	62	35	26	26	NUM
cuesj-183	62	36	and	and	CCONJ
cuesj-183	62	37	35	35	NUM
cuesj-183	62	38	years	year	NOUN
cuesj-183	62	39	(	(	PUNCT
cuesj-183	62	40	young	young	ADJ
cuesj-183	62	41	age	age	NOUN
cuesj-183	62	42	groups	group	NOUN
cuesj-183	62	43	)	)	PUNCT
cuesj-183	62	44	.	.	PUNCT
cuesj-183	63	1	blood	blood	NOUN
cuesj-183	63	2	donors	donor	NOUN
cuesj-183	63	3	with	with	ADP
cuesj-183	63	4	blood	blood	NOUN
cuesj-183	63	5	group	group	NOUN
cuesj-183	63	6	o	o	PROPN
cuesj-183	63	7	were	be	AUX
cuesj-183	63	8	found	find	VERB
cuesj-183	63	9	to	to	PART
cuesj-183	63	10	have	have	VERB
cuesj-183	63	11	the	the	DET
cuesj-183	63	12	highest	high	ADJ
cuesj-183	63	13	frequency	frequency	NOUN
cuesj-183	63	14	for	for	ADP
cuesj-183	63	15	table	table	NOUN
cuesj-183	63	16	1	1	NUM
cuesj-183	63	17	:	:	PUNCT
cuesj-183	63	18	demographic	demographic	ADJ
cuesj-183	63	19	distribution	distribution	NOUN
cuesj-183	63	20	of	of	ADP
cuesj-183	63	21	the	the	DET
cuesj-183	63	22	hbv	hbv	NOUN
cuesj-183	63	23	and/or	and/or	CCONJ
cuesj-183	63	24	bcv	bcv	X
cuesj-183	63	25	positive	positive	ADJ
cuesj-183	63	26	samples	sample	NOUN
cuesj-183	63	27	(	(	PUNCT
cuesj-183	63	28	positive	positive	ADJ
cuesj-183	63	29	blood	blood	NOUN
cuesj-183	63	30	donors	donor	NOUN
cuesj-183	63	31	)	)	PUNCT
cuesj-183	63	32	demographic	demographic	ADJ
cuesj-183	63	33	distribution	distribution	NOUN
cuesj-183	63	34	frequency	frequency	NOUN
cuesj-183	63	35	(	(	PUNCT
cuesj-183	63	36	n=%	n=%	NOUN
cuesj-183	63	37	)	)	PUNCT
cuesj-183	63	38	test	test	NOUN
cuesj-183	63	39	group	group	NOUN
cuesj-183	63	40	age	age	NOUN
cuesj-183	63	41	groups	group	NOUN
cuesj-183	63	42	(	(	PUNCT
cuesj-183	63	43	year	year	NOUN
cuesj-183	63	44	)	)	PUNCT
cuesj-183	63	45	under	under	ADP
cuesj-183	63	46	25	25	NUM
cuesj-183	63	47	4	4	NUM
cuesj-183	63	48	(	(	PUNCT
cuesj-183	63	49	3.7	3.7	NUM
cuesj-183	63	50	)	)	PUNCT
cuesj-183	63	51	2–35	2–35	NUM
cuesj-183	63	52	38	38	NUM
cuesj-183	63	53	(	(	PUNCT
cuesj-183	63	54	35	35	NUM
cuesj-183	63	55	)	)	PUNCT
cuesj-183	63	56	36–45	36–45	NUM
cuesj-183	63	57	33	33	NUM
cuesj-183	63	58	(	(	PUNCT
cuesj-183	63	59	30	30	NUM
cuesj-183	63	60	)	)	PUNCT
cuesj-183	63	61	46–55	46–55	NUM
cuesj-183	63	62	22	22	NUM
cuesj-183	63	63	(	(	PUNCT
cuesj-183	63	64	20	20	NUM
cuesj-183	63	65	)	)	PUNCT
cuesj-183	63	66	56–65	56–65	NUM
cuesj-183	63	67	7	7	NUM
cuesj-183	63	68	(	(	PUNCT
cuesj-183	63	69	6.4	6.4	NUM
cuesj-183	63	70	)	)	PUNCT
cuesj-183	63	71	above	above	ADP
cuesj-183	63	72	66	66	NUM
cuesj-183	63	73	5	5	NUM
cuesj-183	63	74	(	(	PUNCT
cuesj-183	63	75	4.6	4.6	NUM
cuesj-183	63	76	)	)	PUNCT
cuesj-183	63	77	blood	blood	NOUN
cuesj-183	63	78	groups	group	NOUN
cuesj-183	63	79	o	o	NOUN
cuesj-183	63	80	39	39	NUM
cuesj-183	63	81	(	(	PUNCT
cuesj-183	63	82	36	36	NUM
cuesj-183	63	83	)	)	PUNCT
cuesj-183	63	84	a	a	DET
cuesj-183	63	85	36	36	NUM
cuesj-183	63	86	(	(	PUNCT
cuesj-183	63	87	33	33	NUM
cuesj-183	63	88	)	)	PUNCT
cuesj-183	63	89	b	b	NOUN
cuesj-183	63	90	25	25	NUM
cuesj-183	63	91	(	(	PUNCT
cuesj-183	63	92	23	23	NUM
cuesj-183	63	93	)	)	PUNCT
cuesj-183	63	94	ab	ab	PROPN
cuesj-183	63	95	9	9	NUM
cuesj-183	63	96	(	(	PUNCT
cuesj-183	63	97	8)	8)	NUM
cuesj-183	63	98	occupations	occupation	NOUN
cuesj-183	63	99	private	private	ADJ
cuesj-183	63	100	sector	sector	NOUN
cuesj-183	63	101	employee	employee	NOUN
cuesj-183	63	102	73	73	NUM
cuesj-183	63	103	(	(	PUNCT
cuesj-183	63	104	67	67	NUM
cuesj-183	63	105	)	)	PUNCT
cuesj-183	63	106	public	public	ADJ
cuesj-183	63	107	sector	sector	NOUN
cuesj-183	63	108	employee	employee	NOUN
cuesj-183	63	109	30	30	NUM
cuesj-183	63	110	(	(	PUNCT
cuesj-183	63	111	27.5	27.5	NUM
cuesj-183	63	112	)	)	PUNCT
cuesj-183	63	113	unemployed	unemployed	ADJ
cuesj-183	63	114	6	6	NUM
cuesj-183	63	115	(	(	PUNCT
cuesj-183	63	116	5.5	5.5	NUM
cuesj-183	63	117	)	)	PUNCT
cuesj-183	63	118	student	student	NOUN
cuesj-183	63	119	total	total	NOUN
cuesj-183	63	120	109	109	NUM
cuesj-183	63	121	(	(	PUNCT
cuesj-183	63	122	100	100	NUM
cuesj-183	63	123	)	)	PUNCT
cuesj-183	63	124	table	table	NOUN
cuesj-183	63	125	2	2	NUM
cuesj-183	63	126	:	:	PUNCT
cuesj-183	63	127	demographic	demographic	ADJ
cuesj-183	63	128	distribution	distribution	NOUN
cuesj-183	63	129	of	of	ADP
cuesj-183	63	130	the	the	DET
cuesj-183	63	131	samples	sample	NOUN
cuesj-183	63	132	control	control	NOUN
cuesj-183	63	133	group	group	NOUN
cuesj-183	63	134	(	(	PUNCT
cuesj-183	63	135	negative	negative	ADJ
cuesj-183	63	136	blood	blood	NOUN
cuesj-183	63	137	donors	donor	NOUN
cuesj-183	63	138	)	)	PUNCT
cuesj-183	63	139	demographic	demographic	ADJ
cuesj-183	63	140	distribution	distribution	NOUN
cuesj-183	63	141	frequency	frequency	NOUN
cuesj-183	63	142	(	(	PUNCT
cuesj-183	63	143	n=%	n=%	ADJ
cuesj-183	63	144	)	)	PUNCT
cuesj-183	63	145	control	control	NOUN
cuesj-183	63	146	group	group	NOUN
cuesj-183	63	147	age	age	NOUN
cuesj-183	63	148	groups	group	NOUN
cuesj-183	63	149	(	(	PUNCT
cuesj-183	63	150	year	year	NOUN
cuesj-183	63	151	)	)	PUNCT
cuesj-183	63	152	under	under	ADP
cuesj-183	63	153	25	25	NUM
cuesj-183	63	154	6	6	NUM
cuesj-183	63	155	(	(	PUNCT
cuesj-183	63	156	12	12	NUM
cuesj-183	63	157	)	)	PUNCT
cuesj-183	63	158	26–35	26–35	NUM
cuesj-183	63	159	25	25	NUM
cuesj-183	63	160	(	(	PUNCT
cuesj-183	63	161	50	50	NUM
cuesj-183	63	162	)	)	PUNCT
cuesj-183	63	163	36–45	36–45	NUM
cuesj-183	63	164	10	10	NUM
cuesj-183	63	165	(	(	PUNCT
cuesj-183	63	166	20	20	NUM
cuesj-183	63	167	)	)	PUNCT
cuesj-183	63	168	46–55	46–55	NUM
cuesj-183	63	169	8	8	NUM
cuesj-183	63	170	(	(	PUNCT
cuesj-183	63	171	16	16	NUM
cuesj-183	63	172	)	)	PUNCT
cuesj-183	63	173	56–65	56–65	NUM
cuesj-183	63	174	1	1	NUM
cuesj-183	63	175	(	(	PUNCT
cuesj-183	63	176	2	2	NUM
cuesj-183	63	177	)	)	PUNCT
cuesj-183	63	178	above	above	ADP
cuesj-183	63	179	66	66	NUM
cuesj-183	63	180	blood	blood	NOUN
cuesj-183	63	181	groups	group	NOUN
cuesj-183	63	182	o	o	NOUN
cuesj-183	63	183	17	17	NUM
cuesj-183	63	184	(	(	PUNCT
cuesj-183	63	185	34	34	NUM
cuesj-183	63	186	)	)	PUNCT
cuesj-183	63	187	a	a	DET
cuesj-183	63	188	18	18	NUM
cuesj-183	63	189	(	(	PUNCT
cuesj-183	63	190	36	36	NUM
cuesj-183	63	191	)	)	PUNCT
cuesj-183	63	192	b	b	NOUN
cuesj-183	63	193	10	10	NUM
cuesj-183	63	194	(	(	PUNCT
cuesj-183	63	195	20	20	NUM
cuesj-183	63	196	)	)	PUNCT
cuesj-183	63	197	ab	ab	PROPN
cuesj-183	63	198	5	5	NUM
cuesj-183	63	199	(	(	PUNCT
cuesj-183	63	200	10	10	NUM
cuesj-183	63	201	)	)	PUNCT
cuesj-183	63	202	occupations	occupation	NOUN
cuesj-183	63	203	private	private	ADJ
cuesj-183	63	204	sector	sector	NOUN
cuesj-183	63	205	employee	employee	NOUN
cuesj-183	63	206	34	34	NUM
cuesj-183	63	207	(	(	PUNCT
cuesj-183	63	208	68	68	NUM
cuesj-183	63	209	)	)	PUNCT
cuesj-183	63	210	public	public	ADJ
cuesj-183	63	211	sector	sector	NOUN
cuesj-183	63	212	employee	employee	NOUN
cuesj-183	63	213	13	13	NUM
cuesj-183	63	214	(	(	PUNCT
cuesj-183	63	215	26	26	NUM
cuesj-183	63	216	)	)	PUNCT
cuesj-183	63	217	unemployed	unemployed	ADJ
cuesj-183	63	218	1	1	NUM
cuesj-183	63	219	(	(	PUNCT
cuesj-183	63	220	2	2	NUM
cuesj-183	63	221	)	)	PUNCT
cuesj-183	63	222	student	student	NOUN
cuesj-183	63	223	2	2	NUM
cuesj-183	63	224	(	(	PUNCT
cuesj-183	63	225	4	4	NUM
cuesj-183	63	226	)	)	PUNCT
cuesj-183	63	227	total	total	NOUN
cuesj-183	63	228	50	50	NUM
cuesj-183	63	229	(	(	PUNCT
cuesj-183	63	230	100	100	NUM
cuesj-183	63	231	)	)	PUNCT
cuesj-183	63	232	saleh	saleh	NOUN
cuesj-183	63	233	and	and	CCONJ
cuesj-183	63	234	taher	taher	PROPN
cuesj-183	63	235	:	:	PUNCT
cuesj-183	63	236	prevalence	prevalence	NOUN
cuesj-183	63	237	of	of	ADP
cuesj-183	63	238	hepatitis	hepatitis	PROPN
cuesj-183	63	239	b	b	PROPN
cuesj-183	63	240	and	and	CCONJ
cuesj-183	63	241	hepatitis	hepatitis	PROPN
cuesj-183	63	242	c	c	NOUN
cuesj-183	63	243	infection	infection	NOUN
cuesj-183	63	244	in	in	ADP
cuesj-183	63	245	erbil	erbil	PROPN
cuesj-183	63	246	48	48	NUM
cuesj-183	63	247	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-183	63	248	cuesj	cuesj	NOUN
cuesj-183	63	249	2020	2020	NUM
cuesj-183	63	250	,	,	PUNCT
cuesj-183	63	251	4	4	NUM
cuesj-183	63	252	(	(	PUNCT
cuesj-183	63	253	1	1	NUM
cuesj-183	63	254	):	):	PUNCT
cuesj-183	63	255	45	45	NUM
cuesj-183	63	256	-	-	SYM
cuesj-183	63	257	51	51	NUM
cuesj-183	63	258	its	its	PRON
cuesj-183	63	259	immunoreactivity	immunoreactivity	NOUN
cuesj-183	63	260	among	among	ADP
cuesj-183	63	261	test	test	NOUN
cuesj-183	63	262	group	group	NOUN
cuesj-183	63	263	39	39	NUM
cuesj-183	63	264	(	(	PUNCT
cuesj-183	63	265	36	36	NUM
cuesj-183	63	266	%	%	NOUN
cuesj-183	63	267	)	)	PUNCT
cuesj-183	64	1	[	[	X
cuesj-183	64	2	table	table	NOUN
cuesj-183	64	3	1	1	NUM
cuesj-183	64	4	]	]	PUNCT
cuesj-183	64	5	,	,	PUNCT
cuesj-183	64	6	whereas	whereas	SCONJ
cuesj-183	64	7	those	those	PRON
cuesj-183	64	8	with	with	ADP
cuesj-183	64	9	blood	blood	NOUN
cuesj-183	64	10	group	group	NOUN
cuesj-183	64	11	a	a	PROPN
cuesj-183	64	12	are	be	AUX
cuesj-183	64	13	among	among	ADP
cuesj-183	64	14	those	those	PRON
cuesj-183	64	15	with	with	ADP
cuesj-183	64	16	the	the	DET
cuesj-183	64	17	highest	high	ADJ
cuesj-183	64	18	frequency	frequency	NOUN
cuesj-183	64	19	among	among	ADP
cuesj-183	64	20	control	control	PROPN
cuesj-183	64	21	group	group	NOUN
cuesj-183	64	22	18	18	NUM
cuesj-183	64	23	(	(	PUNCT
cuesj-183	64	24	36	36	NUM
cuesj-183	64	25	%	%	NOUN
cuesj-183	64	26	)	)	PUNCT
cuesj-183	65	1	[	[	X
cuesj-183	65	2	table	table	NOUN
cuesj-183	65	3	2	2	NUM
cuesj-183	65	4	]	]	PUNCT
cuesj-183	65	5	.	.	PUNCT
cuesj-183	66	1	most	most	ADJ
cuesj-183	66	2	of	of	ADP
cuesj-183	66	3	the	the	DET
cuesj-183	66	4	reactive	reactive	ADJ
cuesj-183	66	5	individuals	individual	NOUN
cuesj-183	66	6	for	for	ADP
cuesj-183	66	7	hbv	hbv	NOUN
cuesj-183	66	8	positivity	positivity	NOUN
cuesj-183	66	9	were	be	AUX
cuesj-183	66	10	among	among	ADP
cuesj-183	66	11	the	the	DET
cuesj-183	66	12	private	private	ADJ
cuesj-183	66	13	sector	sector	NOUN
cuesj-183	66	14	employees	employee	NOUN
cuesj-183	67	1	[	[	X
cuesj-183	67	2	table	table	NOUN
cuesj-183	67	3	1	1	NUM
cuesj-183	67	4	]	]	PUNCT
cuesj-183	67	5	.	.	PUNCT
cuesj-183	68	1	none	none	NOUN
cuesj-183	68	2	of	of	ADP
cuesj-183	68	3	these	these	DET
cuesj-183	68	4	parameters	parameter	NOUN
cuesj-183	68	5	were	be	AUX
cuesj-183	68	6	statistically	statistically	ADV
cuesj-183	68	7	significant	significant	ADJ
cuesj-183	68	8	.	.	PUNCT
cuesj-183	69	1	molecular	molecular	ADJ
cuesj-183	69	2	detection	detection	NOUN
cuesj-183	69	3	of	of	ADP
cuesj-183	69	4	the	the	DET
cuesj-183	69	5	hbv	hbv	NOUN
cuesj-183	69	6	by	by	ADP
cuesj-183	69	7	realtime	realtime	ADJ
cuesj-183	69	8	quantitative	quantitative	ADJ
cuesj-183	69	9	pcr	pcr	NOUN
cuesj-183	69	10	(	(	PUNCT
cuesj-183	69	11	rt	rt	PROPN
cuesj-183	69	12	qpcr	qpcr	ADV
cuesj-183	69	13	)	)	PUNCT
cuesj-183	69	14	for	for	ADP
cuesj-183	69	15	further	further	ADJ
cuesj-183	69	16	characterization	characterization	NOUN
cuesj-183	69	17	of	of	ADP
cuesj-183	69	18	serum	serum	NOUN
cuesj-183	69	19	samples	sample	NOUN
cuesj-183	69	20	from	from	ADP
cuesj-183	69	21	hbs	hbs	PROPN
cuesj-183	69	22	-	-	PUNCT
cuesj-183	69	23	ag	ag	PROPN
cuesj-183	69	24	negative	negative	NOUN
cuesj-183	69	25	,	,	PUNCT
cuesj-183	69	26	hbs	hbs	PROPN
cuesj-183	69	27	-	-	PUNCT
cuesj-183	69	28	ab	ab	NOUN
cuesj-183	69	29	negative	negative	ADJ
cuesj-183	69	30	,	,	PUNCT
cuesj-183	69	31	and	and	CCONJ
cuesj-183	69	32	hbc	hbc	PROPN
cuesj-183	69	33	-	-	PUNCT
cuesj-183	69	34	ab	ab	PROPN
cuesj-183	69	35	positive	positive	ADJ
cuesj-183	69	36	blood	blood	NOUN
cuesj-183	69	37	donors	donor	NOUN
cuesj-183	69	38	were	be	AUX
cuesj-183	69	39	processed	process	VERB
cuesj-183	69	40	for	for	ADP
cuesj-183	69	41	hbv	hbv	NOUN
cuesj-183	69	42	-	-	PUNCT
cuesj-183	69	43	dna	dna	NOUN
cuesj-183	69	44	detection	detection	NOUN
cuesj-183	69	45	using	use	VERB
cuesj-183	69	46	molecular	molecular	ADJ
cuesj-183	69	47	amplification	amplification	NOUN
cuesj-183	69	48	using	use	VERB
cuesj-183	69	49	the	the	DET
cuesj-183	69	50	rt	rt	PROPN
cuesj-183	69	51	pcr	pcr	NOUN
cuesj-183	69	52	.	.	PUNCT
cuesj-183	70	1	this	this	DET
cuesj-183	70	2	test	test	NOUN
cuesj-183	70	3	was	be	AUX
cuesj-183	70	4	done	do	VERB
cuesj-183	70	5	using	use	VERB
cuesj-183	70	6	artus	artus	PROPN
cuesj-183	70	7	®	®	PROPN
cuesj-183	70	8	hbv	hbv	PROPN
cuesj-183	70	9	rg	rg	PROPN
cuesj-183	70	10	*	*	PROPN
cuesj-183	70	11	pcr	pcr	PROPN
cuesj-183	70	12	kit	kit	NOUN
cuesj-183	70	13	24	24	NUM
cuesj-183	70	14	,	,	PUNCT
cuesj-183	70	15	v1	v1	NOUN
cuesj-183	70	16	(	(	PUNCT
cuesj-183	70	17	qiagen	qiagen	PROPN
cuesj-183	70	18	,	,	PUNCT
cuesj-183	70	19	germany	germany	PROPN
cuesj-183	70	20	)	)	PUNCT
cuesj-183	70	21	.	.	PUNCT
cuesj-183	71	1	after	after	ADP
cuesj-183	71	2	extracting	extract	VERB
cuesj-183	71	3	the	the	DET
cuesj-183	71	4	nucleic	nucleic	ADJ
cuesj-183	71	5	acid	acid	NOUN
cuesj-183	71	6	of	of	ADP
cuesj-183	71	7	the	the	DET
cuesj-183	71	8	hbv	hbv	NOUN
cuesj-183	71	9	by	by	ADP
cuesj-183	71	10	ez1	ez1	NOUN
cuesj-183	71	11	®	®	NOUN
cuesj-183	71	12	virus	virus	NOUN
cuesj-183	71	13	mini	mini	NOUN
cuesj-183	71	14	kit	kit	NOUN
cuesj-183	71	15	v2.0	v2.0	X
cuesj-183	71	16	(	(	PUNCT
cuesj-183	71	17	qiagen	qiagen	PROPN
cuesj-183	71	18	,	,	PUNCT
cuesj-183	71	19	germany	germany	PROPN
cuesj-183	71	20	)	)	PUNCT
cuesj-183	71	21	,	,	PUNCT
cuesj-183	71	22	we	we	PRON
cuesj-183	71	23	ran	run	VERB
cuesj-183	71	24	the	the	DET
cuesj-183	71	25	purified	purified	ADJ
cuesj-183	71	26	dna	dna	NOUN
cuesj-183	71	27	of	of	ADP
cuesj-183	71	28	hbv	hbv	NOUN
cuesj-183	71	29	by	by	ADP
cuesj-183	71	30	rotor	rotor	NOUN
cuesj-183	71	31	-	-	PUNCT
cuesj-183	71	32	gene	gene	NOUN
cuesj-183	71	33	q	q	NOUN
cuesj-183	71	34	(	(	PUNCT
cuesj-183	71	35	qiagen	qiagen	PROPN
cuesj-183	71	36	,	,	PUNCT
cuesj-183	71	37	germany	germany	PROPN
cuesj-183	71	38	)	)	PUNCT
cuesj-183	71	39	.	.	PUNCT
cuesj-183	72	1	twenty	twenty	NUM
cuesj-183	72	2	-	-	PUNCT
cuesj-183	72	3	four	four	NUM
cuesj-183	72	4	samples	sample	NOUN
cuesj-183	72	5	were	be	AUX
cuesj-183	72	6	selected	select	VERB
cuesj-183	72	7	(	(	PUNCT
cuesj-183	72	8	antihbc	antihbc	PROPN
cuesj-183	72	9	igg	igg	PROPN
cuesj-183	72	10	positive	positive	ADJ
cuesj-183	72	11	and	and	CCONJ
cuesj-183	72	12	negative	negative	ADJ
cuesj-183	72	13	for	for	ADP
cuesj-183	72	14	anti	anti	ADJ
cuesj-183	72	15	-	-	ADJ
cuesj-183	72	16	hbs	hbs	ADJ
cuesj-183	72	17	)	)	PUNCT
cuesj-183	72	18	,	,	PUNCT
cuesj-183	72	19	and	and	CCONJ
cuesj-183	72	20	six	six	NUM
cuesj-183	72	21	control	control	NOUN
cuesj-183	72	22	samples	sample	NOUN
cuesj-183	72	23	(	(	PUNCT
cuesj-183	72	24	negative	negative	ADJ
cuesj-183	72	25	control	control	NOUN
cuesj-183	72	26	)	)	PUNCT
cuesj-183	72	27	were	be	AUX
cuesj-183	72	28	also	also	ADV
cuesj-183	72	29	included	include	VERB
cuesj-183	72	30	in	in	ADP
cuesj-183	72	31	the	the	DET
cuesj-183	72	32	study	study	NOUN
cuesj-183	72	33	.	.	PUNCT
cuesj-183	73	1	out	out	ADP
cuesj-183	73	2	of	of	ADP
cuesj-183	73	3	these	these	DET
cuesj-183	73	4	samples	sample	NOUN
cuesj-183	73	5	,	,	PUNCT
cuesj-183	73	6	8	8	NUM
cuesj-183	73	7	of	of	ADP
cuesj-183	73	8	the	the	DET
cuesj-183	73	9	samples	sample	NOUN
cuesj-183	73	10	(	(	PUNCT
cuesj-183	73	11	33	33	NUM
cuesj-183	73	12	%	%	NOUN
cuesj-183	73	13	)	)	PUNCT
cuesj-183	73	14	were	be	AUX
cuesj-183	73	15	positive	positive	ADJ
cuesj-183	73	16	,	,	PUNCT
cuesj-183	73	17	showing	show	VERB
cuesj-183	73	18	the	the	DET
cuesj-183	73	19	dna	dna	NOUN
cuesj-183	73	20	in	in	ADP
cuesj-183	73	21	their	their	PRON
cuesj-183	73	22	blood	blood	NOUN
cuesj-183	73	23	,	,	PUNCT
cuesj-183	73	24	confirming	confirm	VERB
cuesj-183	73	25	the	the	DET
cuesj-183	73	26	diagnosis	diagnosis	NOUN
cuesj-183	73	27	of	of	ADP
cuesj-183	73	28	occult	occult	NOUN
cuesj-183	73	29	hepatitis	hepatitis	PROPN
cuesj-183	73	30	b	b	PROPN
cuesj-183	74	1	[	[	X
cuesj-183	74	2	figure	figure	NOUN
cuesj-183	74	3	3	3	NUM
cuesj-183	74	4	]	]	PUNCT
cuesj-183	74	5	.	.	PUNCT
cuesj-183	75	1	discussion	discussion	NOUN
cuesj-183	75	2	hepatitis	hepatitis	PROPN
cuesj-183	75	3	b	b	PROPN
cuesj-183	75	4	and	and	CCONJ
cuesj-183	75	5	c	c	PROPN
cuesj-183	75	6	viruses	virus	NOUN
cuesj-183	75	7	are	be	AUX
cuesj-183	75	8	responsible	responsible	ADJ
cuesj-183	75	9	for	for	ADP
cuesj-183	75	10	causing	cause	VERB
cuesj-183	75	11	about	about	ADP
cuesj-183	75	12	80	80	NUM
cuesj-183	75	13	%	%	NOUN
cuesj-183	75	14	of	of	ADP
cuesj-183	75	15	liver	liver	NOUN
cuesj-183	75	16	cancer	cancer	NOUN
cuesj-183	75	17	cases	case	NOUN
cuesj-183	75	18	worldwide	worldwide	ADV
cuesj-183	75	19	,	,	PUNCT
cuesj-183	75	20	and	and	CCONJ
cuesj-183	75	21	it	it	PRON
cuesj-183	75	22	could	could	AUX
cuesj-183	75	23	be	be	AUX
cuesj-183	75	24	the	the	DET
cuesj-183	75	25	major	major	ADJ
cuesj-183	75	26	cause	cause	NOUN
cuesj-183	75	27	of	of	ADP
cuesj-183	75	28	morbidity	morbidity	NOUN
cuesj-183	75	29	and	and	CCONJ
cuesj-183	75	30	mortality.[27	mortality.[27	NOUN
cuesj-183	75	31	]	]	PUNCT
cuesj-183	75	32	regarding	regard	VERB
cuesj-183	75	33	hepatitis	hepatitis	NOUN
cuesj-183	75	34	prevalence	prevalence	NOUN
cuesj-183	75	35	,	,	PUNCT
cuesj-183	75	36	the	the	DET
cuesj-183	75	37	world	world	NOUN
cuesj-183	75	38	is	be	AUX
cuesj-183	75	39	divided	divide	VERB
cuesj-183	75	40	into	into	ADP
cuesj-183	75	41	three	three	NUM
cuesj-183	75	42	areas	area	NOUN
cuesj-183	75	43	;	;	PUNCT
cuesj-183	75	44	low	low	ADJ
cuesj-183	75	45	prevalence	prevalence	NOUN
cuesj-183	75	46	area	area	NOUN
cuesj-183	75	47	,	,	PUNCT
cuesj-183	75	48	which	which	PRON
cuesj-183	75	49	means	mean	VERB
cuesj-183	75	50	<	<	X
cuesj-183	75	51	2	2	NUM
cuesj-183	75	52	%	%	NOUN
cuesj-183	75	53	,	,	PUNCT
cuesj-183	75	54	an	an	DET
cuesj-183	75	55	intermediate	intermediate	ADJ
cuesj-183	75	56	area	area	NOUN
cuesj-183	75	57	2–8	2–8	NUM
cuesj-183	75	58	%	%	NOUN
cuesj-183	75	59	and	and	CCONJ
cuesj-183	75	60	high	high	ADJ
cuesj-183	75	61	prevalence	prevalence	NOUN
cuesj-183	75	62	area	area	NOUN
cuesj-183	75	63	more	more	ADJ
cuesj-183	75	64	than	than	ADP
cuesj-183	75	65	8%.[28,29	8%.[28,29	NUM
cuesj-183	75	66	]	]	PUNCT
cuesj-183	75	67	most	most	ADJ
cuesj-183	75	68	countries	country	NOUN
cuesj-183	75	69	on	on	ADP
cuesj-183	75	70	the	the	DET
cuesj-183	75	71	earth	earth	NOUN
cuesj-183	75	72	are	be	AUX
cuesj-183	75	73	still	still	ADV
cuesj-183	75	74	viewed	view	VERB
cuesj-183	75	75	as	as	ADP
cuesj-183	75	76	intermediate	intermediate	ADJ
cuesj-183	75	77	to	to	ADP
cuesj-183	75	78	high	high	ADJ
cuesj-183	75	79	endemicity	endemicity	NOUN
cuesj-183	75	80	for	for	ADP
cuesj-183	75	81	hbv	hbv	NOUN
cuesj-183	75	82	infection.[28,29	infection.[28,29	NOUN
cuesj-183	75	83	]	]	X
cuesj-183	75	84	hcv	hcv	PROPN
cuesj-183	75	85	follows	follow	VERB
cuesj-183	75	86	the	the	DET
cuesj-183	75	87	same	same	ADJ
cuesj-183	75	88	division	division	NOUN
cuesj-183	75	89	regarding	regard	VERB
cuesj-183	75	90	prevalence	prevalence	NOUN
cuesj-183	75	91	such	such	ADJ
cuesj-183	75	92	as	as	ADP
cuesj-183	75	93	low	low	ADJ
cuesj-183	75	94	prevalence	prevalence	NOUN
cuesj-183	75	95	(	(	PUNCT
cuesj-183	75	96	<	<	X
cuesj-183	75	97	1.5	1.5	NUM
cuesj-183	75	98	%	%	NOUN
cuesj-183	75	99	)	)	PUNCT
cuesj-183	75	100	,	,	PUNCT
cuesj-183	75	101	moderate	moderate	ADJ
cuesj-183	75	102	prevalence	prevalence	NOUN
cuesj-183	75	103	(	(	PUNCT
cuesj-183	75	104	1.5%–3.5	1.5%–3.5	NUM
cuesj-183	75	105	%	%	NOUN
cuesj-183	75	106	)	)	PUNCT
cuesj-183	75	107	,	,	PUNCT
cuesj-183	75	108	and	and	CCONJ
cuesj-183	75	109	high	high	ADJ
cuesj-183	75	110	prevalence	prevalence	NOUN
cuesj-183	75	111	area	area	NOUN
cuesj-183	75	112	,	,	PUNCT
cuesj-183	75	113	which	which	PRON
cuesj-183	75	114	is	be	AUX
cuesj-183	75	115	more	more	ADJ
cuesj-183	75	116	than	than	ADP
cuesj-183	75	117	3.5%.[30	3.5%.[30	NUM
cuesj-183	75	118	]	]	X
cuesj-183	75	119	the	the	DET
cuesj-183	75	120	current	current	ADJ
cuesj-183	75	121	study	study	NOUN
cuesj-183	75	122	characterizes	characterize	VERB
cuesj-183	75	123	and	and	CCONJ
cuesj-183	75	124	defines	define	VERB
cuesj-183	75	125	the	the	DET
cuesj-183	75	126	frequency	frequency	NOUN
cuesj-183	75	127	of	of	ADP
cuesj-183	75	128	hbv	hbv	NOUN
cuesj-183	75	129	and	and	CCONJ
cuesj-183	75	130	hcv	hcv	PROPN
cuesj-183	75	131	(	(	PUNCT
cuesj-183	75	132	6173	6173	NUM
cuesj-183	75	133	)	)	PUNCT
cuesj-183	75	134	blood	blood	NOUN
cuesj-183	75	135	donors	donor	NOUN
cuesj-183	75	136	.	.	PUNCT
cuesj-183	76	1	for	for	ADP
cuesj-183	76	2	hbv	hbv	NOUN
cuesj-183	76	3	detection	detection	NOUN
cuesj-183	76	4	,	,	PUNCT
cuesj-183	76	5	two	two	NUM
cuesj-183	76	6	serological	serological	ADJ
cuesj-183	76	7	markers	marker	NOUN
cuesj-183	76	8	were	be	AUX
cuesj-183	76	9	used	use	VERB
cuesj-183	76	10	(	(	PUNCT
cuesj-183	76	11	hbs	hbs	PROPN
cuesj-183	76	12	-	-	PUNCT
cuesj-183	76	13	ag	ag	PROPN
cuesj-183	76	14	and	and	CCONJ
cuesj-183	76	15	hbc	hbc	PROPN
cuesj-183	76	16	-	-	PUNCT
cuesj-183	76	17	ab	ab	NOUN
cuesj-183	76	18	)	)	PUNCT
cuesj-183	76	19	,	,	PUNCT
cuesj-183	76	20	among	among	ADP
cuesj-183	76	21	those	those	PRON
cuesj-183	76	22	,	,	PUNCT
cuesj-183	76	23	98	98	NUM
cuesj-183	76	24	donors	donor	NOUN
cuesj-183	76	25	were	be	AUX
cuesj-183	76	26	reactive	reactive	ADJ
cuesj-183	76	27	for	for	ADP
cuesj-183	76	28	hbc	hbc	PROPN
cuesj-183	76	29	-	-	PUNCT
cuesj-183	76	30	ab	ab	PROPN
cuesj-183	76	31	(	(	PUNCT
cuesj-183	76	32	1.58	1.58	NUM
cuesj-183	76	33	%	%	NOUN
cuesj-183	76	34	)	)	PUNCT
cuesj-183	76	35	,	,	PUNCT
cuesj-183	76	36	whereas	whereas	SCONJ
cuesj-183	76	37	only	only	ADV
cuesj-183	76	38	7	7	NUM
cuesj-183	76	39	people	people	NOUN
cuesj-183	76	40	were	be	AUX
cuesj-183	76	41	positive	positive	ADJ
cuesj-183	76	42	for	for	ADP
cuesj-183	76	43	hbs	hbs	PROPN
cuesj-183	76	44	-	-	PUNCT
cuesj-183	76	45	ag	ag	PROPN
cuesj-183	76	46	(	(	PUNCT
cuesj-183	76	47	0.11	0.11	NUM
cuesj-183	76	48	%	%	NOUN
cuesj-183	76	49	)	)	PUNCT
cuesj-183	76	50	.	.	PUNCT
cuesj-183	77	1	for	for	ADP
cuesj-183	77	2	screening	screening	NOUN
cuesj-183	77	3	of	of	ADP
cuesj-183	77	4	hcv	hcv	PROPN
cuesj-183	77	5	,	,	PUNCT
cuesj-183	77	6	hcv	hcv	PROPN
cuesj-183	77	7	-	-	PUNCT
cuesj-183	77	8	ab	ab	PROPN
cuesj-183	77	9	was	be	AUX
cuesj-183	77	10	used	use	VERB
cuesj-183	77	11	and	and	CCONJ
cuesj-183	77	12	only	only	ADV
cuesj-183	77	13	4	4	NUM
cuesj-183	77	14	blood	blood	NOUN
cuesj-183	77	15	donors	donor	NOUN
cuesj-183	77	16	proved	prove	VERB
cuesj-183	77	17	positive	positive	ADJ
cuesj-183	77	18	for	for	ADP
cuesj-183	77	19	anti	anti	ADJ
cuesj-183	77	20	-	-	ADJ
cuesj-183	77	21	hcv	hcv	ADJ
cuesj-183	77	22	-	-	PUNCT
cuesj-183	77	23	ab	ab	NOUN
cuesj-183	77	24	(	(	PUNCT
cuesj-183	77	25	0.065	0.065	NUM
cuesj-183	77	26	%	%	NOUN
cuesj-183	77	27	)	)	PUNCT
cuesj-183	77	28	,	,	PUNCT
cuesj-183	77	29	as	as	SCONJ
cuesj-183	77	30	described	describe	VERB
cuesj-183	77	31	in	in	ADP
cuesj-183	77	32	figures	figure	NOUN
cuesj-183	77	33	1	1	NUM
cuesj-183	77	34	and	and	CCONJ
cuesj-183	77	35	2	2	NUM
cuesj-183	77	36	.	.	X
cuesj-183	78	1	the	the	DET
cuesj-183	78	2	prevalence	prevalence	NOUN
cuesj-183	78	3	of	of	ADP
cuesj-183	78	4	reactive	reactive	ADJ
cuesj-183	78	5	blood	blood	NOUN
cuesj-183	78	6	donors	donor	NOUN
cuesj-183	78	7	in	in	ADP
cuesj-183	78	8	the	the	DET
cuesj-183	78	9	current	current	ADJ
cuesj-183	78	10	study	study	NOUN
cuesj-183	78	11	for	for	ADP
cuesj-183	78	12	hbv	hbv	NOUN
cuesj-183	78	13	is	be	AUX
cuesj-183	78	14	1.7	1.7	NUM
cuesj-183	78	15	%	%	NOUN
cuesj-183	78	16	(	(	PUNCT
cuesj-183	78	17	105	105	NUM
cuesj-183	78	18	out	out	ADP
cuesj-183	78	19	of	of	ADP
cuesj-183	78	20	6173	6173	NUM
cuesj-183	78	21	)	)	PUNCT
cuesj-183	78	22	from	from	ADP
cuesj-183	78	23	which	which	PRON
cuesj-183	78	24	1.5	1.5	NUM
cuesj-183	78	25	%	%	NOUN
cuesj-183	78	26	is	be	AUX
cuesj-183	78	27	reactive	reactive	ADJ
cuesj-183	78	28	against	against	ADP
cuesj-183	78	29	hbc	hbc	PROPN
cuesj-183	78	30	-	-	PUNCT
cuesj-183	78	31	ab	ab	PROPN
cuesj-183	78	32	and	and	CCONJ
cuesj-183	78	33	0.11	0.11	NUM
cuesj-183	78	34	%	%	NOUN
cuesj-183	78	35	is	be	AUX
cuesj-183	78	36	reactive	reactive	ADJ
cuesj-183	78	37	against	against	ADP
cuesj-183	78	38	hbs	hbs	PROPN
cuesj-183	78	39	-	-	PUNCT
cuesj-183	78	40	ag	ag	PROPN
cuesj-183	78	41	,	,	PUNCT
cuesj-183	78	42	whereas	whereas	SCONJ
cuesj-183	78	43	for	for	ADP
cuesj-183	78	44	hcv	hcv	NOUN
cuesj-183	78	45	is	be	AUX
cuesj-183	78	46	0.06	0.06	NUM
cuesj-183	78	47	%	%	NOUN
cuesj-183	78	48	.	.	PUNCT
cuesj-183	79	1	they	they	PRON
cuesj-183	79	2	are	be	AUX
cuesj-183	79	3	in	in	ADP
cuesj-183	79	4	agreement	agreement	NOUN
cuesj-183	79	5	on	on	ADP
cuesj-183	79	6	a	a	DET
cuesj-183	79	7	national	national	ADJ
cuesj-183	79	8	level	level	NOUN
cuesj-183	79	9	with	with	ADP
cuesj-183	79	10	these	these	DET
cuesj-183	79	11	results	result	NOUN
cuesj-183	79	12	by	by	ADP
cuesj-183	79	13	alhilfi	alhilfi	PROPN
cuesj-183	79	14	et	et	PROPN
cuesj-183	79	15	al	al	PROPN
cuesj-183	79	16	.	.	PROPN
cuesj-183	79	17	,	,	PUNCT
cuesj-183	79	18	who	who	PRON
cuesj-183	79	19	screened	screen	VERB
cuesj-183	79	20	36620	36620	NUM
cuesj-183	79	21	blood	blood	NOUN
cuesj-183	79	22	donors	donor	NOUN
cuesj-183	79	23	in	in	ADP
cuesj-183	79	24	missan	missan	ADJ
cuesj-183	79	25	governorate	governorate	PROPN
cuesj-183	79	26	in	in	ADP
cuesj-183	79	27	iraq	iraq	PROPN
cuesj-183	79	28	,	,	PUNCT
cuesj-183	79	29	figure	figure	VERB
cuesj-183	79	30	1	1	NUM
cuesj-183	79	31	:	:	PUNCT
cuesj-183	79	32	serological	serological	ADJ
cuesj-183	79	33	and	and	CCONJ
cuesj-183	79	34	molecular	molecular	ADJ
cuesj-183	79	35	characterization	characterization	NOUN
cuesj-183	79	36	of	of	ADP
cuesj-183	79	37	hepatitis	hepatitis	PROPN
cuesj-183	79	38	b	b	PROPN
cuesj-183	79	39	virus	virus	NOUN
cuesj-183	79	40	and	and	CCONJ
cuesj-183	79	41	hepatitis	hepatitis	PROPN
cuesj-183	79	42	c	c	PROPN
cuesj-183	79	43	virus	virus	NOUN
cuesj-183	79	44	infection	infection	NOUN
cuesj-183	79	45	among	among	ADP
cuesj-183	79	46	blood	blood	NOUN
cuesj-183	79	47	donors	donor	NOUN
cuesj-183	79	48	in	in	ADP
cuesj-183	79	49	the	the	DET
cuesj-183	79	50	major	major	ADJ
cuesj-183	79	51	blood	blood	NOUN
cuesj-183	79	52	bank	bank	NOUN
cuesj-183	79	53	of	of	ADP
cuesj-183	79	54	erbil	erbil	PROPN
cuesj-183	79	55	city	city	PROPN
cuesj-183	79	56	.	.	PUNCT
cuesj-183	80	1	hbs	hbs	PROPN
cuesj-183	80	2	ab	ab	PROPN
cuesj-183	80	3	–	–	PUNCT
cuesj-183	80	4	hepatitis	hepatitis	PROPN
cuesj-183	80	5	b	b	PROPN
cuesj-183	80	6	surface	surface	NOUN
cuesj-183	80	7	antibodies	antibodie	VERB
cuesj-183	80	8	;	;	PUNCT
cuesj-183	80	9	hbc	hbc	PROPN
cuesj-183	80	10	ab	ab	PROPN
cuesj-183	80	11	–	–	PUNCT
cuesj-183	80	12	hepatitis	hepatitis	PROPN
cuesj-183	80	13	b	b	PROPN
cuesj-183	80	14	core	core	NOUN
cuesj-183	80	15	antibodies	antibodie	VERB
cuesj-183	80	16	:	:	PUNCT
cuesj-183	80	17	pcr	pcr	ADJ
cuesj-183	80	18	–	–	PUNCT
cuesj-183	80	19	a	a	DET
cuesj-183	80	20	polymerase	polymerase	NOUN
cuesj-183	80	21	chain	chain	NOUN
cuesj-183	80	22	reaction	reaction	NOUN
cuesj-183	80	23	figure	figure	NOUN
cuesj-183	80	24	2	2	NUM
cuesj-183	80	25	:	:	PUNCT
cuesj-183	80	26	incidence	incidence	NOUN
cuesj-183	80	27	of	of	ADP
cuesj-183	80	28	both	both	CCONJ
cuesj-183	80	29	hepatitis	hepatitis	PROPN
cuesj-183	80	30	b	b	PROPN
cuesj-183	80	31	virus	virus	NOUN
cuesj-183	80	32	and	and	CCONJ
cuesj-183	80	33	hepatitis	hepatitis	PROPN
cuesj-183	80	34	c	c	PROPN
cuesj-183	80	35	virus	virus	NOUN
cuesj-183	80	36	among	among	ADP
cuesj-183	80	37	blood	blood	NOUN
cuesj-183	80	38	donors	donor	NOUN
cuesj-183	80	39	saleh	saleh	VERB
cuesj-183	80	40	and	and	CCONJ
cuesj-183	80	41	taher	taher	PROPN
cuesj-183	80	42	:	:	PUNCT
cuesj-183	80	43	prevalence	prevalence	NOUN
cuesj-183	80	44	of	of	ADP
cuesj-183	80	45	hepatitis	hepatitis	PROPN
cuesj-183	80	46	b	b	PROPN
cuesj-183	80	47	and	and	CCONJ
cuesj-183	80	48	hepatitis	hepatitis	PROPN
cuesj-183	80	49	c	c	NOUN
cuesj-183	80	50	infection	infection	NOUN
cuesj-183	80	51	in	in	ADP
cuesj-183	80	52	erbil	erbil	PROPN
cuesj-183	80	53	49	49	NUM
cuesj-183	80	54	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-183	80	55	cuesj	cuesj	NOUN
cuesj-183	80	56	2020	2020	NUM
cuesj-183	80	57	,	,	PUNCT
cuesj-183	80	58	4	4	NUM
cuesj-183	80	59	(	(	PUNCT
cuesj-183	80	60	1	1	NUM
cuesj-183	80	61	):	):	PUNCT
cuesj-183	80	62	45	45	NUM
cuesj-183	80	63	-	-	SYM
cuesj-183	80	64	51	51	NUM
cuesj-183	80	65	they	they	PRON
cuesj-183	80	66	found	find	VERB
cuesj-183	80	67	0.12	0.12	NUM
cuesj-183	80	68	%	%	NOUN
cuesj-183	80	69	positivity	positivity	NOUN
cuesj-183	80	70	for	for	ADP
cuesj-183	80	71	hbs	hbs	PROPN
cuesj-183	80	72	-	-	PUNCT
cuesj-183	80	73	ag	ag	PROPN
cuesj-183	80	74	and	and	CCONJ
cuesj-183	80	75	0.09	0.09	NUM
cuesj-183	80	76	%	%	NOUN
cuesj-183	80	77	positivity	positivity	NOUN
cuesj-183	80	78	for	for	ADP
cuesj-183	80	79	hcv	hcv	NOUN
cuesj-183	80	80	-	-	PUNCT
cuesj-183	80	81	ab.[31	ab.[31	NOUN
cuesj-183	80	82	]	]	PUNCT
cuesj-183	80	83	similar	similar	ADJ
cuesj-183	80	84	results	result	NOUN
cuesj-183	80	85	were	be	AUX
cuesj-183	80	86	also	also	ADV
cuesj-183	80	87	found	find	VERB
cuesj-183	80	88	by	by	ADP
cuesj-183	80	89	al	al	PROPN
cuesj-183	80	90	-	-	PUNCT
cuesj-183	80	91	rubaye	rubaye	PROPN
cuesj-183	80	92	et	et	PROPN
cuesj-183	80	93	al	al	PROPN
cuesj-183	80	94	.	.	PROPN
cuesj-183	80	95	,	,	PUNCT
cuesj-183	80	96	who	who	PRON
cuesj-183	80	97	screened	screen	VERB
cuesj-183	80	98	69915	69915	NUM
cuesj-183	80	99	blood	blood	NOUN
cuesj-183	80	100	donors	donor	NOUN
cuesj-183	80	101	in	in	ADP
cuesj-183	80	102	basra	basra	PROPN
cuesj-183	80	103	in	in	ADP
cuesj-183	80	104	2013	2013	NUM
cuesj-183	80	105	,	,	PUNCT
cuesj-183	80	106	from	from	ADP
cuesj-183	80	107	which	which	PRON
cuesj-183	80	108	they	they	PRON
cuesj-183	80	109	found	find	VERB
cuesj-183	80	110	125	125	NUM
cuesj-183	80	111	reactive	reactive	ADJ
cuesj-183	80	112	individuals	individual	NOUN
cuesj-183	80	113	for	for	ADP
cuesj-183	80	114	hbs	hbs	PROPN
cuesj-183	80	115	-	-	PUNCT
cuesj-183	80	116	ag	ag	PROPN
cuesj-183	80	117	(	(	PUNCT
cuesj-183	80	118	0.2	0.2	NUM
cuesj-183	80	119	%	%	NOUN
cuesj-183	80	120	)	)	PUNCT
cuesj-183	80	121	,	,	PUNCT
cuesj-183	80	122	and	and	CCONJ
cuesj-183	80	123	1475	1475	NUM
cuesj-183	80	124	reactive	reactive	ADJ
cuesj-183	80	125	individuals	individual	NOUN
cuesj-183	80	126	for	for	ADP
cuesj-183	80	127	hbc	hbc	NOUN
cuesj-183	80	128	-	-	PUNCT
cuesj-183	80	129	ab	ab	NOUN
cuesj-183	80	130	(	(	PUNCT
cuesj-183	80	131	2.1	2.1	NUM
cuesj-183	80	132	%	%	NOUN
cuesj-183	80	133	)	)	PUNCT
cuesj-183	80	134	and	and	CCONJ
cuesj-183	80	135	hcv	hcv	PROPN
cuesj-183	80	136	-	-	PUNCT
cuesj-183	80	137	ab	ab	NOUN
cuesj-183	80	138	positivity	positivity	NOUN
cuesj-183	80	139	in	in	ADP
cuesj-183	80	140	0.1%.[17	0.1%.[17	NUM
cuesj-183	80	141	]	]	PUNCT
cuesj-183	80	142	on	on	ADP
cuesj-183	80	143	an	an	DET
cuesj-183	80	144	international	international	ADJ
cuesj-183	80	145	level	level	NOUN
cuesj-183	80	146	,	,	PUNCT
cuesj-183	80	147	similar	similar	ADJ
cuesj-183	80	148	results	result	NOUN
cuesj-183	80	149	to	to	ADP
cuesj-183	80	150	ours	ours	PRON
cuesj-183	80	151	were	be	AUX
cuesj-183	80	152	also	also	ADV
cuesj-183	80	153	found	find	VERB
cuesj-183	80	154	in	in	ADP
cuesj-183	80	155	a	a	DET
cuesj-183	80	156	neighboring	neighbor	VERB
cuesj-183	80	157	country	country	NOUN
cuesj-183	80	158	by	by	ADP
cuesj-183	80	159	boustani	boustani	PROPN
cuesj-183	80	160	et	et	PROPN
cuesj-183	80	161	al	al	PROPN
cuesj-183	80	162	.	.	PROPN
cuesj-183	80	163	,	,	PUNCT
cuesj-183	80	164	which	which	PRON
cuesj-183	80	165	was	be	AUX
cuesj-183	80	166	done	do	VERB
cuesj-183	80	167	in	in	ADP
cuesj-183	80	168	ilam	ilam	PROPN
cuesj-183	80	169	city	city	PROPN
cuesj-183	80	170	in	in	ADP
cuesj-183	80	171	iran	iran	PROPN
cuesj-183	80	172	between	between	ADP
cuesj-183	80	173	2009	2009	NUM
cuesj-183	80	174	and	and	CCONJ
cuesj-183	80	175	2013	2013	NUM
cuesj-183	80	176	:	:	PUNCT
cuesj-183	80	177	they	they	PRON
cuesj-183	80	178	screened	screen	VERB
cuesj-183	80	179	72,527	72,527	NUM
cuesj-183	80	180	blood	blood	NOUN
cuesj-183	80	181	donors	donor	NOUN
cuesj-183	80	182	,	,	PUNCT
cuesj-183	80	183	they	they	PRON
cuesj-183	80	184	found	find	VERB
cuesj-183	80	185	hbs	hbs	PROPN
cuesj-183	80	186	-	-	PUNCT
cuesj-183	80	187	ag	ag	PROPN
cuesj-183	80	188	in	in	ADP
cuesj-183	80	189	102	102	NUM
cuesj-183	80	190	(	(	PUNCT
cuesj-183	80	191	0.14	0.14	NUM
cuesj-183	80	192	%	%	NOUN
cuesj-183	80	193	)	)	PUNCT
cuesj-183	80	194	,	,	PUNCT
cuesj-183	80	195	and	and	CCONJ
cuesj-183	80	196	hcv	hcv	PROPN
cuesj-183	80	197	-	-	PUNCT
cuesj-183	80	198	ab	ab	NOUN
cuesj-183	80	199	in	in	ADP
cuesj-183	80	200	27	27	NUM
cuesj-183	80	201	(	(	PUNCT
cuesj-183	80	202	0.037%).[32	0.037%).[32	SYM
cuesj-183	80	203	]	]	X
cuesj-183	80	204	moreover	moreover	ADV
cuesj-183	80	205	,	,	PUNCT
cuesj-183	80	206	another	another	DET
cuesj-183	80	207	study	study	NOUN
cuesj-183	80	208	conducted	conduct	VERB
cuesj-183	80	209	in	in	ADP
cuesj-183	80	210	southwestern	southwestern	ADJ
cuesj-183	80	211	iran	iran	PROPN
cuesj-183	80	212	,	,	PUNCT
cuesj-183	80	213	by	by	ADP
cuesj-183	80	214	sajjadi	sajjadi	PROPN
cuesj-183	80	215	et	et	PROPN
cuesj-183	80	216	al	al	PROPN
cuesj-183	80	217	.	.	PROPN
cuesj-183	80	218	,	,	PUNCT
cuesj-183	80	219	they	they	PRON
cuesj-183	80	220	screened	screen	VERB
cuesj-183	80	221	180,304	180,304	NUM
cuesj-183	80	222	blood	blood	NOUN
cuesj-183	80	223	donors	donor	NOUN
cuesj-183	80	224	and	and	CCONJ
cuesj-183	80	225	found	find	VERB
cuesj-183	80	226	hbv	hbv	NOUN
cuesj-183	80	227	in	in	ADP
cuesj-183	80	228	0.13	0.13	NUM
cuesj-183	80	229	%	%	NOUN
cuesj-183	80	230	and	and	CCONJ
cuesj-183	80	231	hcv	hcv	NOUN
cuesj-183	80	232	in	in	ADP
cuesj-183	80	233	0.06%.[33	0.06%.[33	NOUN
cuesj-183	80	234	]	]	PUNCT
cuesj-183	80	235	on	on	ADP
cuesj-183	80	236	the	the	DET
cuesj-183	80	237	other	other	ADJ
cuesj-183	80	238	hand	hand	NOUN
cuesj-183	80	239	,	,	PUNCT
cuesj-183	80	240	our	our	PRON
cuesj-183	80	241	data	datum	NOUN
cuesj-183	80	242	were	be	AUX
cuesj-183	80	243	much	much	ADV
cuesj-183	80	244	lower	low	ADJ
cuesj-183	80	245	than	than	ADP
cuesj-183	80	246	that	that	PRON
cuesj-183	80	247	of	of	ADP
cuesj-183	80	248	other	other	ADJ
cuesj-183	80	249	related	related	ADJ
cuesj-183	80	250	studies	study	NOUN
cuesj-183	80	251	performed	perform	VERB
cuesj-183	80	252	in	in	ADP
cuesj-183	80	253	other	other	ADJ
cuesj-183	80	254	centers	center	NOUN
cuesj-183	80	255	.	.	PUNCT
cuesj-183	81	1	nationally	nationally	ADV
cuesj-183	81	2	,	,	PUNCT
cuesj-183	81	3	hussein	hussein	PROPN
cuesj-183	81	4	et	et	PROPN
cuesj-183	81	5	al	al	PROPN
cuesj-183	81	6	.	.	PROPN
cuesj-183	81	7	performed	perform	VERB
cuesj-183	81	8	a	a	DET
cuesj-183	81	9	study	study	NOUN
cuesj-183	81	10	in	in	ADP
cuesj-183	81	11	duhok	duhok	NOUN
cuesj-183	81	12	at	at	ADP
cuesj-183	81	13	2004	2004	NUM
cuesj-183	81	14	found	find	VERB
cuesj-183	81	15	hbs	hbs	PROPN
cuesj-183	81	16	-	-	PUNCT
cuesj-183	81	17	ag	ag	PROPN
cuesj-183	81	18	in	in	ADP
cuesj-183	81	19	62/7900	62/7900	PROPN
cuesj-183	81	20	(	(	PUNCT
cuesj-183	81	21	0.78	0.78	NUM
cuesj-183	81	22	%	%	NOUN
cuesj-183	81	23	)	)	PUNCT
cuesj-183	81	24	,	,	PUNCT
cuesj-183	81	25	and	and	CCONJ
cuesj-183	81	26	hcv	hcv	PROPN
cuesj-183	81	27	-	-	PUNCT
cuesj-183	81	28	ab	ab	NOUN
cuesj-183	81	29	in	in	ADP
cuesj-183	81	30	16/7900	16/7900	PROPN
cuesj-183	81	31	(	(	PUNCT
cuesj-183	81	32	0.2%).[15	0.2%).[15	PROPN
cuesj-183	81	33	]	]	PUNCT
cuesj-183	81	34	in	in	ADP
cuesj-183	81	35	addition	addition	NOUN
cuesj-183	81	36	,	,	PUNCT
cuesj-183	81	37	internationally	internationally	ADV
cuesj-183	81	38	,	,	PUNCT
cuesj-183	81	39	our	our	PRON
cuesj-183	81	40	result	result	NOUN
cuesj-183	81	41	was	be	AUX
cuesj-183	81	42	lower	low	ADJ
cuesj-183	81	43	than	than	ADP
cuesj-183	81	44	those	those	PRON
cuesj-183	81	45	found	find	VERB
cuesj-183	81	46	in	in	ADP
cuesj-183	81	47	india	india	PROPN
cuesj-183	81	48	in	in	ADP
cuesj-183	81	49	a	a	DET
cuesj-183	81	50	study	study	NOUN
cuesj-183	81	51	conducted	conduct	VERB
cuesj-183	81	52	by	by	ADP
cuesj-183	81	53	gulia	gulia	PROPN
cuesj-183	81	54	,	,	PUNCT
cuesj-183	81	55	they	they	PRON
cuesj-183	81	56	found	find	VERB
cuesj-183	81	57	hbv	hbv	NOUN
cuesj-183	81	58	in	in	ADP
cuesj-183	81	59	2.54%.[34	2.54%.[34	NUM
cuesj-183	81	60	]	]	PUNCT
cuesj-183	81	61	in	in	ADP
cuesj-183	81	62	libya	libya	PROPN
cuesj-183	81	63	,	,	PUNCT
cuesj-183	81	64	a	a	DET
cuesj-183	81	65	study	study	NOUN
cuesj-183	81	66	carried	carry	VERB
cuesj-183	81	67	out	out	ADP
cuesj-183	81	68	by	by	ADP
cuesj-183	81	69	qowaider	qowaider	PROPN
cuesj-183	81	70	et	et	PROPN
cuesj-183	81	71	al	al	PROPN
cuesj-183	81	72	.	.	PROPN
cuesj-183	81	73	,	,	PUNCT
cuesj-183	81	74	they	they	PRON
cuesj-183	81	75	examined	examine	VERB
cuesj-183	81	76	78,987	78,987	NUM
cuesj-183	81	77	blood	blood	NOUN
cuesj-183	81	78	donors	donor	NOUN
cuesj-183	81	79	in	in	ADP
cuesj-183	81	80	different	different	ADJ
cuesj-183	81	81	regions	region	NOUN
cuesj-183	81	82	in	in	ADP
cuesj-183	81	83	the	the	DET
cuesj-183	81	84	northeast	northeast	NOUN
cuesj-183	81	85	in	in	ADP
cuesj-183	81	86	libya	libya	PROPN
cuesj-183	81	87	,	,	PUNCT
cuesj-183	81	88	and	and	CCONJ
cuesj-183	81	89	they	they	PRON
cuesj-183	81	90	found	find	VERB
cuesj-183	81	91	hbv	hbv	NOUN
cuesj-183	81	92	in	in	ADP
cuesj-183	81	93	172	172	NUM
cuesj-183	81	94	blood	blood	NOUN
cuesj-183	81	95	donors	donor	NOUN
cuesj-183	81	96	(	(	PUNCT
cuesj-183	81	97	0.21	0.21	NUM
cuesj-183	81	98	%	%	NOUN
cuesj-183	81	99	)	)	PUNCT
cuesj-183	81	100	,	,	PUNCT
cuesj-183	81	101	and	and	CCONJ
cuesj-183	81	102	hcv	hcv	VERB
cuesj-183	81	103	in	in	ADP
cuesj-183	81	104	197	197	NUM
cuesj-183	81	105	blood	blood	NOUN
cuesj-183	81	106	donors	donor	NOUN
cuesj-183	81	107	(	(	PUNCT
cuesj-183	81	108	0.24%).[35	0.24%).[35	NUM
cuesj-183	81	109	]	]	PUNCT
cuesj-183	81	110	furthermore	furthermore	ADV
cuesj-183	81	111	,	,	PUNCT
cuesj-183	81	112	in	in	ADP
cuesj-183	81	113	turkey	turkey	PROPN
cuesj-183	81	114	,	,	PUNCT
cuesj-183	81	115	hope	hope	VERB
cuesj-183	81	116	et	et	PROPN
cuesj-183	81	117	al	al	PROPN
cuesj-183	81	118	.	.	PROPN
cuesj-183	81	119	,	,	PUNCT
cuesj-183	81	120	examined	examine	VERB
cuesj-183	81	121	53,985	53,985	NUM
cuesj-183	81	122	blood	blood	NOUN
cuesj-183	81	123	donors	donor	NOUN
cuesj-183	81	124	,	,	PUNCT
cuesj-183	81	125	among	among	ADP
cuesj-183	81	126	them	they	PRON
cuesj-183	81	127	2.1	2.1	NUM
cuesj-183	81	128	%	%	NOUN
cuesj-183	81	129	were	be	AUX
cuesj-183	81	130	positive	positive	ADJ
cuesj-183	81	131	for	for	ADP
cuesj-183	81	132	hbv	hbv	NOUN
cuesj-183	81	133	and	and	CCONJ
cuesj-183	81	134	0.3	0.3	NUM
cuesj-183	81	135	%	%	NOUN
cuesj-183	81	136	for	for	ADP
cuesj-183	81	137	hcv.[36	hcv.[36	NOUN
cuesj-183	81	138	]	]	PUNCT
cuesj-183	81	139	besides	besides	SCONJ
cuesj-183	81	140	the	the	DET
cuesj-183	81	141	blood	blood	NOUN
cuesj-183	81	142	screening	screening	NOUN
cuesj-183	81	143	,	,	PUNCT
cuesj-183	81	144	we	we	PRON
cuesj-183	81	145	further	far	ADV
cuesj-183	81	146	characterized	characterize	VERB
cuesj-183	81	147	the	the	DET
cuesj-183	81	148	reactive	reactive	ADJ
cuesj-183	81	149	blood	blood	NOUN
cuesj-183	81	150	donors	donor	NOUN
cuesj-183	81	151	(	(	PUNCT
cuesj-183	81	152	positive	positive	ADJ
cuesj-183	81	153	samples	sample	NOUN
cuesj-183	81	154	)	)	PUNCT
cuesj-183	81	155	among	among	ADP
cuesj-183	81	156	105	105	NUM
cuesj-183	81	157	positive	positive	ADJ
cuesj-183	81	158	samples	sample	NOUN
cuesj-183	81	159	for	for	ADP
cuesj-183	81	160	hbc	hbc	PROPN
cuesj-183	81	161	ab	ab	PROPN
cuesj-183	81	162	(	(	PUNCT
cuesj-183	81	163	1.7	1.7	NUM
cuesj-183	81	164	%	%	NOUN
cuesj-183	81	165	)	)	PUNCT
cuesj-183	81	166	,	,	PUNCT
cuesj-183	81	167	98	98	NUM
cuesj-183	81	168	samples	sample	NOUN
cuesj-183	81	169	were	be	AUX
cuesj-183	81	170	hbc	hbc	NOUN
cuesj-183	81	171	-	-	PUNCT
cuesj-183	81	172	ab	ab	NOUN
cuesj-183	81	173	positive	positive	ADJ
cuesj-183	81	174	but	but	CCONJ
cuesj-183	81	175	negative	negative	ADJ
cuesj-183	81	176	for	for	ADP
cuesj-183	81	177	hbs	hbs	PROPN
cuesj-183	81	178	-	-	PUNCT
cuesj-183	81	179	ag	ag	PROPN
cuesj-183	81	180	(	(	PUNCT
cuesj-183	81	181	hbs	hbs	PROPN
cuesj-183	81	182	-	-	PUNCT
cuesj-183	81	183	ag	ag	PROPN
cuesj-183	81	184	−ve	−ve	PROPN
cuesj-183	81	185	/	/	SYM
cuesj-183	81	186	hbc	hbc	PROPN
cuesj-183	81	187	-	-	PUNCT
cuesj-183	81	188	ab	ab	NOUN
cuesj-183	81	189	+	+	PROPN
cuesj-183	81	190	ve	ve	PROPN
cuesj-183	81	191	)	)	PUNCT
cuesj-183	81	192	,	,	PUNCT
cuesj-183	81	193	further	further	ADJ
cuesj-183	81	194	characterization	characterization	NOUN
cuesj-183	81	195	was	be	AUX
cuesj-183	81	196	done	do	VERB
cuesj-183	81	197	for	for	ADP
cuesj-183	81	198	these	these	DET
cuesj-183	81	199	group	group	NOUN
cuesj-183	81	200	by	by	ADP
cuesj-183	81	201	investigating	investigate	VERB
cuesj-183	81	202	for	for	ADP
cuesj-183	81	203	hbs	hbs	PROPN
cuesj-183	81	204	-	-	PUNCT
cuesj-183	81	205	ab	ab	PROPN
cuesj-183	81	206	,	,	PUNCT
cuesj-183	81	207	among	among	ADP
cuesj-183	81	208	these	these	DET
cuesj-183	81	209	74	74	NUM
cuesj-183	81	210	(	(	PUNCT
cuesj-183	81	211	75.5	75.5	NUM
cuesj-183	81	212	%	%	NOUN
cuesj-183	81	213	)	)	PUNCT
cuesj-183	81	214	blood	blood	NOUN
cuesj-183	81	215	donors	donor	NOUN
cuesj-183	81	216	were	be	AUX
cuesj-183	81	217	hbs	hbs	PROPN
cuesj-183	81	218	-	-	PUNCT
cuesj-183	81	219	ab	ab	PROPN
cuesj-183	81	220	positive	positive	ADJ
cuesj-183	81	221	(	(	PUNCT
cuesj-183	81	222	hbc	hbc	PROPN
cuesj-183	81	223	-	-	PUNCT
cuesj-183	81	224	ab	ab	NOUN
cuesj-183	81	225	+	+	PROPN
cuesj-183	81	226	ve	ve	PROPN
cuesj-183	81	227	,	,	PUNCT
cuesj-183	81	228	hbs	hbs	PROPN
cuesj-183	81	229	-	-	PUNCT
cuesj-183	81	230	ag	ag	PROPN
cuesj-183	81	231	–	–	PUNCT
cuesj-183	81	232	ve	ve	VERB
cuesj-183	81	233	,	,	PUNCT
cuesj-183	81	234	and	and	CCONJ
cuesj-183	82	1	hbs	hbs	PROPN
cuesj-183	82	2	ab	ab	PROPN
cuesj-183	82	3	+	+	PROPN
cuesj-183	82	4	ve	ve	VERB
cuesj-183	82	5	)	)	PUNCT
cuesj-183	82	6	which	which	PRON
cuesj-183	82	7	indicated	indicate	VERB
cuesj-183	82	8	that	that	SCONJ
cuesj-183	82	9	they	they	PRON
cuesj-183	82	10	are	be	AUX
cuesj-183	82	11	cured	cure	VERB
cuesj-183	82	12	of	of	ADP
cuesj-183	82	13	natural	natural	ADJ
cuesj-183	82	14	infection	infection	NOUN
cuesj-183	82	15	[	[	X
cuesj-183	82	16	figure	figure	NOUN
cuesj-183	82	17	1	1	NUM
cuesj-183	82	18	and	and	CCONJ
cuesj-183	82	19	table	table	NOUN
cuesj-183	82	20	3	3	NUM
cuesj-183	82	21	]	]	PUNCT
cuesj-183	82	22	whereas	whereas	SCONJ
cuesj-183	82	23	the	the	DET
cuesj-183	82	24	remaining	remain	VERB
cuesj-183	82	25	24	24	NUM
cuesj-183	82	26	blood	blood	NOUN
cuesj-183	82	27	donors	donor	NOUN
cuesj-183	82	28	(	(	PUNCT
cuesj-183	82	29	24.5	24.5	NUM
cuesj-183	82	30	%	%	NOUN
cuesj-183	82	31	)	)	PUNCT
cuesj-183	82	32	were	be	AUX
cuesj-183	82	33	hbc	hbc	NOUN
cuesj-183	82	34	-	-	PUNCT
cuesj-183	82	35	ab	ab	NOUN
cuesj-183	82	36	positive	positive	ADJ
cuesj-183	82	37	but	but	CCONJ
cuesj-183	82	38	negative	negative	ADJ
cuesj-183	82	39	both	both	PRON
cuesj-183	82	40	for	for	ADP
cuesj-183	82	41	hbs	hbs	PROPN
cuesj-183	82	42	-	-	PUNCT
cuesj-183	82	43	ag	ag	PROPN
cuesj-183	82	44	and	and	CCONJ
cuesj-183	82	45	hbs	hbs	PROPN
cuesj-183	82	46	-	-	PUNCT
cuesj-183	82	47	ab	ab	PROPN
cuesj-183	82	48	.	.	PUNCT
cuesj-183	83	1	individuals	individual	NOUN
cuesj-183	83	2	with	with	ADP
cuesj-183	83	3	negative	negative	ADJ
cuesj-183	83	4	hbs	hbs	PROPN
cuesj-183	83	5	-	-	PUNCT
cuesj-183	83	6	ag	ag	PROPN
cuesj-183	83	7	and	and	CCONJ
cuesj-183	83	8	hbs	hbs	PROPN
cuesj-183	83	9	-	-	PUNCT
cuesj-183	83	10	ab	ab	PROPN
cuesj-183	83	11	but	but	CCONJ
cuesj-183	83	12	positive	positive	ADJ
cuesj-183	83	13	hbc	hbc	PROPN
cuesj-183	83	14	-	-	PUNCT
cuesj-183	83	15	ab	ab	PROPN
cuesj-183	83	16	are	be	AUX
cuesj-183	83	17	defined	define	VERB
cuesj-183	83	18	as	as	ADP
cuesj-183	83	19	occult	occult	NOUN
cuesj-183	83	20	hbv	hbv	NOUN
cuesj-183	83	21	infection	infection	NOUN
cuesj-183	83	22	(	(	PUNCT
cuesj-183	83	23	obi	obi	PROPN
cuesj-183	83	24	)	)	PUNCT
cuesj-183	83	25	,	,	PUNCT
cuesj-183	83	26	this	this	PRON
cuesj-183	83	27	is	be	AUX
cuesj-183	83	28	because	because	SCONJ
cuesj-183	83	29	hbc	hbc	PROPN
cuesj-183	83	30	-	-	PUNCT
cuesj-183	83	31	ab	ab	PROPN
cuesj-183	83	32	is	be	AUX
cuesj-183	83	33	regarded	regard	VERB
cuesj-183	83	34	as	as	ADP
cuesj-183	83	35	a	a	DET
cuesj-183	83	36	pathognomonic	pathognomonic	ADJ
cuesj-183	83	37	marker	marker	NOUN
cuesj-183	83	38	of	of	ADP
cuesj-183	83	39	hbv	hbv	NOUN
cuesj-183	83	40	infection	infection	NOUN
cuesj-183	83	41	,	,	PUNCT
cuesj-183	83	42	particularly	particularly	ADV
cuesj-183	83	43	when	when	SCONJ
cuesj-183	83	44	hbs	hbs	PROPN
cuesj-183	83	45	-	-	PUNCT
cuesj-183	83	46	ag	ag	PROPN
cuesj-183	83	47	and	and	CCONJ
cuesj-183	83	48	hbs	hbs	PROPN
cuesj-183	83	49	-	-	PUNCT
cuesj-183	83	50	ab	ab	PROPN
cuesj-183	83	51	are	be	AUX
cuesj-183	83	52	negative	negative	ADJ
cuesj-183	83	53	.	.	PUNCT
cuesj-183	84	1	we	we	PRON
cuesj-183	84	2	performed	perform	VERB
cuesj-183	84	3	hbv	hbv	NOUN
cuesj-183	84	4	-	-	PUNCT
cuesj-183	84	5	dna	dna	PROPN
cuesj-183	84	6	detection	detection	NOUN
cuesj-183	84	7	assay	assay	VERB
cuesj-183	84	8	solely	solely	ADV
cuesj-183	84	9	on	on	ADP
cuesj-183	84	10	samples	sample	NOUN
cuesj-183	84	11	of	of	ADP
cuesj-183	84	12	blood	blood	NOUN
cuesj-183	84	13	donors	donor	NOUN
cuesj-183	84	14	who	who	PRON
cuesj-183	84	15	tested	test	VERB
cuesj-183	84	16	positive	positive	ADJ
cuesj-183	84	17	for	for	ADP
cuesj-183	84	18	hbc	hbc	NOUN
cuesj-183	84	19	-	-	PUNCT
cuesj-183	84	20	ab	ab	NOUN
cuesj-183	84	21	but	but	CCONJ
cuesj-183	84	22	negative	negative	ADJ
cuesj-183	84	23	for	for	ADP
cuesj-183	84	24	both	both	PRON
cuesj-183	84	25	hbs	hbs	PROPN
cuesj-183	84	26	-	-	PUNCT
cuesj-183	84	27	ag	ag	PROPN
cuesj-183	84	28	and	and	CCONJ
cuesj-183	84	29	hbs	hbs	PROPN
cuesj-183	84	30	-	-	PUNCT
cuesj-183	84	31	ab	ab	PROPN
cuesj-183	84	32	(	(	PUNCT
cuesj-183	84	33	24	24	NUM
cuesj-183	84	34	samples	sample	NOUN
cuesj-183	84	35	)	)	PUNCT
cuesj-183	84	36	,	,	PUNCT
cuesj-183	84	37	including	include	VERB
cuesj-183	84	38	six	six	NUM
cuesj-183	84	39	control	control	NOUN
cuesj-183	84	40	samples	sample	NOUN
cuesj-183	84	41	as	as	ADV
cuesj-183	84	42	well	well	ADV
cuesj-183	84	43	.	.	PUNCT
cuesj-183	85	1	among	among	ADP
cuesj-183	85	2	24	24	NUM
cuesj-183	85	3	samples	sample	NOUN
cuesj-183	85	4	we	we	PRON
cuesj-183	85	5	could	could	AUX
cuesj-183	85	6	confirm	confirm	VERB
cuesj-183	85	7	the	the	DET
cuesj-183	85	8	presence	presence	NOUN
cuesj-183	85	9	of	of	ADP
cuesj-183	85	10	hcv	hcv	PROPN
cuesj-183	85	11	dna	dna	PROPN
cuesj-183	85	12	only	only	ADV
cuesj-183	85	13	in	in	ADP
cuesj-183	85	14	8	8	NUM
cuesj-183	85	15	(	(	PUNCT
cuesj-183	85	16	33	33	NUM
cuesj-183	85	17	%	%	NOUN
cuesj-183	85	18	)	)	PUNCT
cuesj-183	85	19	samples	sample	NOUN
cuesj-183	85	20	,	,	PUNCT
cuesj-183	85	21	using	use	VERB
cuesj-183	85	22	rt	rt	PROPN
cuesj-183	85	23	pcr	pcr	NOUN
cuesj-183	85	24	,	,	PUNCT
cuesj-183	85	25	indicating	indicate	VERB
cuesj-183	85	26	the	the	DET
cuesj-183	85	27	overall	overall	ADJ
cuesj-183	85	28	incidence	incidence	NOUN
cuesj-183	85	29	of	of	ADP
cuesj-183	85	30	obi	obi	PROPN
cuesj-183	85	31	by	by	ADP
cuesj-183	85	32	dna	dna	PROPN
cuesj-183	85	33	detection	detection	NOUN
cuesj-183	85	34	to	to	PART
cuesj-183	85	35	be	be	AUX
cuesj-183	85	36	about	about	ADP
cuesj-183	85	37	(	(	PUNCT
cuesj-183	85	38	0.13	0.13	NUM
cuesj-183	85	39	%	%	NOUN
cuesj-183	85	40	;	;	PUNCT
cuesj-183	85	41	8	8	NUM
cuesj-183	85	42	out	out	ADP
cuesj-183	85	43	of	of	ADP
cuesj-183	85	44	6173	6173	NUM
cuesj-183	85	45	)	)	PUNCT
cuesj-183	86	1	[	[	X
cuesj-183	86	2	figures	figure	NOUN
cuesj-183	86	3	1	1	NUM
cuesj-183	86	4	and	and	CCONJ
cuesj-183	86	5	3	3	NUM
cuesj-183	86	6	]	]	PUNCT
cuesj-183	86	7	.	.	PUNCT
cuesj-183	87	1	based	base	VERB
cuesj-183	87	2	on	on	ADP
cuesj-183	87	3	the	the	DET
cuesj-183	87	4	reaction	reaction	NOUN
cuesj-183	87	5	graph	graph	NOUN
cuesj-183	87	6	,	,	PUNCT
cuesj-183	87	7	most	most	ADJ
cuesj-183	87	8	of	of	ADP
cuesj-183	87	9	the	the	DET
cuesj-183	87	10	positive	positive	ADJ
cuesj-183	87	11	sample	sample	NOUN
cuesj-183	87	12	has	have	VERB
cuesj-183	87	13	very	very	ADV
cuesj-183	87	14	low	low	ADJ
cuesj-183	87	15	copy	copy	NOUN
cuesj-183	87	16	numbers	number	NOUN
cuesj-183	87	17	since	since	SCONJ
cuesj-183	87	18	the	the	DET
cuesj-183	87	19	reaction	reaction	NOUN
cuesj-183	87	20	was	be	AUX
cuesj-183	87	21	arrived	arrive	VERB
cuesj-183	87	22	at	at	ADP
cuesj-183	87	23	between	between	ADP
cuesj-183	87	24	the	the	DET
cuesj-183	87	25	35	35	NUM
cuesj-183	87	26	and	and	CCONJ
cuesj-183	87	27	40	40	NUM
cuesj-183	87	28	cycles	cycle	NOUN
cuesj-183	87	29	[	[	X
cuesj-183	87	30	figure	figure	NOUN
cuesj-183	87	31	3	3	NUM
cuesj-183	87	32	]	]	PUNCT
cuesj-183	87	33	.	.	PUNCT
cuesj-183	88	1	meanwhile	meanwhile	ADV
cuesj-183	88	2	,	,	PUNCT
cuesj-183	88	3	the	the	DET
cuesj-183	88	4	remaining	remain	VERB
cuesj-183	88	5	16	16	NUM
cuesj-183	88	6	(	(	PUNCT
cuesj-183	88	7	66	66	NUM
cuesj-183	88	8	%	%	NOUN
cuesj-183	88	9	)	)	PUNCT
cuesj-183	88	10	samples	sample	NOUN
cuesj-183	88	11	were	be	AUX
cuesj-183	88	12	hbc	hbc	NOUN
cuesj-183	88	13	-	-	PUNCT
cuesj-183	88	14	ab	ab	NOUN
cuesj-183	88	15	positive	positive	ADJ
cuesj-183	88	16	but	but	CCONJ
cuesj-183	88	17	failed	fail	VERB
cuesj-183	88	18	to	to	PART
cuesj-183	88	19	be	be	AUX
cuesj-183	88	20	confirmed	confirm	VERB
cuesj-183	88	21	by	by	ADP
cuesj-183	88	22	hbv	hbv	NOUN
cuesj-183	88	23	-	-	PUNCT
cuesj-183	88	24	dna	dna	PROPN
cuesj-183	88	25	table	table	NOUN
cuesj-183	88	26	3	3	NUM
cuesj-183	88	27	:	:	PUNCT
cuesj-183	88	28	distribution	distribution	NOUN
cuesj-183	88	29	of	of	ADP
cuesj-183	88	30	hbs	hbs	PROPN
cuesj-183	88	31	-	-	PUNCT
cuesj-183	88	32	ab	ab	PROPN
cuesj-183	88	33	among	among	ADP
cuesj-183	88	34	hbc	hbc	PROPN
cuesj-183	88	35	-	-	PUNCT
cuesj-183	88	36	ab	ab	X
cuesj-183	88	37	positive	positive	ADJ
cuesj-183	88	38	individuals	individual	NOUN
cuesj-183	88	39	and	and	CCONJ
cuesj-183	88	40	control	control	NOUN
cuesj-183	88	41	group	group	NOUN
cuesj-183	88	42	serology	serology	NOUN
cuesj-183	88	43	(	(	PUNCT
cuesj-183	88	44	hbc	hbc	PROPN
cuesj-183	88	45	igg	igg	PROPN
cuesj-183	88	46	)	)	PUNCT
cuesj-183	88	47	serology	serology	NOUN
cuesj-183	88	48	(	(	PUNCT
cuesj-183	88	49	hbs	hbs	ADJ
cuesj-183	88	50	antibody	antibody	NOUN
cuesj-183	88	51	)	)	PUNCT
cuesj-183	89	1	p	p	X
cuesj-183	89	2	-	-	PUNCT
cuesj-183	89	3	value	value	NOUN
cuesj-183	89	4	positive	positive	ADJ
cuesj-183	89	5	(	(	PUNCT
cuesj-183	89	6	n=	n=	ADJ
cuesj-183	89	7	)	)	PUNCT
cuesj-183	89	8	negative	negative	ADJ
cuesj-183	89	9	(	(	PUNCT
cuesj-183	89	10	n=	n=	ADJ
cuesj-183	89	11	)	)	PUNCT
cuesj-183	89	12	total	total	NOUN
cuesj-183	89	13	(	(	PUNCT
cuesj-183	89	14	n=	n=	ADJ
cuesj-183	89	15	)	)	PUNCT
cuesj-183	89	16	positive	positive	ADJ
cuesj-183	89	17	74	74	NUM
cuesj-183	89	18	24	24	NUM
cuesj-183	89	19	98	98	NUM
cuesj-183	89	20	<	<	NOUN
cuesj-183	89	21	0.05	0.05	NUM
cuesj-183	89	22	negative	negative	ADJ
cuesj-183	89	23	6	6	NUM
cuesj-183	89	24	55	55	NUM
cuesj-183	89	25	61	61	NUM
cuesj-183	89	26	total	total	NOUN
cuesj-183	89	27	80	80	NUM
cuesj-183	89	28	79	79	NUM
cuesj-183	89	29	159	159	NUM
cuesj-183	89	30	hbs	hbs	PROPN
cuesj-183	89	31	ab	ab	PROPN
cuesj-183	89	32	:	:	PUNCT
cuesj-183	89	33	hepatitis	hepatitis	PROPN
cuesj-183	89	34	b	b	PROPN
cuesj-183	89	35	surface	surface	NOUN
cuesj-183	89	36	antibodies	antibody	NOUN
cuesj-183	89	37	figure	figure	VERB
cuesj-183	89	38	3	3	NUM
cuesj-183	89	39	:	:	PUNCT
cuesj-183	89	40	quantitation	quantitation	NOUN
cuesj-183	89	41	data	datum	NOUN
cuesj-183	89	42	for	for	ADP
cuesj-183	89	43	cycling	cycle	VERB
cuesj-183	89	44	a.	a.	NOUN
cuesj-183	89	45	green	green	NOUN
cuesj-183	89	46	for	for	ADP
cuesj-183	89	47	hepatitis	hepatitis	PROPN
cuesj-183	89	48	b	b	PROPN
cuesj-183	89	49	virus	virus	NOUN
cuesj-183	89	50	by	by	ADP
cuesj-183	89	51	real	real	ADJ
cuesj-183	89	52	-	-	PUNCT
cuesj-183	89	53	time	time	NOUN
cuesj-183	89	54	quantitative	quantitative	ADJ
cuesj-183	89	55	polymerase	polymerase	NOUN
cuesj-183	89	56	chain	chain	NOUN
cuesj-183	89	57	reaction	reaction	NOUN
cuesj-183	89	58	table	table	NOUN
cuesj-183	89	59	4	4	NUM
cuesj-183	89	60	:	:	PUNCT
cuesj-183	89	61	the	the	DET
cuesj-183	89	62	incidence	incidence	NOUN
cuesj-183	89	63	and	and	CCONJ
cuesj-183	89	64	percentage	percentage	NOUN
cuesj-183	89	65	of	of	ADP
cuesj-183	89	66	hcv	hcv	X
cuesj-183	89	67	reactive	reactive	ADJ
cuesj-183	89	68	donors	donor	NOUN
cuesj-183	89	69	and	and	CCONJ
cuesj-183	89	70	dual	dual	ADJ
cuesj-183	89	71	infection	infection	NOUN
cuesj-183	89	72	serology	serology	NOUN
cuesj-183	89	73	(	(	PUNCT
cuesj-183	89	74	hbs	hbs	PROPN
cuesj-183	89	75	antigen	antigen	PROPN
cuesj-183	89	76	)	)	PUNCT
cuesj-183	89	77	serology	serology	NOUN
cuesj-183	89	78	(	(	PUNCT
cuesj-183	89	79	hcv	hcv	PROPN
cuesj-183	89	80	-	-	PUNCT
cuesj-183	89	81	ab	ab	NOUN
cuesj-183	89	82	)	)	PUNCT
cuesj-183	89	83	positive	positive	ADJ
cuesj-183	89	84	negative	negative	ADJ
cuesj-183	89	85	total	total	ADJ
cuesj-183	89	86	n=	n=	ADJ
cuesj-183	89	87	%	%	NOUN
cuesj-183	89	88	n=%	n=%	ADV
cuesj-183	89	89	n=%	n=%	ADV
cuesj-183	89	90	positive	positive	ADJ
cuesj-183	89	91	1	1	NUM
cuesj-183	89	92	(	(	PUNCT
cuesj-183	89	93	0.6	0.6	NUM
cuesj-183	89	94	)	)	PUNCT
cuesj-183	89	95	7	7	NUM
cuesj-183	89	96	(	(	PUNCT
cuesj-183	89	97	4.4	4.4	NUM
cuesj-183	89	98	)	)	PUNCT
cuesj-183	89	99	8	8	NUM
cuesj-183	89	100	(	(	PUNCT
cuesj-183	89	101	5.0	5.0	NUM
cuesj-183	89	102	)	)	PUNCT
cuesj-183	89	103	negative	negative	ADJ
cuesj-183	89	104	3	3	NUM
cuesj-183	89	105	(	(	PUNCT
cuesj-183	89	106	1.9	1.9	NUM
cuesj-183	89	107	)	)	PUNCT
cuesj-183	89	108	148	148	NUM
cuesj-183	89	109	(	(	PUNCT
cuesj-183	89	110	93.1	93.1	NUM
cuesj-183	89	111	)	)	SYM
cuesj-183	89	112	151	151	NUM
cuesj-183	89	113	(	(	PUNCT
cuesj-183	89	114	95.0	95.0	NUM
cuesj-183	89	115	)	)	PUNCT
cuesj-183	89	116	total	total	NOUN
cuesj-183	89	117	4	4	NUM
cuesj-183	89	118	(	(	PUNCT
cuesj-183	89	119	2.5	2.5	NUM
cuesj-183	89	120	)	)	PUNCT
cuesj-183	89	121	155	155	NUM
cuesj-183	89	122	(	(	PUNCT
cuesj-183	89	123	97.5	97.5	NUM
cuesj-183	89	124	)	)	PUNCT
cuesj-183	89	125	159	159	NUM
cuesj-183	89	126	(	(	PUNCT
cuesj-183	89	127	100.0	100.0	NUM
cuesj-183	89	128	)	)	PUNCT
cuesj-183	89	129	hcv	hcv	PROPN
cuesj-183	89	130	-	-	PUNCT
cuesj-183	89	131	ab	ab	NOUN
cuesj-183	89	132	:	:	PUNCT
cuesj-183	89	133	hepatitis	hepatitis	PROPN
cuesj-183	89	134	b	b	PROPN
cuesj-183	89	135	surface	surface	NOUN
cuesj-183	89	136	antibodies	antibodie	VERB
cuesj-183	89	137	saleh	saleh	NOUN
cuesj-183	89	138	and	and	CCONJ
cuesj-183	89	139	taher	taher	PROPN
cuesj-183	89	140	:	:	PUNCT
cuesj-183	89	141	prevalence	prevalence	NOUN
cuesj-183	89	142	of	of	ADP
cuesj-183	89	143	hepatitis	hepatitis	PROPN
cuesj-183	89	144	b	b	PROPN
cuesj-183	89	145	and	and	CCONJ
cuesj-183	89	146	hepatitis	hepatitis	PROPN
cuesj-183	89	147	c	c	NOUN
cuesj-183	89	148	infection	infection	NOUN
cuesj-183	89	149	in	in	ADP
cuesj-183	89	150	erbil	erbil	PROPN
cuesj-183	89	151	50	50	NUM
cuesj-183	89	152	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-183	89	153	cuesj	cuesj	NOUN
cuesj-183	89	154	2020	2020	NUM
cuesj-183	89	155	,	,	PUNCT
cuesj-183	89	156	4	4	NUM
cuesj-183	89	157	(	(	PUNCT
cuesj-183	89	158	1	1	NUM
cuesj-183	89	159	):	):	PUNCT
cuesj-183	89	160	45	45	NUM
cuesj-183	89	161	-	-	SYM
cuesj-183	89	162	51	51	NUM
cuesj-183	89	163	detection	detection	NOUN
cuesj-183	89	164	.	.	PUNCT
cuesj-183	90	1	in	in	ADP
cuesj-183	90	2	most	most	ADJ
cuesj-183	90	3	of	of	ADP
cuesj-183	90	4	the	the	DET
cuesj-183	90	5	areas	area	NOUN
cuesj-183	90	6	,	,	PUNCT
cuesj-183	90	7	these	these	DET
cuesj-183	90	8	groups	group	NOUN
cuesj-183	90	9	of	of	ADP
cuesj-183	90	10	blood	blood	NOUN
cuesj-183	90	11	donors	donor	NOUN
cuesj-183	90	12	are	be	AUX
cuesj-183	90	13	still	still	ADV
cuesj-183	90	14	regarded	regard	VERB
cuesj-183	90	15	as	as	ADP
cuesj-183	90	16	obi	obi	PROPN
cuesj-183	90	17	,	,	PUNCT
cuesj-183	90	18	and	and	CCONJ
cuesj-183	90	19	their	their	PRON
cuesj-183	90	20	blood	blood	NOUN
cuesj-183	90	21	will	will	AUX
cuesj-183	90	22	be	be	AUX
cuesj-183	90	23	discarded	discard	VERB
cuesj-183	90	24	to	to	PART
cuesj-183	90	25	prevent	prevent	VERB
cuesj-183	90	26	virus	virus	NOUN
cuesj-183	90	27	transmission.[37	transmission.[37	PROPN
cuesj-183	90	28	]	]	PUNCT
cuesj-183	90	29	internationally	internationally	ADV
cuesj-183	90	30	,	,	PUNCT
cuesj-183	90	31	many	many	ADJ
cuesj-183	90	32	studies	study	NOUN
cuesj-183	90	33	have	have	AUX
cuesj-183	90	34	been	be	AUX
cuesj-183	90	35	published	publish	VERB
cuesj-183	90	36	throughout	throughout	ADP
cuesj-183	90	37	the	the	DET
cuesj-183	90	38	world	world	NOUN
cuesj-183	90	39	showing	show	VERB
cuesj-183	90	40	the	the	DET
cuesj-183	90	41	frequency	frequency	NOUN
cuesj-183	90	42	of	of	ADP
cuesj-183	90	43	obi	obi	PROPN
cuesj-183	90	44	within	within	ADP
cuesj-183	90	45	hbs	hbs	PROPN
cuesj-183	90	46	-	-	PUNCT
cuesj-183	90	47	ag	ag	PROPN
cuesj-183	90	48	-	-	PUNCT
cuesj-183	90	49	negative	negative	ADJ
cuesj-183	90	50	donors	donor	NOUN
cuesj-183	90	51	,	,	PUNCT
cuesj-183	90	52	the	the	DET
cuesj-183	90	53	results	result	NOUN
cuesj-183	90	54	are	be	AUX
cuesj-183	90	55	varied	varied	ADJ
cuesj-183	90	56	:	:	PUNCT
cuesj-183	90	57	for	for	ADP
cuesj-183	90	58	example	example	NOUN
cuesj-183	90	59	in	in	ADP
cuesj-183	90	60	the	the	DET
cuesj-183	90	61	united	united	PROPN
cuesj-183	90	62	kingdom	kingdom	PROPN
cuesj-183	90	63	it	it	PRON
cuesj-183	90	64	was	be	AUX
cuesj-183	90	65	0.56%;[38	0.56%;[38	NOUN
cuesj-183	90	66	]	]	PUNCT
cuesj-183	90	67	in	in	ADP
cuesj-183	90	68	the	the	DET
cuesj-183	90	69	united	united	PROPN
cuesj-183	90	70	state	state	PROPN
cuesj-183	90	71	of	of	ADP
cuesj-183	90	72	america	america	PROPN
cuesj-183	90	73	it	it	PRON
cuesj-183	90	74	was	be	AUX
cuesj-183	90	75	0.8%;[39	0.8%;[39	NUM
cuesj-183	90	76	]	]	X
cuesj-183	90	77	in	in	ADP
cuesj-183	90	78	iran	iran	PROPN
cuesj-183	90	79	it	it	PRON
cuesj-183	90	80	was	be	AUX
cuesj-183	90	81	2.1%;[40	2.1%;[40	NOUN
cuesj-183	90	82	]	]	PUNCT
cuesj-183	90	83	and	and	CCONJ
cuesj-183	90	84	in	in	ADP
cuesj-183	90	85	brazil	brazil	PROPN
cuesj-183	90	86	it	it	PRON
cuesj-183	90	87	was	be	AUX
cuesj-183	90	88	3.1%.[41	3.1%.[41	NUM
cuesj-183	90	89	]	]	PUNCT
cuesj-183	90	90	on	on	ADP
cuesj-183	90	91	a	a	DET
cuesj-183	90	92	national	national	ADJ
cuesj-183	90	93	level	level	NOUN
cuesj-183	90	94	,	,	PUNCT
cuesj-183	90	95	a	a	DET
cuesj-183	90	96	similar	similar	ADJ
cuesj-183	90	97	study	study	NOUN
cuesj-183	90	98	performed	perform	VERB
cuesj-183	90	99	in	in	ADP
cuesj-183	90	100	erbil	erbil	PROPN
cuesj-183	90	101	city	city	PROPN
cuesj-183	90	102	of	of	ADP
cuesj-183	90	103	iraq	iraq	PROPN
cuesj-183	90	104	shows	show	VERB
cuesj-183	90	105	obi	obi	PROPN
cuesj-183	90	106	in	in	ADP
cuesj-183	90	107	0.09	0.09	NUM
cuesj-183	90	108	%	%	NOUN
cuesj-183	90	109	which	which	PRON
cuesj-183	90	110	is	be	AUX
cuesj-183	90	111	close	close	ADJ
cuesj-183	90	112	to	to	ADP
cuesj-183	90	113	our	our	PRON
cuesj-183	90	114	finding	finding	NOUN
cuesj-183	90	115	(	(	PUNCT
cuesj-183	90	116	0.13%).[42	0.13%).[42	X
cuesj-183	90	117	]	]	PUNCT
cuesj-183	90	118	discarding	discard	VERB
cuesj-183	90	119	the	the	DET
cuesj-183	90	120	infected	infected	ADJ
cuesj-183	90	121	blood	blood	NOUN
cuesj-183	90	122	on	on	ADP
cuesj-183	90	123	the	the	DET
cuesj-183	90	124	basis	basis	NOUN
cuesj-183	90	125	of	of	ADP
cuesj-183	90	126	hbc	hbc	PROPN
cuesj-183	90	127	-	-	PUNCT
cuesj-183	90	128	ab	ab	NOUN
cuesj-183	90	129	detection	detection	NOUN
cuesj-183	90	130	,	,	PUNCT
cuesj-183	90	131	especially	especially	ADV
cuesj-183	90	132	in	in	ADP
cuesj-183	90	133	areas	area	NOUN
cuesj-183	90	134	where	where	SCONJ
cuesj-183	90	135	the	the	DET
cuesj-183	90	136	prevalence	prevalence	NOUN
cuesj-183	90	137	of	of	ADP
cuesj-183	90	138	hbc	hbc	PROPN
cuesj-183	90	139	-	-	PUNCT
cuesj-183	90	140	ab	ab	PROPN
cuesj-183	90	141	is	be	AUX
cuesj-183	90	142	high	high	ADJ
cuesj-183	90	143	(	(	PUNCT
cuesj-183	90	144	more	more	ADJ
cuesj-183	90	145	than	than	ADP
cuesj-183	90	146	10	10	NUM
cuesj-183	90	147	%	%	NOUN
cuesj-183	90	148	)	)	PUNCT
cuesj-183	90	149	,	,	PUNCT
cuesj-183	90	150	will	will	AUX
cuesj-183	90	151	negatively	negatively	ADV
cuesj-183	90	152	affect	affect	VERB
cuesj-183	90	153	the	the	DET
cuesj-183	90	154	blood	blood	NOUN
cuesj-183	90	155	supply	supply	NOUN
cuesj-183	90	156	.	.	PUNCT
cuesj-183	91	1	in	in	ADP
cuesj-183	91	2	the	the	DET
cuesj-183	91	3	present	present	ADJ
cuesj-183	91	4	study	study	NOUN
cuesj-183	91	5	,	,	PUNCT
cuesj-183	91	6	we	we	PRON
cuesj-183	91	7	found	find	VERB
cuesj-183	91	8	that	that	SCONJ
cuesj-183	91	9	the	the	DET
cuesj-183	91	10	incidence	incidence	NOUN
cuesj-183	91	11	of	of	ADP
cuesj-183	91	12	hbc	hbc	PROPN
cuesj-183	91	13	-	-	PUNCT
cuesj-183	91	14	ab	ab	NOUN
cuesj-183	91	15	in	in	ADP
cuesj-183	91	16	the	the	DET
cuesj-183	91	17	erbil	erbil	PROPN
cuesj-183	91	18	city	city	NOUN
cuesj-183	91	19	was	be	AUX
cuesj-183	91	20	low	low	ADJ
cuesj-183	91	21	(	(	PUNCT
cuesj-183	91	22	1.56	1.56	NUM
cuesj-183	91	23	%	%	NOUN
cuesj-183	91	24	,	,	PUNCT
cuesj-183	91	25	98	98	NUM
cuesj-183	91	26	out	out	ADP
cuesj-183	91	27	of	of	ADP
cuesj-183	91	28	6173	6173	NUM
cuesj-183	91	29	)	)	PUNCT
cuesj-183	92	1	[	[	X
cuesj-183	92	2	figure	figure	NOUN
cuesj-183	92	3	1	1	NUM
cuesj-183	92	4	]	]	PUNCT
cuesj-183	92	5	.	.	PUNCT
cuesj-183	93	1	further	further	ADJ
cuesj-183	93	2	detection	detection	NOUN
cuesj-183	93	3	of	of	ADP
cuesj-183	93	4	hbs	hbs	PROPN
cuesj-183	93	5	-	-	PUNCT
cuesj-183	93	6	ab	ab	PROPN
cuesj-183	93	7	saved	save	VERB
cuesj-183	93	8	78	78	NUM
cuesj-183	93	9	of	of	ADP
cuesj-183	93	10	our	our	PRON
cuesj-183	93	11	samples	sample	NOUN
cuesj-183	93	12	(	(	PUNCT
cuesj-183	93	13	75.5	75.5	NUM
cuesj-183	93	14	%	%	NOUN
cuesj-183	93	15	)	)	PUNCT
cuesj-183	93	16	since	since	SCONJ
cuesj-183	93	17	they	they	PRON
cuesj-183	93	18	were	be	AUX
cuesj-183	93	19	positive	positive	ADJ
cuesj-183	93	20	for	for	ADP
cuesj-183	93	21	hbs	hbs	PROPN
cuesj-183	93	22	-	-	PUNCT
cuesj-183	93	23	ab	ab	PROPN
cuesj-183	93	24	.	.	PUNCT
cuesj-183	94	1	on	on	ADP
cuesj-183	94	2	the	the	DET
cuesj-183	94	3	other	other	ADJ
cuesj-183	94	4	hand	hand	NOUN
cuesj-183	94	5	,	,	PUNCT
cuesj-183	94	6	dna	dna	PROPN
cuesj-183	94	7	confirms	confirm	VERB
cuesj-183	94	8	the	the	DET
cuesj-183	94	9	obi	obi	NOUN
cuesj-183	94	10	only	only	ADV
cuesj-183	94	11	in	in	ADP
cuesj-183	94	12	8	8	NUM
cuesj-183	94	13	samples	sample	NOUN
cuesj-183	94	14	(	(	PUNCT
cuesj-183	94	15	33	33	NUM
cuesj-183	94	16	%	%	NOUN
cuesj-183	94	17	)	)	PUNCT
cuesj-183	94	18	.	.	PUNCT
cuesj-183	95	1	in	in	ADP
cuesj-183	95	2	high	high	ADJ
cuesj-183	95	3	prevalence	prevalence	NOUN
cuesj-183	95	4	area	area	NOUN
cuesj-183	95	5	based	base	VERB
cuesj-183	95	6	on	on	ADP
cuesj-183	95	7	hbc	hbc	PROPN
cuesj-183	95	8	-	-	PUNCT
cuesj-183	95	9	ab	ab	NOUN
cuesj-183	95	10	detection	detection	NOUN
cuesj-183	95	11	such	such	ADJ
cuesj-183	95	12	as	as	ADP
cuesj-183	95	13	korea	korea	PROPN
cuesj-183	95	14	,	,	PUNCT
cuesj-183	95	15	greece	greece	PROPN
cuesj-183	95	16	,	,	PUNCT
cuesj-183	95	17	and	and	CCONJ
cuesj-183	95	18	ghana	ghana	PROPN
cuesj-183	95	19	,	,	PUNCT
cuesj-183	95	20	they	they	PRON
cuesj-183	95	21	discarded	discard	VERB
cuesj-183	95	22	only	only	ADV
cuesj-183	95	23	blood	blood	NOUN
cuesj-183	95	24	that	that	PRON
cuesj-183	95	25	is	be	AUX
cuesj-183	95	26	positive	positive	ADJ
cuesj-183	95	27	for	for	ADP
cuesj-183	95	28	hbvdna	hbvdna	ADV
cuesj-183	95	29	,	,	PUNCT
cuesj-183	95	30	consequently	consequently	ADV
cuesj-183	95	31	saving	save	VERB
cuesj-183	95	32	more	more	ADJ
cuesj-183	95	33	blood	blood	NOUN
cuesj-183	95	34	units.[43,44	units.[43,44	NOUN
cuesj-183	95	35	]	]	PUNCT
cuesj-183	95	36	meanwhile	meanwhile	ADV
cuesj-183	95	37	,	,	PUNCT
cuesj-183	95	38	in	in	ADP
cuesj-183	95	39	many	many	ADJ
cuesj-183	95	40	places	place	NOUN
cuesj-183	95	41	,	,	PUNCT
cuesj-183	95	42	especially	especially	ADV
cuesj-183	95	43	in	in	ADP
cuesj-183	95	44	low	low	ADJ
cuesj-183	95	45	prevalence	prevalence	NOUN
cuesj-183	95	46	countries	country	NOUN
cuesj-183	95	47	,	,	PUNCT
cuesj-183	95	48	blood	blood	NOUN
cuesj-183	95	49	donor	donor	NOUN
cuesj-183	95	50	samples	sample	NOUN
cuesj-183	95	51	were	be	AUX
cuesj-183	95	52	still	still	ADV
cuesj-183	95	53	considered	consider	VERB
cuesj-183	95	54	as	as	ADP
cuesj-183	95	55	obi	obi	PROPN
cuesj-183	95	56	based	base	VERB
cuesj-183	95	57	on	on	ADP
cuesj-183	95	58	hbc	hbc	PROPN
cuesj-183	95	59	-	-	PUNCT
cuesj-183	95	60	ab	ab	NOUN
cuesj-183	95	61	positivity	positivity	NOUN
cuesj-183	95	62	,	,	PUNCT
cuesj-183	95	63	and	and	CCONJ
cuesj-183	95	64	all	all	DET
cuesj-183	95	65	such	such	ADJ
cuesj-183	95	66	donated	donated	ADJ
cuesj-183	95	67	blood	blood	NOUN
cuesj-183	95	68	was	be	AUX
cuesj-183	95	69	discarded	discard	VERB
cuesj-183	95	70	to	to	PART
cuesj-183	95	71	prevent	prevent	VERB
cuesj-183	95	72	transfusion	transfusion	NOUN
cuesj-183	95	73	-	-	PUNCT
cuesj-183	95	74	transmitted	transmit	VERB
cuesj-183	95	75	viral	viral	ADJ
cuesj-183	95	76	infection	infection	NOUN
cuesj-183	95	77	.	.	PUNCT
cuesj-183	96	1	despite	despite	SCONJ
cuesj-183	96	2	the	the	DET
cuesj-183	96	3	above	above	NOUN
cuesj-183	96	4	,	,	PUNCT
cuesj-183	96	5	the	the	DET
cuesj-183	96	6	failure	failure	NOUN
cuesj-183	96	7	of	of	ADP
cuesj-183	96	8	detecting	detect	VERB
cuesj-183	96	9	hbv	hbv	NOUN
cuesj-183	96	10	-	-	PUNCT
cuesj-183	96	11	dna	dna	NOUN
cuesj-183	96	12	might	might	AUX
cuesj-183	96	13	be	be	AUX
cuesj-183	96	14	due	due	ADJ
cuesj-183	96	15	to	to	ADP
cuesj-183	96	16	a	a	DET
cuesj-183	96	17	mutation	mutation	NOUN
cuesj-183	96	18	in	in	ADP
cuesj-183	96	19	viral	viral	ADJ
cuesj-183	96	20	structure	structure	NOUN
cuesj-183	96	21	,	,	PUNCT
cuesj-183	96	22	and	and	CCONJ
cuesj-183	96	23	the	the	DET
cuesj-183	96	24	false	false	ADJ
cuesj-183	96	25	serological	serological	ADJ
cuesj-183	96	26	result	result	NOUN
cuesj-183	96	27	might	might	AUX
cuesj-183	96	28	be	be	AUX
cuesj-183	96	29	due	due	ADJ
cuesj-183	96	30	to	to	ADP
cuesj-183	96	31	the	the	DET
cuesj-183	96	32	imperfection	imperfection	NOUN
cuesj-183	96	33	of	of	ADP
cuesj-183	96	34	the	the	DET
cuesj-183	96	35	assays	assay	NOUN
cuesj-183	96	36	used	use	VERB
cuesj-183	96	37	for	for	ADP
cuesj-183	96	38	such	such	ADJ
cuesj-183	96	39	purpose.[37	purpose.[37	NOUN
cuesj-183	96	40	]	]	PUNCT
cuesj-183	96	41	many	many	ADJ
cuesj-183	96	42	researchers	researcher	NOUN
cuesj-183	96	43	argued	argue	VERB
cuesj-183	96	44	in	in	ADP
cuesj-183	96	45	favor	favor	NOUN
cuesj-183	96	46	of	of	ADP
cuesj-183	96	47	the	the	DET
cuesj-183	96	48	implementation	implementation	NOUN
cuesj-183	96	49	of	of	ADP
cuesj-183	96	50	hbc	hbc	PROPN
cuesj-183	96	51	-	-	PUNCT
cuesj-183	96	52	ab	ab	PROPN
cuesj-183	96	53	or	or	CCONJ
cuesj-183	96	54	hbv	hbv	PROPN
cuesj-183	96	55	dna	dna	PROPN
cuesj-183	96	56	alone	alone	ADJ
cuesj-183	96	57	or	or	CCONJ
cuesj-183	96	58	combination	combination	NOUN
cuesj-183	96	59	for	for	ADP
cuesj-183	96	60	the	the	DET
cuesj-183	96	61	screening	screening	NOUN
cuesj-183	96	62	of	of	ADP
cuesj-183	96	63	donated	donate	VERB
cuesj-183	96	64	blood.[45,46	blood.[45,46	PROPN
cuesj-183	96	65	]	]	PUNCT
cuesj-183	96	66	in	in	ADP
cuesj-183	96	67	a	a	DET
cuesj-183	96	68	large	large	ADJ
cuesj-183	96	69	study	study	NOUN
cuesj-183	96	70	screening	screening	NOUN
cuesj-183	96	71	,	,	PUNCT
cuesj-183	96	72	6.5	6.5	NUM
cuesj-183	96	73	million	million	NUM
cuesj-183	96	74	participants	participant	NOUN
cuesj-183	96	75	using	use	VERB
cuesj-183	96	76	three	three	NUM
cuesj-183	96	77	markers	marker	NOUN
cuesj-183	96	78	(	(	PUNCT
cuesj-183	96	79	hbs	hbs	PROPN
cuesj-183	96	80	-	-	PUNCT
cuesj-183	96	81	ag	ag	PROPN
cuesj-183	96	82	,	,	PUNCT
cuesj-183	96	83	hbc	hbc	PROPN
cuesj-183	96	84	-	-	PUNCT
cuesj-183	96	85	ab	ab	NOUN
cuesj-183	96	86	,	,	PUNCT
cuesj-183	96	87	and	and	CCONJ
cuesj-183	96	88	pcr	pcr	NOUN
cuesj-183	96	89	for	for	ADP
cuesj-183	96	90	hbv	hbv	PROPN
cuesj-183	96	91	dna	dna	PROPN
cuesj-183	96	92	)	)	PUNCT
cuesj-183	96	93	,	,	PUNCT
cuesj-183	96	94	prioritizing	prioritize	VERB
cuesj-183	96	95	the	the	DET
cuesj-183	96	96	use	use	NOUN
cuesj-183	96	97	of	of	ADP
cuesj-183	96	98	hbc	hbc	PROPN
cuesj-183	96	99	-	-	PUNCT
cuesj-183	96	100	ab	ab	PROPN
cuesj-183	96	101	along	along	ADP
cuesj-183	96	102	with	with	ADP
cuesj-183	96	103	the	the	DET
cuesj-183	96	104	dna	dna	PROPN
cuesj-183	96	105	nucleic	nucleic	ADJ
cuesj-183	96	106	acid	acid	NOUN
cuesj-183	96	107	testing	testing	NOUN
cuesj-183	96	108	was	be	AUX
cuesj-183	96	109	confirmed	confirm	VERB
cuesj-183	96	110	for	for	ADP
cuesj-183	96	111	the	the	DET
cuesj-183	96	112	detection	detection	NOUN
cuesj-183	96	113	of	of	ADP
cuesj-183	96	114	a	a	DET
cuesj-183	96	115	low	low	ADJ
cuesj-183	96	116	level	level	NOUN
cuesj-183	96	117	of	of	ADP
cuesj-183	96	118	hbv	hbv	NOUN
cuesj-183	96	119	dna	dna	PROPN
cuesj-183	96	120	positive	positive	ADJ
cuesj-183	96	121	donors.[46	donors.[46	PROPN
cuesj-183	96	122	]	]	PUNCT
cuesj-183	96	123	conclusion	conclusion	NOUN
cuesj-183	96	124	the	the	DET
cuesj-183	96	125	overall	overall	ADJ
cuesj-183	96	126	incidences	incidence	NOUN
cuesj-183	96	127	of	of	ADP
cuesj-183	96	128	hbv	hbv	NOUN
cuesj-183	96	129	and	and	CCONJ
cuesj-183	96	130	hcv	hcv	PROPN
cuesj-183	96	131	among	among	ADP
cuesj-183	96	132	examined	examine	VERB
cuesj-183	96	133	blood	blood	NOUN
cuesj-183	96	134	donors	donor	NOUN
cuesj-183	96	135	were	be	AUX
cuesj-183	96	136	0.5	0.5	NUM
cuesj-183	96	137	%	%	NOUN
cuesj-183	96	138	and	and	CCONJ
cuesj-183	96	139	0.06	0.06	NUM
cuesj-183	96	140	%	%	NOUN
cuesj-183	96	141	,	,	PUNCT
cuesj-183	96	142	respectively	respectively	ADV
cuesj-183	96	143	.	.	PUNCT
cuesj-183	97	1	among	among	ADP
cuesj-183	97	2	that	that	PRON
cuesj-183	97	3	,	,	PUNCT
cuesj-183	97	4	0.39	0.39	NUM
cuesj-183	97	5	%	%	NOUN
cuesj-183	97	6	were	be	AUX
cuesj-183	97	7	diagnosed	diagnose	VERB
cuesj-183	97	8	as	as	ADP
cuesj-183	97	9	obi	obi	PROPN
cuesj-183	97	10	.	.	PUNCT
cuesj-183	98	1	the	the	DET
cuesj-183	98	2	highest	high	ADJ
cuesj-183	98	3	avoidance	avoidance	NOUN
cuesj-183	98	4	of	of	ADP
cuesj-183	98	5	hbv	hbv	NOUN
cuesj-183	98	6	blood	blood	NOUN
cuesj-183	98	7	transmission	transmission	NOUN
cuesj-183	98	8	can	can	AUX
cuesj-183	98	9	be	be	AUX
cuesj-183	98	10	attained	attain	VERB
cuesj-183	98	11	by	by	ADP
cuesj-183	98	12	combining	combine	VERB
cuesj-183	98	13	a	a	DET
cuesj-183	98	14	different	different	ADJ
cuesj-183	98	15	,	,	PUNCT
cuesj-183	98	16	more	more	ADV
cuesj-183	98	17	sensitive	sensitive	ADJ
cuesj-183	98	18	,	,	PUNCT
cuesj-183	98	19	method	method	NOUN
cuesj-183	98	20	for	for	ADP
cuesj-183	98	21	hbv	hbv	NOUN
cuesj-183	98	22	detection	detection	NOUN
cuesj-183	98	23	with	with	ADP
cuesj-183	98	24	the	the	DET
cuesj-183	98	25	evolving	evolving	NOUN
cuesj-183	98	26	of	of	ADP
cuesj-183	98	27	tests	test	NOUN
cuesj-183	98	28	that	that	PRON
cuesj-183	98	29	have	have	VERB
cuesj-183	98	30	high	high	ADJ
cuesj-183	98	31	sensitivity	sensitivity	NOUN
cuesj-183	98	32	and	and	CCONJ
cuesj-183	98	33	specificity	specificity	NOUN
cuesj-183	98	34	for	for	ADP
cuesj-183	98	35	hbs	hbs	PROPN
cuesj-183	98	36	ag	ag	PROPN
cuesj-183	98	37	and	and	CCONJ
cuesj-183	98	38	hbc	hbc	PROPN
cuesj-183	98	39	ab	ab	PROPN
cuesj-183	98	40	detection	detection	PROPN
cuesj-183	98	41	.	.	PUNCT
cuesj-183	99	1	further	far	ADV
cuesj-183	99	2	,	,	PUNCT
cuesj-183	99	3	developing	develop	VERB
cuesj-183	99	4	a	a	DET
cuesj-183	99	5	molecular	molecular	ADJ
cuesj-183	99	6	tool	tool	NOUN
cuesj-183	99	7	that	that	PRON
cuesj-183	99	8	is	be	AUX
cuesj-183	99	9	sensitive	sensitive	ADJ
cuesj-183	99	10	enough	enough	ADV
cuesj-183	99	11	to	to	PART
cuesj-183	99	12	detect	detect	VERB
cuesj-183	99	13	a	a	DET
cuesj-183	99	14	very	very	ADV
cuesj-183	99	15	low	low	ADJ
cuesj-183	99	16	copy	copy	NOUN
cuesj-183	99	17	of	of	ADP
cuesj-183	99	18	viral	viral	ADJ
cuesj-183	99	19	dna	dna	NOUN
cuesj-183	99	20	would	would	AUX
cuesj-183	99	21	conserve	conserve	VERB
cuesj-183	99	22	many	many	ADJ
cuesj-183	99	23	pints	pint	NOUN
cuesj-183	99	24	of	of	ADP
cuesj-183	99	25	blood	blood	NOUN
cuesj-183	99	26	.	.	PUNCT
cuesj-183	100	1	acknowledgments	acknowledgment	NOUN
cuesj-183	100	2	i	i	PRON
cuesj-183	100	3	would	would	AUX
cuesj-183	100	4	like	like	VERB
cuesj-183	100	5	to	to	PART
cuesj-183	100	6	express	express	VERB
cuesj-183	100	7	my	my	PRON
cuesj-183	100	8	very	very	ADV
cuesj-183	100	9	great	great	ADJ
cuesj-183	100	10	appreciation	appreciation	NOUN
cuesj-183	100	11	to	to	ADP
cuesj-183	100	12	the	the	DET
cuesj-183	100	13	directorate	directorate	NOUN
cuesj-183	100	14	of	of	ADP
cuesj-183	100	15	blood	blood	NOUN
cuesj-183	100	16	bank	bank	NOUN
cuesj-183	100	17	and	and	CCONJ
cuesj-183	100	18	those	those	PRON
cuesj-183	100	19	working	work	VERB
cuesj-183	100	20	in	in	ADP
cuesj-183	100	21	the	the	DET
cuesj-183	100	22	central	central	ADJ
cuesj-183	100	23	laboratory	laboratory	NOUN
cuesj-183	100	24	,	,	PUNCT
cuesj-183	100	25	as	as	ADV
cuesj-183	100	26	well	well	ADV
cuesj-183	100	27	as	as	ADP
cuesj-183	100	28	to	to	ADP
cuesj-183	100	29	all	all	DET
cuesj-183	100	30	those	those	PRON
cuesj-183	100	31	who	who	PRON
cuesj-183	100	32	have	have	AUX
cuesj-183	100	33	helped	help	VERB
cuesj-183	100	34	to	to	PART
cuesj-183	100	35	make	make	VERB
cuesj-183	100	36	possible	possible	ADJ
cuesj-183	100	37	my	my	PRON
cuesj-183	100	38	undertaking	undertaking	NOUN
cuesj-183	100	39	of	of	ADP
cuesj-183	100	40	this	this	DET
cuesj-183	100	41	research	research	NOUN
cuesj-183	100	42	.	.	PUNCT
cuesj-183	101	1	conflicts	conflict	NOUN
cuesj-183	101	2	of	of	ADP
cuesj-183	101	3	interest	interest	NOUN
cuesj-183	101	4	there	there	PRON
cuesj-183	101	5	are	be	VERB
cuesj-183	101	6	no	no	DET
cuesj-183	101	7	conflicts	conflict	NOUN
cuesj-183	101	8	of	of	ADP
cuesj-183	101	9	interests	interest	NOUN
cuesj-183	101	10	to	to	PART
cuesj-183	101	11	be	be	AUX
cuesj-183	101	12	declared	declare	VERB
cuesj-183	101	13	.	.	PUNCT
cuesj-183	102	1	references	reference	NOUN
cuesj-183	102	2	1	1	NUM
cuesj-183	102	3	.	.	PUNCT
cuesj-183	102	4	b.	b.	PROPN
cuesj-183	102	5	liu	liu	PROPN
cuesj-183	102	6	,	,	PUNCT
cuesj-183	102	7	j.	j.	PROPN
cuesj-183	102	8	li	li	PROPN
cuesj-183	102	9	,	,	PUNCT
cuesj-183	102	10	y.	y.	PROPN
cuesj-183	102	11	han	han	PROPN
cuesj-183	102	12	,	,	PUNCT
cuesj-183	102	13	y.	y.	PROPN
cuesj-183	102	14	liu	liu	PROPN
cuesj-183	102	15	,	,	PUNCT
cuesj-183	102	16	l.	l.	PROPN
cuesj-183	102	17	kong	kong	PROPN
cuesj-183	102	18	,	,	PUNCT
cuesj-183	102	19	y.	y.	PROPN
cuesj-183	102	20	cao	cao	PROPN
cuesj-183	102	21	and	and	CCONJ
cuesj-183	102	22	z.	z.	PROPN
cuesj-183	102	23	j.	j.	PROPN
cuesj-183	102	24	h.	h.	PROPN
cuesj-183	102	25	huang	huang	PROPN
cuesj-183	102	26	.	.	PUNCT
cuesj-183	103	1	“	"	PUNCT
cuesj-183	103	2	dynamic	dynamic	ADJ
cuesj-183	103	3	analysis	analysis	NOUN
cuesj-183	103	4	of	of	ADP
cuesj-183	103	5	lymphocyte	lymphocyte	ADJ
cuesj-183	103	6	subsets	subset	NOUN
cuesj-183	103	7	of	of	ADP
cuesj-183	103	8	peripheral	peripheral	ADJ
cuesj-183	103	9	blood	blood	NOUN
cuesj-183	103	10	in	in	ADP
cuesj-183	103	11	patients	patient	NOUN
cuesj-183	103	12	with	with	ADP
cuesj-183	103	13	acute	acute	ADJ
cuesj-183	103	14	self	self	NOUN
cuesj-183	103	15	-	-	PUNCT
cuesj-183	103	16	limited	limit	VERB
cuesj-183	103	17	hepatitis	hepatitis	NOUN
cuesj-183	103	18	b	b	NOUN
cuesj-183	103	19	”	"	PUNCT
cuesj-183	103	20	.	.	PUNCT
cuesj-183	104	1	health	health	NOUN
cuesj-183	104	2	,	,	PUNCT
cuesj-183	104	3	vol	vol	NOUN
cuesj-183	104	4	.	.	PROPN
cuesj-183	104	5	2	2	NUM
cuesj-183	104	6	,	,	PUNCT
cuesj-183	104	7	pp	pp	ADJ
cuesj-183	104	8	.	.	PUNCT
cuesj-183	105	1	736	736	NUM
cuesj-183	105	2	-	-	SYM
cuesj-183	105	3	741	741	NUM
cuesj-183	105	4	,	,	PUNCT
cuesj-183	105	5	2010	2010	NUM
cuesj-183	105	6	.	.	PUNCT
cuesj-183	106	1	2	2	X
cuesj-183	106	2	.	.	PUNCT
cuesj-183	106	3	j.	j.	PROPN
cuesj-183	106	4	a.	a.	PROPN
cuesj-183	106	5	hobden	hobden	PROPN
cuesj-183	106	6	and	and	CCONJ
cuesj-183	106	7	k.	k.	PROPN
cuesj-183	106	8	c.	c.	PROPN
cuesj-183	106	9	carroll	carroll	PROPN
cuesj-183	106	10	.	.	PUNCT
cuesj-183	107	1	“	"	PUNCT
cuesj-183	107	2	jawetz	jawetz	ADJ
cuesj-183	107	3	,	,	PUNCT
cuesj-183	107	4	melnick	melnick	PROPN
cuesj-183	107	5	and	and	CCONJ
cuesj-183	107	6	adelberg	adelberg	PROPN
cuesj-183	107	7	’s	’s	PART
cuesj-183	107	8	medical	medical	ADJ
cuesj-183	107	9	microbiology	microbiology	NOUN
cuesj-183	107	10	”	"	PUNCT
cuesj-183	107	11	.	.	PUNCT
cuesj-183	108	1	new	new	PROPN
cuesj-183	108	2	york	york	PROPN
cuesj-183	108	3	:	:	PUNCT
cuesj-183	108	4	mcgraw	mcgraw	PROPN
cuesj-183	108	5	-	-	PUNCT
cuesj-183	108	6	hill	hill	PROPN
cuesj-183	108	7	,	,	PUNCT
cuesj-183	108	8	2016	2016	NUM
cuesj-183	108	9	.	.	PUNCT
cuesj-183	109	1	3	3	X
cuesj-183	109	2	.	.	X
cuesj-183	109	3	s.	s.	PROPN
cuesj-183	109	4	amini	amini	PROPN
cuesj-183	109	5	kafi	kafi	PROPN
cuesj-183	109	6	-	-	PUNCT
cuesj-183	109	7	abad	abad	PROPN
cuesj-183	109	8	,	,	PUNCT
cuesj-183	109	9	h.	h.	PROPN
cuesj-183	109	10	rezvan	rezvan	PROPN
cuesj-183	109	11	,	,	PUNCT
cuesj-183	109	12	h.	h.	PROPN
cuesj-183	109	13	abolghasemi	abolghasemi	PROPN
cuesj-183	109	14	and	and	CCONJ
cuesj-183	109	15	a.	a.	NOUN
cuesj-183	109	16	talebian	talebian	PROPN
cuesj-183	109	17	.	.	PUNCT
cuesj-183	110	1	“	"	PUNCT
cuesj-183	110	2	prevalence	prevalence	NOUN
cuesj-183	110	3	and	and	CCONJ
cuesj-183	110	4	trends	trend	NOUN
cuesj-183	110	5	of	of	ADP
cuesj-183	110	6	human	human	ADJ
cuesj-183	110	7	immunodeficiency	immunodeficiency	NOUN
cuesj-183	110	8	virus	virus	NOUN
cuesj-183	110	9	,	,	PUNCT
cuesj-183	110	10	hepatitis	hepatitis	PROPN
cuesj-183	110	11	b	b	PROPN
cuesj-183	110	12	virus	virus	NOUN
cuesj-183	110	13	,	,	PUNCT
cuesj-183	110	14	and	and	CCONJ
cuesj-183	110	15	hepatitis	hepatitis	PROPN
cuesj-183	110	16	c	c	PROPN
cuesj-183	110	17	virus	virus	NOUN
cuesj-183	110	18	among	among	ADP
cuesj-183	110	19	blood	blood	NOUN
cuesj-183	110	20	donors	donor	NOUN
cuesj-183	110	21	in	in	ADP
cuesj-183	110	22	iran	iran	PROPN
cuesj-183	110	23	,	,	PUNCT
cuesj-183	110	24	2004	2004	NUM
cuesj-183	110	25	through	through	ADP
cuesj-183	110	26	2007	2007	NUM
cuesj-183	110	27	”	"	PUNCT
cuesj-183	110	28	.	.	PUNCT
cuesj-183	111	1	transfusion	transfusion	NOUN
cuesj-183	111	2	,	,	PUNCT
cuesj-183	111	3	vol	vol	NOUN
cuesj-183	111	4	.	.	PROPN
cuesj-183	111	5	49	49	NUM
cuesj-183	111	6	,	,	PUNCT
cuesj-183	111	7	pp	pp	ADJ
cuesj-183	111	8	.	.	PUNCT
cuesj-183	112	1	2214	2214	NUM
cuesj-183	112	2	-	-	SYM
cuesj-183	112	3	2220	2220	NUM
cuesj-183	112	4	,	,	PUNCT
cuesj-183	112	5	2009	2009	NUM
cuesj-183	112	6	.	.	PUNCT
cuesj-183	113	1	4	4	X
cuesj-183	113	2	.	.	X
cuesj-183	113	3	y.	y.	NOUN
cuesj-183	113	4	song	song	PROPN
cuesj-183	113	5	,	,	PUNCT
cuesj-183	113	6	y.	y.	PROPN
cuesj-183	113	7	bian	bian	PROPN
cuesj-183	113	8	,	,	PUNCT
cuesj-183	113	9	m.	m.	NOUN
cuesj-183	113	10	petzold	petzold	NOUN
cuesj-183	113	11	and	and	CCONJ
cuesj-183	113	12	c.o	c.o	PROPN
cuesj-183	113	13	.	.	PROPN
cuesj-183	113	14	ung	ung	PROPN
cuesj-183	113	15	.	.	PUNCT
cuesj-183	114	1	“	"	PUNCT
cuesj-183	114	2	prevalence	prevalence	NOUN
cuesj-183	114	3	and	and	CCONJ
cuesj-183	114	4	trend	trend	NOUN
cuesj-183	114	5	of	of	ADP
cuesj-183	114	6	major	major	ADJ
cuesj-183	114	7	transfusion	transfusion	NOUN
cuesj-183	114	8	-	-	PUNCT
cuesj-183	114	9	transmissible	transmissible	ADJ
cuesj-183	114	10	infections	infection	NOUN
cuesj-183	114	11	among	among	ADP
cuesj-183	114	12	blood	blood	NOUN
cuesj-183	114	13	donors	donor	NOUN
cuesj-183	114	14	in	in	ADP
cuesj-183	114	15	western	western	ADJ
cuesj-183	114	16	china	china	PROPN
cuesj-183	114	17	,	,	PUNCT
cuesj-183	114	18	2005	2005	NUM
cuesj-183	114	19	through	through	ADP
cuesj-183	114	20	2010	2010	NUM
cuesj-183	114	21	”	"	PUNCT
cuesj-183	114	22	.	.	PUNCT
cuesj-183	115	1	plos	plos	PROPN
cuesj-183	115	2	one	one	NUM
cuesj-183	115	3	,	,	PUNCT
cuesj-183	115	4	vol	vol	NOUN
cuesj-183	115	5	.	.	NOUN
cuesj-183	115	6	9	9	NUM
cuesj-183	115	7	,	,	PUNCT
cuesj-183	115	8	p.	p.	NOUN
cuesj-183	115	9	e94528	e94528	NOUN
cuesj-183	115	10	,	,	PUNCT
cuesj-183	115	11	2014	2014	NUM
cuesj-183	115	12	.	.	PUNCT
cuesj-183	116	1	5	5	NUM
cuesj-183	116	2	.	.	X
cuesj-183	116	3	d.	d.	PROPN
cuesj-183	116	4	candotti	candotti	PROPN
cuesj-183	116	5	and	and	CCONJ
cuesj-183	116	6	j.	j.	PROPN
cuesj-183	116	7	p.	p.	PROPN
cuesj-183	116	8	allain	allain	PROPN
cuesj-183	116	9	.	.	PUNCT
cuesj-183	117	1	“	"	PUNCT
cuesj-183	117	2	transfusion	transfusion	NOUN
cuesj-183	117	3	-	-	PUNCT
cuesj-183	117	4	transmitted	transmit	VERB
cuesj-183	117	5	hepatitis	hepatitis	PROPN
cuesj-183	117	6	b	b	PROPN
cuesj-183	117	7	virus	virus	NOUN
cuesj-183	117	8	infection	infection	NOUN
cuesj-183	117	9	”	"	PUNCT
cuesj-183	117	10	.	.	PUNCT
cuesj-183	118	1	journal	journal	PROPN
cuesj-183	118	2	of	of	ADP
cuesj-183	118	3	hepatology	hepatology	NOUN
cuesj-183	118	4	,	,	PUNCT
cuesj-183	118	5	vol	vol	NOUN
cuesj-183	118	6	.	.	PROPN
cuesj-183	118	7	51	51	NUM
cuesj-183	118	8	,	,	PUNCT
cuesj-183	118	9	pp	pp	ADJ
cuesj-183	118	10	.	.	PUNCT
cuesj-183	119	1	798	798	NUM
cuesj-183	119	2	-	-	SYM
cuesj-183	119	3	809	809	NUM
cuesj-183	119	4	,	,	PUNCT
cuesj-183	119	5	2009	2009	NUM
cuesj-183	119	6	.	.	PUNCT
cuesj-183	120	1	6	6	NUM
cuesj-183	120	2	.	.	PUNCT
cuesj-183	120	3	c.	c.	PROPN
cuesj-183	120	4	velati	velati	PROPN
cuesj-183	120	5	,	,	PUNCT
cuesj-183	120	6	l.	l.	PROPN
cuesj-183	120	7	fomiatti	fomiatti	PROPN
cuesj-183	120	8	,	,	PUNCT
cuesj-183	120	9	l.	l.	PROPN
cuesj-183	120	10	baruffi	baruffi	PROPN
cuesj-183	120	11	,	,	PUNCT
cuesj-183	120	12	v.	v.	CCONJ
cuesj-183	120	13	piccinini	piccinini	X
cuesj-183	120	14	,	,	PUNCT
cuesj-183	120	15	d.	d.	PROPN
cuesj-183	120	16	prati	prati	PROPN
cuesj-183	120	17	,	,	PUNCT
cuesj-183	120	18	a.	a.	PROPN
cuesj-183	120	19	reina	reina	PROPN
cuesj-183	120	20	,	,	PUNCT
cuesj-183	120	21	a.	a.	NOUN
cuesj-183	120	22	lobbiani	lobbiani	PROPN
cuesj-183	120	23	,	,	PUNCT
cuesj-183	120	24	a.	a.	NOUN
cuesj-183	120	25	zanetti	zanetti	PROPN
cuesj-183	120	26	and	and	CCONJ
cuesj-183	120	27	l.	l.	PROPN
cuesj-183	120	28	romanò	romanò	PROPN
cuesj-183	120	29	.	.	PUNCT
cuesj-183	121	1	“	"	PUNCT
cuesj-183	121	2	criteria	criterion	NOUN
cuesj-183	121	3	for	for	ADP
cuesj-183	121	4	hepatitis	hepatitis	PROPN
cuesj-183	121	5	b	b	PROPN
cuesj-183	121	6	virus	virus	NOUN
cuesj-183	121	7	screening	screening	NOUN
cuesj-183	121	8	and	and	CCONJ
cuesj-183	121	9	validation	validation	NOUN
cuesj-183	121	10	of	of	ADP
cuesj-183	121	11	blood	blood	NOUN
cuesj-183	121	12	components	component	NOUN
cuesj-183	121	13	in	in	ADP
cuesj-183	121	14	italy	italy	PROPN
cuesj-183	121	15	:	:	PUNCT
cuesj-183	121	16	the	the	DET
cuesj-183	121	17	position	position	NOUN
cuesj-183	121	18	of	of	ADP
cuesj-183	121	19	the	the	DET
cuesj-183	121	20	simti	simti	PROPN
cuesj-183	121	21	hbv	hbv	PROPN
cuesj-183	121	22	working	working	PROPN
cuesj-183	121	23	group	group	NOUN
cuesj-183	121	24	”	"	PUNCT
cuesj-183	121	25	.	.	PUNCT
cuesj-183	122	1	blood	blood	NOUN
cuesj-183	122	2	transfusion	transfusion	NOUN
cuesj-183	122	3	,	,	PUNCT
cuesj-183	122	4	vol	vol	NOUN
cuesj-183	122	5	.	.	NOUN
cuesj-183	122	6	9	9	NUM
cuesj-183	122	7	,	,	PUNCT
cuesj-183	122	8	pp	pp	ADJ
cuesj-183	122	9	.	.	PUNCT
cuesj-183	123	1	455	455	NUM
cuesj-183	123	2	-	-	SYM
cuesj-183	123	3	461	461	NUM
cuesj-183	123	4	,	,	PUNCT
cuesj-183	123	5	2011	2011	NUM
cuesj-183	123	6	.	.	PUNCT
cuesj-183	124	1	7	7	X
cuesj-183	124	2	.	.	X
cuesj-183	124	3	m.	m.	NOUN
cuesj-183	124	4	k.	k.	PROPN
cuesj-183	125	1	hourfar	hourfar	PROPN
cuesj-183	125	2	,	,	PUNCT
cuesj-183	125	3	l.	l.	PROPN
cuesj-183	125	4	a.	a.	PROPN
cuesj-183	125	5	walch	walch	PROPN
cuesj-183	125	6	,	,	PUNCT
cuesj-183	125	7	g.	g.	PROPN
cuesj-183	125	8	geusendam	geusendam	PROPN
cuesj-183	125	9	,	,	PUNCT
cuesj-183	125	10	t.	t.	NOUN
cuesj-183	125	11	dengler	dengler	NOUN
cuesj-183	125	12	,	,	PUNCT
cuesj-183	125	13	k.	k.	PROPN
cuesj-183	125	14	janetzko	janetzko	PROPN
cuesj-183	125	15	,	,	PUNCT
cuesj-183	125	16	k.	k.	PROPN
cuesj-183	125	17	gubbe	gubbe	PROPN
cuesj-183	125	18	,	,	PUNCT
cuesj-183	125	19	k.	k.	PROPN
cuesj-183	125	20	frank	frank	PROPN
cuesj-183	125	21	,	,	PUNCT
cuesj-183	125	22	a.	a.	PROPN
cuesj-183	125	23	karl	karl	PROPN
cuesj-183	125	24	,	,	PUNCT
cuesj-183	125	25	m.	m.	NOUN
cuesj-183	125	26	löhr	löhr	PROPN
cuesj-183	125	27	,	,	PUNCT
cuesj-183	125	28	w.	w.	PROPN
cuesj-183	125	29	sireis	sireis	PROPN
cuesj-183	125	30	,	,	PUNCT
cuesj-183	125	31	e.	e.	PROPN
cuesj-183	125	32	seifried	seifrie	VERB
cuesj-183	125	33	and	and	CCONJ
cuesj-183	125	34	m.	m.	NOUN
cuesj-183	125	35	schmidt	schmidt	PROPN
cuesj-183	125	36	.	.	PUNCT
cuesj-183	126	1	“	"	PUNCT
cuesj-183	126	2	sensitivity	sensitivity	NOUN
cuesj-183	126	3	and	and	CCONJ
cuesj-183	126	4	specificity	specificity	NOUN
cuesj-183	126	5	of	of	ADP
cuesj-183	126	6	anti	anti	ADJ
cuesj-183	126	7	-	-	ADJ
cuesj-183	126	8	hbc	hbc	ADJ
cuesj-183	126	9	screening	screening	NOUN
cuesj-183	126	10	assays	assay	NOUN
cuesj-183	126	11	which	which	PRON
cuesj-183	126	12	assay	assay	VERB
cuesj-183	126	13	is	be	AUX
cuesj-183	126	14	best	good	ADJ
cuesj-183	126	15	for	for	ADP
cuesj-183	126	16	blood	blood	NOUN
cuesj-183	126	17	donor	donor	NOUN
cuesj-183	126	18	screening	screen	VERB
cuesj-183	126	19	”	"	PUNCT
cuesj-183	126	20	?	?	PUNCT
cuesj-183	127	1	international	international	ADJ
cuesj-183	127	2	journal	journal	NOUN
cuesj-183	127	3	of	of	ADP
cuesj-183	127	4	laboratory	laboratory	NOUN
cuesj-183	127	5	hematology	hematology	NOUN
cuesj-183	127	6	,	,	PUNCT
cuesj-183	127	7	vol	vol	NOUN
cuesj-183	127	8	.	.	PROPN
cuesj-183	127	9	31	31	NUM
cuesj-183	127	10	,	,	PUNCT
cuesj-183	127	11	pp	pp	ADJ
cuesj-183	127	12	.	.	PUNCT
cuesj-183	128	1	649656	649656	NUM
cuesj-183	128	2	,	,	PUNCT
cuesj-183	128	3	2009	2009	NUM
cuesj-183	128	4	.	.	PUNCT
cuesj-183	129	1	8	8	NUM
cuesj-183	129	2	.	.	PUNCT
cuesj-183	129	3	y.	y.	PROPN
cuesj-183	129	4	h.	h.	PROPN
cuesj-183	129	5	majeed	majeed	PROPN
cuesj-183	129	6	.	.	PUNCT
cuesj-183	130	1	“	"	PUNCT
cuesj-183	130	2	hepatitis	hepatitis	PROPN
cuesj-183	130	3	b	b	PROPN
cuesj-183	130	4	surface	surface	NOUN
cuesj-183	130	5	antigen	antigen	ADJ
cuesj-183	130	6	prevalence	prevalence	NOUN
cuesj-183	130	7	among	among	ADP
cuesj-183	130	8	screened	screen	VERB
cuesj-183	130	9	populations	population	NOUN
cuesj-183	130	10	and	and	CCONJ
cuesj-183	130	11	certain	certain	ADJ
cuesj-183	130	12	risk	risk	NOUN
cuesj-183	130	13	groups	group	NOUN
cuesj-183	130	14	in	in	ADP
cuesj-183	130	15	al	al	PROPN
cuesj-183	130	16	-	-	PUNCT
cuesj-183	130	17	anbar	anbar	PROPN
cuesj-183	130	18	governorate	governorate	PROPN
cuesj-183	130	19	,	,	PUNCT
cuesj-183	130	20	west	west	NOUN
cuesj-183	130	21	of	of	ADP
cuesj-183	130	22	iraq	iraq	PROPN
cuesj-183	130	23	”	"	PUNCT
cuesj-183	130	24	.	.	PUNCT
cuesj-183	131	1	al	al	PROPN
cuesj-183	131	2	-	-	PUNCT
cuesj-183	131	3	anbar	anbar	PROPN
cuesj-183	131	4	medical	medical	ADJ
cuesj-183	131	5	journal	journal	PROPN
cuesj-183	131	6	,	,	PUNCT
cuesj-183	131	7	vol	vol	NOUN
cuesj-183	131	8	.	.	PROPN
cuesj-183	131	9	13	13	NUM
cuesj-183	131	10	,	,	PUNCT
cuesj-183	131	11	pp	pp	ADJ
cuesj-183	131	12	.	.	PUNCT
cuesj-183	132	1	14	14	NUM
cuesj-183	132	2	-	-	SYM
cuesj-183	132	3	19	19	NUM
cuesj-183	132	4	,	,	PUNCT
cuesj-183	132	5	2016	2016	NUM
cuesj-183	132	6	.	.	PUNCT
cuesj-183	133	1	9	9	X
cuesj-183	133	2	.	.	X
cuesj-183	133	3	n.	n.	PROPN
cuesj-183	133	4	g.	g.	PROPN
cuesj-183	133	5	sawke	sawke	PROPN
cuesj-183	133	6	and	and	CCONJ
cuesj-183	133	7	g.	g.	PROPN
cuesj-183	133	8	sawke	sawke	NOUN
cuesj-183	133	9	.	.	PUNCT
cuesj-183	134	1	“	"	PUNCT
cuesj-183	134	2	preventing	prevent	VERB
cuesj-183	134	3	post	post	ADJ
cuesj-183	134	4	-	-	ADJ
cuesj-183	134	5	transfusion	transfusion	ADJ
cuesj-183	134	6	hepatitis	hepatitis	NOUN
cuesj-183	134	7	by	by	ADP
cuesj-183	134	8	screening	screen	VERB
cuesj-183	134	9	blood	blood	NOUN
cuesj-183	134	10	donors	donor	NOUN
cuesj-183	134	11	for	for	ADP
cuesj-183	134	12	igm	igm	NOUN
cuesj-183	134	13	antibody	antibody	NOUN
cuesj-183	134	14	to	to	ADP
cuesj-183	134	15	hepatitis	hepatitis	PROPN
cuesj-183	134	16	b	b	PROPN
cuesj-183	134	17	core	core	NOUN
cuesj-183	134	18	antigen	antigen	PROPN
cuesj-183	134	19	”	"	PUNCT
cuesj-183	134	20	.	.	PUNCT
cuesj-183	135	1	journal	journal	PROPN
cuesj-183	135	2	of	of	ADP
cuesj-183	135	3	global	global	ADJ
cuesj-183	135	4	infectious	infectious	ADJ
cuesj-183	135	5	diseases	disease	NOUN
cuesj-183	135	6	,	,	PUNCT
cuesj-183	135	7	vol	vol	NOUN
cuesj-183	135	8	.	.	PROPN
cuesj-183	135	9	2	2	NUM
cuesj-183	135	10	,	,	PUNCT
cuesj-183	135	11	pp	pp	ADJ
cuesj-183	135	12	.	.	PUNCT
cuesj-183	135	13	246247	246247	NUM
cuesj-183	135	14	,	,	PUNCT
cuesj-183	135	15	2010	2010	NUM
cuesj-183	135	16	.	.	PUNCT
cuesj-183	136	1	10	10	NUM
cuesj-183	136	2	.	.	PUNCT
cuesj-183	136	3	g.	g.	PROPN
cuesj-183	136	4	raimondo	raimondo	PROPN
cuesj-183	136	5	,	,	PUNCT
cuesj-183	136	6	t.	t.	PROPN
cuesj-183	136	7	pollicino	pollicino	PROPN
cuesj-183	136	8	,	,	PUNCT
cuesj-183	136	9	i.	i.	PROPN
cuesj-183	136	10	cacciola	cacciola	PROPN
cuesj-183	136	11	and	and	CCONJ
cuesj-183	136	12	g.	g.	PROPN
cuesj-183	136	13	squadrito	squadrito	PROPN
cuesj-183	136	14	.	.	PUNCT
cuesj-183	137	1	“	"	PUNCT
cuesj-183	137	2	occult	occult	VERB
cuesj-183	137	3	hepatitis	hepatitis	PROPN
cuesj-183	137	4	b	b	PROPN
cuesj-183	137	5	virus	virus	NOUN
cuesj-183	137	6	infection	infection	NOUN
cuesj-183	137	7	”	"	PUNCT
cuesj-183	137	8	.	.	PUNCT
cuesj-183	138	1	journal	journal	PROPN
cuesj-183	138	2	of	of	ADP
cuesj-183	138	3	hepatology	hepatology	NOUN
cuesj-183	138	4	,	,	PUNCT
cuesj-183	138	5	vol	vol	NOUN
cuesj-183	138	6	.	.	PROPN
cuesj-183	138	7	46	46	NUM
cuesj-183	138	8	,	,	PUNCT
cuesj-183	138	9	pp	pp	ADJ
cuesj-183	138	10	.	.	PUNCT
cuesj-183	139	1	160	160	NUM
cuesj-183	139	2	-	-	SYM
cuesj-183	139	3	170	170	NUM
cuesj-183	139	4	,	,	PUNCT
cuesj-183	139	5	2007	2007	NUM
cuesj-183	139	6	.	.	PUNCT
cuesj-183	140	1	11	11	NUM
cuesj-183	140	2	.	.	PUNCT
cuesj-183	140	3	j.	j.	PROPN
cuesj-183	140	4	h.	h.	PROPN
cuesj-183	140	5	maclachlan	maclachlan	PROPN
cuesj-183	140	6	and	and	CCONJ
cuesj-183	140	7	b.	b.	PROPN
cuesj-183	140	8	c.	c.	PROPN
cuesj-183	140	9	cowie	cowie	PROPN
cuesj-183	140	10	.	.	PUNCT
cuesj-183	141	1	“	"	PUNCT
cuesj-183	141	2	hepatitis	hepatitis	PROPN
cuesj-183	141	3	b	b	PROPN
cuesj-183	141	4	virus	virus	NOUN
cuesj-183	141	5	epidemiology	epidemiology	NOUN
cuesj-183	141	6	”	"	PUNCT
cuesj-183	141	7	.	.	PUNCT
cuesj-183	142	1	cold	cold	ADJ
cuesj-183	142	2	spring	spring	NOUN
cuesj-183	142	3	harbor	harbor	NOUN
cuesj-183	142	4	perspectives	perspective	NOUN
cuesj-183	142	5	in	in	ADP
cuesj-183	142	6	medicine	medicine	NOUN
cuesj-183	142	7	,	,	PUNCT
cuesj-183	142	8	vol	vol	NOUN
cuesj-183	142	9	.	.	PROPN
cuesj-183	142	10	5	5	NUM
cuesj-183	142	11	,	,	PUNCT
cuesj-183	142	12	p.	p.	NOUN
cuesj-183	142	13	a021410	a021410	PROPN
cuesj-183	142	14	,	,	PUNCT
cuesj-183	142	15	2015	2015	NUM
cuesj-183	142	16	.	.	PUNCT
cuesj-183	143	1	12	12	NUM
cuesj-183	143	2	.	.	PUNCT
cuesj-183	144	1	d.	d.	PROPN
cuesj-183	144	2	n.	n.	PROPN
cuesj-183	144	3	noah	noah	PROPN
cuesj-183	144	4	,	,	PUNCT
cuesj-183	144	5	f.	f.	PROPN
cuesj-183	144	6	a.	a.	PROPN
cuesj-183	144	7	andoulo	andoulo	PROPN
cuesj-183	144	8	,	,	PUNCT
cuesj-183	144	9	b.	b.	PROPN
cuesj-183	144	10	v.	v.	PROPN
cuesj-183	144	11	m.	m.	PROPN
cuesj-183	144	12	essoh	essoh	PROPN
cuesj-183	144	13	,	,	PUNCT
cuesj-183	144	14	g.	g.	PROPN
cuesj-183	144	15	n.	n.	PROPN
cuesj-183	144	16	ayissi	ayissi	PROPN
cuesj-183	144	17	,	,	PUNCT
cuesj-183	144	18	s.	s.	PROPN
cuesj-183	144	19	a.	a.	PROPN
cuesj-183	144	20	f.	f.	PROPN
cuesj-183	144	21	bagnaka	bagnaka	PROPN
cuesj-183	144	22	and	and	CCONJ
cuesj-183	144	23	m.	m.	PROPN
cuesj-183	144	24	b.	b.	PROPN
cuesj-183	144	25	sida	sida	PROPN
cuesj-183	144	26	.	.	PUNCT
cuesj-183	145	1	“	"	PUNCT
cuesj-183	145	2	prevalence	prevalence	NOUN
cuesj-183	145	3	of	of	ADP
cuesj-183	145	4	hbs	hbs	PROPN
cuesj-183	145	5	antigen	antigen	PROPN
cuesj-183	145	6	,	,	PUNCT
cuesj-183	145	7	and	and	CCONJ
cuesj-183	145	8	hcv	hcv	PROPN
cuesj-183	145	9	and	and	CCONJ
cuesj-183	145	10	hiv	hiv	PROPN
cuesj-183	145	11	antibodies	antibodie	VERB
cuesj-183	145	12	in	in	ADP
cuesj-183	145	13	a	a	DET
cuesj-183	145	14	young	young	ADJ
cuesj-183	145	15	male	male	ADJ
cuesj-183	145	16	population	population	NOUN
cuesj-183	145	17	in	in	ADP
cuesj-183	145	18	cameroon	cameroon	PROPN
cuesj-183	145	19	”	"	PUNCT
cuesj-183	145	20	.	.	PUNCT
cuesj-183	146	1	open	open	ADJ
cuesj-183	146	2	journal	journal	PROPN
cuesj-183	146	3	of	of	ADP
cuesj-183	146	4	gastroenterology	gastroenterology	NOUN
cuesj-183	146	5	,	,	PUNCT
cuesj-183	146	6	vol	vol	NOUN
cuesj-183	146	7	.	.	PROPN
cuesj-183	146	8	5	5	NUM
cuesj-183	146	9	,	,	PUNCT
cuesj-183	146	10	pp	pp	ADJ
cuesj-183	146	11	.	.	PUNCT
cuesj-183	147	1	185	185	NUM
cuesj-183	147	2	-	-	SYM
cuesj-183	147	3	190	190	NUM
cuesj-183	147	4	,	,	PUNCT
cuesj-183	147	5	2015	2015	NUM
cuesj-183	147	6	.	.	PUNCT
cuesj-183	148	1	13	13	NUM
cuesj-183	148	2	.	.	PUNCT
cuesj-183	149	1	j.	j.	PROPN
cuesj-183	149	2	lara	lara	PROPN
cuesj-183	149	3	,	,	PUNCT
cuesj-183	149	4	f.	f.	PROPN
cuesj-183	149	5	x.	x.	PROPN
cuesj-183	149	6	lópez	lópez	PROPN
cuesj-183	149	7	-	-	PUNCT
cuesj-183	149	8	labrador	labrador	PROPN
cuesj-183	149	9	,	,	PUNCT
cuesj-183	149	10	f.	f.	PROPN
cuesj-183	149	11	gonzález	gonzález	PROPN
cuesj-183	149	12	-	-	PUNCT
cuesj-183	149	13	candelas	candelas	PROPN
cuesj-183	149	14	,	,	PUNCT
cuesj-183	149	15	m.	m.	NOUN
cuesj-183	149	16	berenguer	berenguer	PROPN
cuesj-183	149	17	and	and	CCONJ
cuesj-183	149	18	y.	y.	PROPN
cuesj-183	149	19	e.	e.	PROPN
cuesj-183	149	20	khudyakov	khudyakov	PROPN
cuesj-183	149	21	.	.	PUNCT
cuesj-183	150	1	“	"	PUNCT
cuesj-183	150	2	computational	computational	ADJ
cuesj-183	150	3	models	model	NOUN
cuesj-183	150	4	of	of	ADP
cuesj-183	150	5	liver	liver	NOUN
cuesj-183	150	6	fibrosis	fibrosis	NOUN
cuesj-183	150	7	progression	progression	NOUN
cuesj-183	150	8	for	for	ADP
cuesj-183	150	9	hepatitis	hepatitis	PROPN
cuesj-183	150	10	c	c	PROPN
cuesj-183	150	11	virus	virus	NOUN
cuesj-183	150	12	chronic	chronic	ADJ
cuesj-183	150	13	infection	infection	NOUN
cuesj-183	150	14	”	"	PUNCT
cuesj-183	150	15	.	.	PUNCT
cuesj-183	151	1	bmc	bmc	ADJ
cuesj-183	151	2	bioinformatics	bioinformatics	PROPN
cuesj-183	151	3	,	,	PUNCT
cuesj-183	151	4	vol	vol	NOUN
cuesj-183	151	5	.	.	PROPN
cuesj-183	151	6	15	15	NUM
cuesj-183	151	7	,	,	PUNCT
cuesj-183	151	8	p.	p.	PROPN
cuesj-183	151	9	s5	s5	PROPN
cuesj-183	151	10	,	,	PUNCT
cuesj-183	151	11	2014	2014	NUM
cuesj-183	151	12	.	.	PUNCT
cuesj-183	152	1	14	14	NUM
cuesj-183	152	2	.	.	PUNCT
cuesj-183	153	1	f.	f.	PROPN
cuesj-183	153	2	sorvillo	sorvillo	PROPN
cuesj-183	153	3	,	,	PUNCT
cuesj-183	153	4	g.	g.	PROPN
cuesj-183	153	5	mazziotti	mazziotti	PROPN
cuesj-183	153	6	,	,	PUNCT
cuesj-183	153	7	a.	a.	NOUN
cuesj-183	153	8	carbone	carbone	NOUN
cuesj-183	153	9	,	,	PUNCT
cuesj-183	153	10	f.	f.	PROPN
cuesj-183	153	11	morisco	morisco	PROPN
cuesj-183	153	12	,	,	PUNCT
cuesj-183	153	13	m.	m.	NOUN
cuesj-183	153	14	cioffi	cioffi	PROPN
cuesj-183	153	15	,	,	PUNCT
cuesj-183	153	16	m.	m.	NOUN
cuesj-183	153	17	rotondi	rotondi	PROPN
cuesj-183	153	18	,	,	PUNCT
cuesj-183	153	19	g.	g.	PROPN
cuesj-183	153	20	stornaiuolo	stornaiuolo	PROPN
cuesj-183	153	21	,	,	PUNCT
cuesj-183	153	22	g.	g.	PROPN
cuesj-183	153	23	amato	amato	PROPN
cuesj-183	153	24	and	and	CCONJ
cuesj-183	153	25	g.	g.	PROPN
cuesj-183	153	26	b.	b.	PROPN
cuesj-183	153	27	gaeta	gaeta	PROPN
cuesj-183	153	28	.	.	PUNCT
cuesj-183	154	1	“	"	PUNCT
cuesj-183	154	2	increased	increase	VERB
cuesj-183	154	3	serum	serum	NOUN
cuesj-183	154	4	reverse	reverse	NOUN
cuesj-183	154	5	triiodothyronine	triiodothyronine	NOUN
cuesj-183	154	6	levels	level	NOUN
cuesj-183	154	7	at	at	ADP
cuesj-183	154	8	diagnosis	diagnosis	NOUN
cuesj-183	154	9	of	of	ADP
cuesj-183	154	10	hepatocellular	hepatocellular	ADJ
cuesj-183	154	11	carcinoma	carcinoma	NOUN
cuesj-183	154	12	in	in	ADP
cuesj-183	154	13	patients	patient	NOUN
cuesj-183	154	14	with	with	ADP
cuesj-183	154	15	compensated	compensate	VERB
cuesj-183	154	16	hcvrelated	hcvrelate	VERB
cuesj-183	154	17	liver	liver	NOUN
cuesj-183	154	18	cirrhosis	cirrhosis	NOUN
cuesj-183	154	19	”	"	PUNCT
cuesj-183	154	20	.	.	PUNCT
cuesj-183	155	1	clinical	clinical	ADJ
cuesj-183	155	2	endocrinology	endocrinology	NOUN
cuesj-183	155	3	,	,	PUNCT
cuesj-183	155	4	vol	vol	NOUN
cuesj-183	155	5	.	.	PROPN
cuesj-183	155	6	58	58	NUM
cuesj-183	155	7	,	,	PUNCT
cuesj-183	155	8	pp	pp	ADJ
cuesj-183	155	9	.	.	PUNCT
cuesj-183	155	10	207212	207212	NUM
cuesj-183	155	11	,	,	PUNCT
cuesj-183	155	12	2003	2003	NUM
cuesj-183	155	13	.	.	PUNCT
cuesj-183	156	1	15	15	NUM
cuesj-183	156	2	.	.	PUNCT
cuesj-183	156	3	n.	n.	PROPN
cuesj-183	156	4	r.	r.	PROPN
cuesj-183	156	5	hussein	hussein	PROPN
cuesj-183	156	6	,	,	PUNCT
cuesj-183	156	7	s.	s.	PROPN
cuesj-183	156	8	m.	m.	PROPN
cuesj-183	156	9	haj	haj	PROPN
cuesj-183	156	10	,	,	PUNCT
cuesj-183	156	11	l.	l.	PROPN
cuesj-183	156	12	a.	a.	PROPN
cuesj-183	156	13	almizori	almizori	PROPN
cuesj-183	156	14	and	and	CCONJ
cuesj-183	156	15	a.	a.	NOUN
cuesj-183	156	16	a.	a.	PROPN
cuesj-183	156	17	taha	taha	PROPN
cuesj-183	156	18	.	.	PUNCT
cuesj-183	157	1	“	"	PUNCT
cuesj-183	157	2	the	the	DET
cuesj-183	157	3	prevalence	prevalence	NOUN
cuesj-183	157	4	of	of	ADP
cuesj-183	157	5	hepatitis	hepatitis	PROPN
cuesj-183	157	6	b	b	PROPN
cuesj-183	157	7	and	and	CCONJ
cuesj-183	157	8	c	c	PROPN
cuesj-183	157	9	viruses	virus	NOUN
cuesj-183	157	10	among	among	ADP
cuesj-183	157	11	blood	blood	NOUN
cuesj-183	157	12	donors	donor	NOUN
cuesj-183	157	13	attending	attend	VERB
cuesj-183	157	14	blood	blood	NOUN
cuesj-183	157	15	bank	bank	NOUN
cuesj-183	157	16	in	in	ADP
cuesj-183	157	17	duhok	duhok	PROPN
cuesj-183	157	18	,	,	PUNCT
cuesj-183	157	19	kurdistan	kurdistan	PROPN
cuesj-183	157	20	region	region	NOUN
cuesj-183	157	21	,	,	PUNCT
cuesj-183	157	22	iraq	iraq	PROPN
cuesj-183	157	23	”	"	PUNCT
cuesj-183	157	24	.	.	PUNCT
cuesj-183	158	1	international	international	ADJ
cuesj-183	158	2	journal	journal	NOUN
cuesj-183	158	3	of	of	ADP
cuesj-183	158	4	infection	infection	NOUN
cuesj-183	158	5	,	,	PUNCT
cuesj-183	158	6	vol	vol	NOUN
cuesj-183	158	7	.	.	PROPN
cuesj-183	158	8	4	4	NUM
cuesj-183	158	9	,	,	PUNCT
cuesj-183	158	10	p.	p.	NOUN
cuesj-183	158	11	e39008	e39008	PROPN
cuesj-183	158	12	,	,	PUNCT
cuesj-183	158	13	2017	2017	NUM
cuesj-183	158	14	.	.	PUNCT
cuesj-183	159	1	16	16	NUM
cuesj-183	159	2	.	.	PUNCT
cuesj-183	159	3	a.	a.	PROPN
cuesj-183	159	4	m.	m.	PROPN
cuesj-183	159	5	tarky	tarky	PROPN
cuesj-183	159	6	,	,	PUNCT
cuesj-183	159	7	w.	w.	PROPN
cuesj-183	159	8	akram	akram	PROPN
cuesj-183	159	9	,	,	PUNCT
cuesj-183	159	10	a.	a.	PROPN
cuesj-183	159	11	s.	s.	PROPN
cuesj-183	159	12	al	al	PROPN
cuesj-183	159	13	-	-	PROPN
cuesj-183	159	14	naaimi	naaimi	PROPN
cuesj-183	159	15	and	and	CCONJ
cuesj-183	159	16	a.	a.	NOUN
cuesj-183	159	17	omer	omer	PROPN
cuesj-183	159	18	.	.	PUNCT
cuesj-183	160	1	“	"	PUNCT
cuesj-183	160	2	epidemiology	epidemiology	NOUN
cuesj-183	160	3	of	of	ADP
cuesj-183	160	4	viral	viral	ADJ
cuesj-183	160	5	hepatitis	hepatitis	PROPN
cuesj-183	160	6	b	b	PROPN
cuesj-183	160	7	and	and	CCONJ
cuesj-183	160	8	c	c	PROPN
cuesj-183	160	9	in	in	ADP
cuesj-183	160	10	iraq	iraq	PROPN
cuesj-183	160	11	:	:	PUNCT
cuesj-183	160	12	a	a	DET
cuesj-183	160	13	national	national	ADJ
cuesj-183	160	14	survey	survey	NOUN
cuesj-183	160	15	2005	2005	NUM
cuesj-183	160	16	-	-	SYM
cuesj-183	160	17	2006	2006	NUM
cuesj-183	160	18	”	"	PUNCT
cuesj-183	160	19	.	.	PUNCT
cuesj-183	161	1	zanco	zanco	PROPN
cuesj-183	161	2	journal	journal	PROPN
cuesj-183	161	3	of	of	ADP
cuesj-183	161	4	medical	medical	ADJ
cuesj-183	161	5	sciences	science	NOUN
cuesj-183	161	6	,	,	PUNCT
cuesj-183	161	7	vol	vol	NOUN
cuesj-183	161	8	.	.	PROPN
cuesj-183	161	9	17	17	NUM
cuesj-183	161	10	,	,	PUNCT
cuesj-183	161	11	pp	pp	ADJ
cuesj-183	161	12	.	.	PUNCT
cuesj-183	162	1	370	370	NUM
cuesj-183	162	2	-	-	SYM
cuesj-183	162	3	380	380	NUM
cuesj-183	162	4	,	,	PUNCT
cuesj-183	162	5	2013	2013	NUM
cuesj-183	162	6	.	.	PUNCT
cuesj-183	163	1	17	17	NUM
cuesj-183	163	2	.	.	PUNCT
cuesj-183	163	3	a.	a.	PROPN
cuesj-183	163	4	al	al	PROPN
cuesj-183	163	5	-	-	PUNCT
cuesj-183	163	6	rubaye	rubaye	PROPN
cuesj-183	163	7	,	,	PUNCT
cuesj-183	163	8	z.	z.	PROPN
cuesj-183	163	9	tariq	tariq	PROPN
cuesj-183	163	10	and	and	CCONJ
cuesj-183	163	11	l.	l.	PROPN
cuesj-183	163	12	alrubaiy	alrubaiy	PROPN
cuesj-183	163	13	.	.	PUNCT
cuesj-183	164	1	“	"	PUNCT
cuesj-183	164	2	prevalence	prevalence	NOUN
cuesj-183	164	3	of	of	ADP
cuesj-183	164	4	hepatitis	hepatitis	PROPN
cuesj-183	164	5	b	b	PROPN
cuesj-183	164	6	seromarkers	seromarker	NOUN
cuesj-183	164	7	and	and	CCONJ
cuesj-183	164	8	hepatitis	hepatitis	PROPN
cuesj-183	164	9	c	c	PROPN
cuesj-183	164	10	antibodies	antibodie	VERB
cuesj-183	164	11	in	in	ADP
cuesj-183	164	12	blood	blood	NOUN
cuesj-183	164	13	donors	donor	NOUN
cuesj-183	164	14	in	in	ADP
cuesj-183	164	15	basra	basra	PROPN
cuesj-183	164	16	,	,	PUNCT
cuesj-183	164	17	iraq	iraq	PROPN
cuesj-183	164	18	”	"	PUNCT
cuesj-183	164	19	.	.	PUNCT
cuesj-183	165	1	bmj	bmj	PROPN
cuesj-183	165	2	open	open	ADJ
cuesj-183	165	3	gastroenterology	gastroenterology	NOUN
cuesj-183	165	4	,	,	PUNCT
cuesj-183	165	5	vol	vol	NOUN
cuesj-183	165	6	.	.	PROPN
cuesj-183	166	1	3	3	NUM
cuesj-183	166	2	,	,	PUNCT
cuesj-183	166	3	p.	p.	NOUN
cuesj-183	166	4	e000067	e000067	NOUN
cuesj-183	166	5	,	,	PUNCT
cuesj-183	166	6	2016	2016	NUM
cuesj-183	166	7	.	.	PUNCT
cuesj-183	167	1	saleh	saleh	NOUN
cuesj-183	167	2	and	and	CCONJ
cuesj-183	167	3	taher	taher	PROPN
cuesj-183	167	4	:	:	PUNCT
cuesj-183	167	5	prevalence	prevalence	NOUN
cuesj-183	167	6	of	of	ADP
cuesj-183	167	7	hepatitis	hepatitis	PROPN
cuesj-183	167	8	b	b	PROPN
cuesj-183	167	9	and	and	CCONJ
cuesj-183	167	10	hepatitis	hepatitis	PROPN
cuesj-183	167	11	c	c	NOUN
cuesj-183	167	12	infection	infection	NOUN
cuesj-183	167	13	in	in	ADP
cuesj-183	167	14	erbil	erbil	PROPN
cuesj-183	167	15	51	51	NUM
cuesj-183	167	16	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-183	167	17	cuesj	cuesj	NOUN
cuesj-183	167	18	2020	2020	NUM
cuesj-183	167	19	,	,	PUNCT
cuesj-183	167	20	4	4	NUM
cuesj-183	167	21	(	(	PUNCT
cuesj-183	167	22	1	1	NUM
cuesj-183	167	23	):	):	PUNCT
cuesj-183	167	24	45	45	NUM
cuesj-183	167	25	-	-	SYM
cuesj-183	167	26	51	51	NUM
cuesj-183	167	27	18	18	NUM
cuesj-183	167	28	.	.	PUNCT
cuesj-183	168	1	i.	i.	PROPN
cuesj-183	168	2	h.	h.	PROPN
cuesj-183	168	3	saadoon	saadoon	PROPN
cuesj-183	168	4	.	.	PUNCT
cuesj-183	169	1	“	"	PUNCT
cuesj-183	169	2	seroprevalence	seroprevalence	NOUN
cuesj-183	169	3	of	of	ADP
cuesj-183	169	4	hgv	hgv	NOUN
cuesj-183	169	5	among	among	ADP
cuesj-183	169	6	blood	blood	NOUN
cuesj-183	169	7	donors	donor	NOUN
cuesj-183	169	8	with	with	ADP
cuesj-183	169	9	hcv	hcv	NOUN
cuesj-183	169	10	and/or	and/or	CCONJ
cuesj-183	169	11	hbv	hbv	NOUN
cuesj-183	169	12	in	in	ADP
cuesj-183	169	13	tikrit	tikrit	NOUN
cuesj-183	169	14	city	city	NOUN
cuesj-183	169	15	”	"	PUNCT
cuesj-183	169	16	.	.	PUNCT
cuesj-183	170	1	tikrit	tikrit	PROPN
cuesj-183	170	2	journal	journal	PROPN
cuesj-183	170	3	of	of	ADP
cuesj-183	170	4	pharmaceutical	pharmaceutical	NOUN
cuesj-183	170	5	sciences	science	NOUN
cuesj-183	170	6	,	,	PUNCT
cuesj-183	170	7	vol	vol	NOUN
cuesj-183	170	8	.	.	PROPN
cuesj-183	170	9	11	11	NUM
cuesj-183	170	10	,	,	PUNCT
cuesj-183	170	11	pp	pp	ADJ
cuesj-183	170	12	.	.	PUNCT
cuesj-183	171	1	15	15	NUM
cuesj-183	171	2	-	-	SYM
cuesj-183	171	3	20	20	NUM
cuesj-183	171	4	,	,	PUNCT
cuesj-183	171	5	2016	2016	NUM
cuesj-183	171	6	.	.	PUNCT
cuesj-183	172	1	19	19	NUM
cuesj-183	172	2	.	.	PUNCT
cuesj-183	172	3	h.	h.	PROPN
cuesj-183	172	4	b.	b.	PROPN
cuesj-183	173	1	el	el	PROPN
cuesj-183	173	2	-	-	NOUN
cuesj-183	173	3	serag	serag	NOUN
cuesj-183	173	4	.	.	PUNCT
cuesj-183	174	1	“	"	PUNCT
cuesj-183	174	2	epidemiology	epidemiology	NOUN
cuesj-183	174	3	of	of	ADP
cuesj-183	174	4	viral	viral	ADJ
cuesj-183	174	5	hepatitis	hepatitis	NOUN
cuesj-183	174	6	and	and	CCONJ
cuesj-183	174	7	hepatocellular	hepatocellular	ADJ
cuesj-183	174	8	carcinoma	carcinoma	NOUN
cuesj-183	174	9	”	"	PUNCT
cuesj-183	174	10	.	.	PUNCT
cuesj-183	175	1	gastroenterology	gastroenterology	NOUN
cuesj-183	175	2	,	,	PUNCT
cuesj-183	175	3	vol	vol	NOUN
cuesj-183	175	4	.	.	PROPN
cuesj-183	175	5	142	142	NUM
cuesj-183	175	6	,	,	PUNCT
cuesj-183	175	7	pp	pp	ADV
cuesj-183	175	8	.	.	PUNCT
cuesj-183	176	1	1264	1264	NUM
cuesj-183	176	2	-	-	SYM
cuesj-183	176	3	1273	1273	NUM
cuesj-183	176	4	,	,	PUNCT
cuesj-183	176	5	2012	2012	NUM
cuesj-183	176	6	.	.	PUNCT
cuesj-183	177	1	20	20	NUM
cuesj-183	177	2	.	.	PUNCT
cuesj-183	177	3	a.	a.	PROPN
cuesj-183	177	4	m.	m.	PROPN
cuesj-183	177	5	alsamarai	alsamarai	PROPN
cuesj-183	177	6	,	,	PUNCT
cuesj-183	177	7	g.	g.	PROPN
cuesj-183	177	8	abdulrazaq	abdulrazaq	PROPN
cuesj-183	177	9	,	,	PUNCT
cuesj-183	177	10	a.	a.	PROPN
cuesj-183	177	11	fatah	fatah	PROPN
cuesj-183	177	12	and	and	CCONJ
cuesj-183	177	13	a.	a.	NOUN
cuesj-183	177	14	alobaidi	alobaidi	NOUN
cuesj-183	177	15	.	.	PUNCT
cuesj-183	178	1	“	"	PUNCT
cuesj-183	178	2	seroprevalence	seroprevalence	NOUN
cuesj-183	178	3	of	of	ADP
cuesj-183	178	4	hepatitis	hepatitis	PROPN
cuesj-183	178	5	b	b	PROPN
cuesj-183	178	6	virus	virus	NOUN
cuesj-183	178	7	in	in	ADP
cuesj-183	178	8	iraqi	iraqi	ADJ
cuesj-183	178	9	population	population	NOUN
cuesj-183	178	10	”	"	PUNCT
cuesj-183	178	11	.	.	PUNCT
cuesj-183	179	1	journal	journal	PROPN
cuesj-183	179	2	of	of	ADP
cuesj-183	179	3	vaccines	vaccine	NOUN
cuesj-183	179	4	,	,	PUNCT
cuesj-183	179	5	immunology	immunology	NOUN
cuesj-183	179	6	and	and	CCONJ
cuesj-183	179	7	immunopathology	immunopathology	NOUN
cuesj-183	179	8	,	,	PUNCT
cuesj-183	179	9	vol	vol	NOUN
cuesj-183	179	10	.	.	NOUN
cuesj-183	179	11	2016	2016	NUM
cuesj-183	179	12	,	,	PUNCT
cuesj-183	179	13	p.	p.	NOUN
cuesj-183	179	14	j102	j102	PROPN
cuesj-183	179	15	,	,	PUNCT
cuesj-183	179	16	2016	2016	NUM
cuesj-183	179	17	.	.	PUNCT
cuesj-183	180	1	21	21	NUM
cuesj-183	180	2	.	.	PUNCT
cuesj-183	181	1	t.	t.	PROPN
cuesj-183	181	2	d.	d.	PROPN
cuesj-183	181	3	ly	ly	PROPN
cuesj-183	181	4	,	,	PUNCT
cuesj-183	181	5	a.	a.	NOUN
cuesj-183	181	6	servant	servant	NOUN
cuesj-183	181	7	-	-	PUNCT
cuesj-183	181	8	delmas	delmas	PROPN
cuesj-183	181	9	,	,	PUNCT
cuesj-183	181	10	s.	s.	PROPN
cuesj-183	181	11	bagot	bagot	PROPN
cuesj-183	181	12	,	,	PUNCT
cuesj-183	181	13	s.	s.	PROPN
cuesj-183	181	14	gonzalo	gonzalo	PROPN
cuesj-183	181	15	,	,	PUNCT
cuesj-183	181	16	m.	m.	NOUN
cuesj-183	181	17	p.	p.	PROPN
cuesj-183	181	18	ferey	ferey	PROPN
cuesj-183	181	19	,	,	PUNCT
cuesj-183	181	20	a.	a.	NOUN
cuesj-183	181	21	ebel	ebel	PROPN
cuesj-183	181	22	,	,	PUNCT
cuesj-183	181	23	e.	e.	PROPN
cuesj-183	181	24	dussaix	dussaix	PROPN
cuesj-183	181	25	,	,	PUNCT
cuesj-183	181	26	s.	s.	PROPN
cuesj-183	181	27	laperche	laperche	PROPN
cuesj-183	181	28	and	and	CCONJ
cuesj-183	181	29	a.	a.	NOUN
cuesj-183	181	30	m.	m.	NOUN
cuesj-183	181	31	roque	roque	PROPN
cuesj-183	181	32	-	-	PUNCT
cuesj-183	181	33	afonso	afonso	PROPN
cuesj-183	181	34	.	.	PUNCT
cuesj-183	182	1	“	"	PUNCT
cuesj-183	182	2	sensitivities	sensitivity	NOUN
cuesj-183	182	3	of	of	ADP
cuesj-183	182	4	four	four	NUM
cuesj-183	182	5	new	new	ADJ
cuesj-183	182	6	commercial	commercial	ADJ
cuesj-183	182	7	hepatitis	hepatitis	PROPN
cuesj-183	182	8	b	b	PROPN
cuesj-183	182	9	virus	virus	NOUN
cuesj-183	182	10	surface	surface	NOUN
cuesj-183	182	11	antigen	antigen	NOUN
cuesj-183	182	12	(	(	PUNCT
cuesj-183	182	13	hbsag	hbsag	NOUN
cuesj-183	182	14	)	)	PUNCT
cuesj-183	182	15	assays	assay	NOUN
cuesj-183	182	16	in	in	ADP
cuesj-183	182	17	detection	detection	NOUN
cuesj-183	182	18	of	of	ADP
cuesj-183	182	19	hbsag	hbsag	ADJ
cuesj-183	182	20	mutant	mutant	ADJ
cuesj-183	182	21	forms	form	NOUN
cuesj-183	182	22	”	"	PUNCT
cuesj-183	182	23	.	.	PUNCT
cuesj-183	183	1	journal	journal	NOUN
cuesj-183	183	2	of	of	ADP
cuesj-183	183	3	clinical	clinical	ADJ
cuesj-183	183	4	microbiology	microbiology	NOUN
cuesj-183	183	5	,	,	PUNCT
cuesj-183	183	6	vol	vol	NOUN
cuesj-183	183	7	.	.	PROPN
cuesj-183	183	8	44	44	NUM
cuesj-183	183	9	,	,	PUNCT
cuesj-183	183	10	pp	pp	ADJ
cuesj-183	183	11	.	.	PUNCT
cuesj-183	184	1	2321	2321	NUM
cuesj-183	184	2	-	-	SYM
cuesj-183	184	3	2326	2326	NUM
cuesj-183	184	4	,	,	PUNCT
cuesj-183	184	5	2006	2006	NUM
cuesj-183	184	6	.	.	PUNCT
cuesj-183	185	1	22	22	NUM
cuesj-183	185	2	.	.	PUNCT
cuesj-183	185	3	a.	a.	NOUN
cuesj-183	185	4	a.	a.	NOUN
cuesj-183	185	5	olotu	olotu	PROPN
cuesj-183	185	6	,	,	PUNCT
cuesj-183	185	7	a.	a.	NOUN
cuesj-183	185	8	o.	o.	PROPN
cuesj-183	185	9	oyelese	oyelese	PROPN
cuesj-183	185	10	,	,	PUNCT
cuesj-183	185	11	l.	l.	PROPN
cuesj-183	185	12	salawu	salawu	PROPN
cuesj-183	185	13	,	,	PUNCT
cuesj-183	185	14	r.	r.	PROPN
cuesj-183	185	15	a.	a.	PROPN
cuesj-183	185	16	audu	audu	PROPN
cuesj-183	185	17	,	,	PUNCT
cuesj-183	185	18	a.	a.	PROPN
cuesj-183	185	19	p.	p.	PROPN
cuesj-183	185	20	okwuraiwe	okwuraiwe	PROPN
cuesj-183	185	21	and	and	CCONJ
cuesj-183	185	22	a.	a.	NOUN
cuesj-183	185	23	o.	o.	PROPN
cuesj-183	185	24	aboderin	aboderin	INTJ
cuesj-183	185	25	.	.	PUNCT
cuesj-183	186	1	“	"	PUNCT
cuesj-183	186	2	occult	occult	VERB
cuesj-183	186	3	hepatitis	hepatitis	PROPN
cuesj-183	186	4	b	b	PROPN
cuesj-183	186	5	virus	virus	NOUN
cuesj-183	186	6	infection	infection	NOUN
cuesj-183	186	7	in	in	ADP
cuesj-183	186	8	previously	previously	ADV
cuesj-183	186	9	screened	screen	VERB
cuesj-183	186	10	,	,	PUNCT
cuesj-183	186	11	blood	blood	NOUN
cuesj-183	186	12	donors	donor	NOUN
cuesj-183	186	13	in	in	ADP
cuesj-183	186	14	ile	ile	PROPN
cuesj-183	186	15	-	-	PUNCT
cuesj-183	186	16	ife	ife	PROPN
cuesj-183	186	17	,	,	PUNCT
cuesj-183	186	18	nigeria	nigeria	PRON
cuesj-183	186	19	:	:	PUNCT
cuesj-183	186	20	implications	implication	NOUN
cuesj-183	186	21	for	for	ADP
cuesj-183	186	22	blood	blood	NOUN
cuesj-183	186	23	transfusion	transfusion	NOUN
cuesj-183	186	24	and	and	CCONJ
cuesj-183	186	25	stem	stem	NOUN
cuesj-183	186	26	cell	cell	NOUN
cuesj-183	186	27	transplantation	transplantation	NOUN
cuesj-183	186	28	”	"	PUNCT
cuesj-183	186	29	.	.	PUNCT
cuesj-183	187	1	virology	virology	NOUN
cuesj-183	187	2	journal	journal	PROPN
cuesj-183	187	3	,	,	PUNCT
cuesj-183	187	4	vol	vol	NOUN
cuesj-183	187	5	.	.	PROPN
cuesj-183	187	6	13	13	NUM
cuesj-183	187	7	,	,	PUNCT
cuesj-183	187	8	76	76	NUM
cuesj-183	187	9	,	,	PUNCT
cuesj-183	187	10	2016	2016	NUM
cuesj-183	187	11	.	.	PUNCT
cuesj-183	188	1	23	23	NUM
cuesj-183	188	2	.	.	PUNCT
cuesj-183	189	1	s.	s.	PROPN
cuesj-183	189	2	kinn	kinn	PROPN
cuesj-183	189	3	,	,	PUNCT
cuesj-183	189	4	s.	s.	PROPN
cuesj-183	189	5	akhavan	akhavan	PROPN
cuesj-183	189	6	,	,	PUNCT
cuesj-183	189	7	h.	h.	PROPN
cuesj-183	189	8	agut	agut	PROPN
cuesj-183	189	9	and	and	CCONJ
cuesj-183	189	10	v.	v.	ADP
cuesj-183	189	11	thibault	thibault	PROPN
cuesj-183	189	12	.	.	PUNCT
cuesj-183	190	1	“	"	PUNCT
cuesj-183	190	2	performance	performance	NOUN
cuesj-183	190	3	of	of	ADP
cuesj-183	190	4	the	the	DET
cuesj-183	190	5	diasorin	diasorin	NOUN
cuesj-183	190	6	liaison	liaison	NOUN
cuesj-183	190	7	®	®	NOUN
cuesj-183	190	8	anti	anti	ADJ
cuesj-183	190	9	-	-	ADJ
cuesj-183	190	10	hbs	hbs	ADJ
cuesj-183	190	11	ii	ii	PROPN
cuesj-183	190	12	for	for	ADP
cuesj-183	190	13	the	the	DET
cuesj-183	190	14	detection	detection	NOUN
cuesj-183	190	15	of	of	ADP
cuesj-183	190	16	hepatitis	hepatitis	PROPN
cuesj-183	190	17	b	b	PROPN
cuesj-183	190	18	surface	surface	NOUN
cuesj-183	190	19	antibodies	antibodie	VERB
cuesj-183	190	20	:	:	PUNCT
cuesj-183	190	21	comparison	comparison	NOUN
cuesj-183	190	22	with	with	ADP
cuesj-183	190	23	the	the	DET
cuesj-183	190	24	abbott	abbott	PROPN
cuesj-183	190	25	architect	architect	PROPN
cuesj-183	190	26	anti	anti	ADJ
cuesj-183	190	27	-	-	ADJ
cuesj-183	190	28	hbs	hbs	ADJ
cuesj-183	190	29	assay	assay	NOUN
cuesj-183	190	30	”	"	PUNCT
cuesj-183	190	31	.	.	PUNCT
cuesj-183	191	1	journal	journal	NOUN
cuesj-183	191	2	of	of	ADP
cuesj-183	191	3	clinical	clinical	ADJ
cuesj-183	191	4	virology	virology	NOUN
cuesj-183	191	5	,	,	PUNCT
cuesj-183	191	6	vol	vol	NOUN
cuesj-183	191	7	.	.	PROPN
cuesj-183	191	8	50	50	NUM
cuesj-183	191	9	,	,	PUNCT
cuesj-183	191	10	pp	pp	ADJ
cuesj-183	191	11	.	.	PUNCT
cuesj-183	192	1	297	297	NUM
cuesj-183	192	2	-	-	SYM
cuesj-183	192	3	302	302	NUM
cuesj-183	192	4	,	,	PUNCT
cuesj-183	192	5	2011	2011	NUM
cuesj-183	192	6	.	.	PUNCT
cuesj-183	193	1	24	24	NUM
cuesj-183	193	2	.	.	PUNCT
cuesj-183	194	1	h.	h.	PROPN
cuesj-183	194	2	a.	a.	PROPN
cuesj-183	194	3	croom	croom	PROPN
cuesj-183	194	4	,	,	PUNCT
cuesj-183	194	5	k.	k.	PROPN
cuesj-183	194	6	m.	m.	PROPN
cuesj-183	194	7	richards	richards	PROPN
cuesj-183	194	8	,	,	PUNCT
cuesj-183	194	9	s.	s.	PROPN
cuesj-183	194	10	j.	j.	PROPN
cuesj-183	194	11	best	best	PROPN
cuesj-183	194	12	,	,	PUNCT
cuesj-183	194	13	b.	b.	PROPN
cuesj-183	194	14	h.	h.	PROPN
cuesj-183	194	15	francis	francis	PROPN
cuesj-183	194	16	,	,	PUNCT
cuesj-183	194	17	e.	e.	PROPN
cuesj-183	194	18	i.	i.	PROPN
cuesj-183	194	19	m.	m.	PROPN
cuesj-183	194	20	johnson	johnson	PROPN
cuesj-183	194	21	,	,	PUNCT
cuesj-183	194	22	e.	e.	PROPN
cuesj-183	194	23	m.	m.	PROPN
cuesj-183	194	24	dax	dax	PROPN
cuesj-183	194	25	and	and	CCONJ
cuesj-183	194	26	k.	k.	PROPN
cuesj-183	194	27	m.	m.	PROPN
cuesj-183	194	28	wilson	wilson	PROPN
cuesj-183	194	29	.	.	PUNCT
cuesj-183	195	1	“	"	PUNCT
cuesj-183	195	2	commercial	commercial	ADJ
cuesj-183	195	3	enzyme	enzyme	NOUN
cuesj-183	195	4	immunoassay	immunoassay	NOUN
cuesj-183	195	5	adapted	adapt	VERB
cuesj-183	195	6	for	for	ADP
cuesj-183	195	7	the	the	DET
cuesj-183	195	8	detection	detection	NOUN
cuesj-183	195	9	of	of	ADP
cuesj-183	195	10	antibodies	antibody	NOUN
cuesj-183	195	11	to	to	ADP
cuesj-183	195	12	hepatitis	hepatitis	PROPN
cuesj-183	195	13	c	c	PROPN
cuesj-183	195	14	virus	virus	NOUN
cuesj-183	195	15	in	in	ADP
cuesj-183	195	16	dried	dry	VERB
cuesj-183	195	17	blood	blood	NOUN
cuesj-183	195	18	spots	spot	NOUN
cuesj-183	195	19	”	"	PUNCT
cuesj-183	195	20	.	.	PUNCT
cuesj-183	196	1	journal	journal	NOUN
cuesj-183	196	2	of	of	ADP
cuesj-183	196	3	clinical	clinical	ADJ
cuesj-183	196	4	virology	virology	NOUN
cuesj-183	196	5	,	,	PUNCT
cuesj-183	196	6	vol	vol	NOUN
cuesj-183	196	7	.	.	PROPN
cuesj-183	196	8	36	36	NUM
cuesj-183	196	9	,	,	PUNCT
cuesj-183	196	10	pp	pp	ADJ
cuesj-183	196	11	.	.	PUNCT
cuesj-183	197	1	68	68	NUM
cuesj-183	197	2	-	-	SYM
cuesj-183	197	3	71	71	NUM
cuesj-183	197	4	,	,	PUNCT
cuesj-183	197	5	2006	2006	NUM
cuesj-183	197	6	.	.	PUNCT
cuesj-183	198	1	25	25	NUM
cuesj-183	198	2	.	.	PUNCT
cuesj-183	198	3	h.	h.	PROPN
cuesj-183	198	4	frickmann	frickmann	PROPN
cuesj-183	198	5	,	,	PUNCT
cuesj-183	198	6	r.	r.	PROPN
cuesj-183	198	7	hinz	hinz	PROPN
cuesj-183	198	8	and	and	CCONJ
cuesj-183	198	9	r.	r.	PROPN
cuesj-183	198	10	hagen	hagen	PROPN
cuesj-183	198	11	.	.	PUNCT
cuesj-183	199	1	“	"	PUNCT
cuesj-183	199	2	comparison	comparison	NOUN
cuesj-183	199	3	of	of	ADP
cuesj-183	199	4	an	an	DET
cuesj-183	199	5	automated	automate	VERB
cuesj-183	199	6	nucleic	nucleic	ADJ
cuesj-183	199	7	acid	acid	NOUN
cuesj-183	199	8	extraction	extraction	NOUN
cuesj-183	199	9	system	system	NOUN
cuesj-183	199	10	with	with	ADP
cuesj-183	199	11	the	the	DET
cuesj-183	199	12	column	column	NOUN
cuesj-183	199	13	-	-	PUNCT
cuesj-183	199	14	based	base	VERB
cuesj-183	199	15	procedure	procedure	NOUN
cuesj-183	199	16	”	"	PUNCT
cuesj-183	199	17	.	.	PUNCT
cuesj-183	200	1	european	european	PROPN
cuesj-183	200	2	journal	journal	PROPN
cuesj-183	200	3	of	of	ADP
cuesj-183	200	4	microbiology	microbiology	NOUN
cuesj-183	200	5	and	and	CCONJ
cuesj-183	200	6	immunology	immunology	NOUN
cuesj-183	200	7	,	,	PUNCT
cuesj-183	200	8	vol	vol	NOUN
cuesj-183	200	9	.	.	PROPN
cuesj-183	200	10	5	5	NUM
cuesj-183	200	11	,	,	PUNCT
cuesj-183	200	12	94	94	NUM
cuesj-183	200	13	-	-	SYM
cuesj-183	200	14	102	102	NUM
cuesj-183	200	15	,	,	PUNCT
cuesj-183	200	16	2015	2015	NUM
cuesj-183	200	17	.	.	PUNCT
cuesj-183	201	1	26	26	NUM
cuesj-183	201	2	.	.	PUNCT
cuesj-183	201	3	m.	m.	PROPN
cuesj-183	201	4	s.	s.	PROPN
cuesj-183	201	5	han	han	PROPN
cuesj-183	201	6	,	,	PUNCT
cuesj-183	201	7	y.	y.	PROPN
cuesj-183	201	8	park	park	PROPN
cuesj-183	201	9	,	,	PUNCT
cuesj-183	201	10	h.	h.	PROPN
cuesj-183	201	11	nah	nah	INTJ
cuesj-183	201	12	and	and	CCONJ
cuesj-183	201	13	h.	h.	PROPN
cuesj-183	201	14	s.	s.	PROPN
cuesj-183	201	15	kim	kim	PROPN
cuesj-183	201	16	.	.	PUNCT
cuesj-183	202	1	“	"	PUNCT
cuesj-183	202	2	comparison	comparison	NOUN
cuesj-183	202	3	of	of	ADP
cuesj-183	202	4	the	the	DET
cuesj-183	202	5	qiagen	qiagen	PROPN
cuesj-183	202	6	artus	artus	PROPN
cuesj-183	202	7	hbv	hbv	PROPN
cuesj-183	202	8	qs	qs	PROPN
cuesj-183	202	9	-	-	PUNCT
cuesj-183	202	10	rgq	rgq	NOUN
cuesj-183	202	11	assay	assay	NOUN
cuesj-183	202	12	with	with	ADP
cuesj-183	202	13	the	the	DET
cuesj-183	202	14	roche	roche	PROPN
cuesj-183	202	15	cobas	cobas	PROPN
cuesj-183	202	16	ampliprep	ampliprep	PROPN
cuesj-183	202	17	/	/	SYM
cuesj-183	202	18	cobas	cobas	ADJ
cuesj-183	202	19	taqman	taqman	NOUN
cuesj-183	202	20	hbv	hbv	NOUN
cuesj-183	202	21	assay	assay	VERB
cuesj-183	202	22	for	for	ADP
cuesj-183	202	23	quantifying	quantify	VERB
cuesj-183	202	24	viral	viral	ADJ
cuesj-183	202	25	dna	dna	NOUN
cuesj-183	202	26	in	in	ADP
cuesj-183	202	27	sera	sera	NOUN
cuesj-183	202	28	of	of	ADP
cuesj-183	202	29	chronic	chronic	ADJ
cuesj-183	202	30	hepatitis	hepatitis	PROPN
cuesj-183	202	31	b	b	PROPN
cuesj-183	202	32	patients	patient	NOUN
cuesj-183	202	33	”	"	PUNCT
cuesj-183	202	34	.	.	PUNCT
cuesj-183	203	1	annals	annal	NOUN
cuesj-183	203	2	of	of	ADP
cuesj-183	203	3	laboratory	laboratory	NOUN
cuesj-183	203	4	medicine	medicine	NOUN
cuesj-183	203	5	,	,	PUNCT
cuesj-183	203	6	vol	vol	NOUN
cuesj-183	203	7	.	.	PROPN
cuesj-183	203	8	37	37	NUM
cuesj-183	203	9	,	,	PUNCT
cuesj-183	203	10	p.	p.	NOUN
cuesj-183	203	11	248	248	NUM
cuesj-183	203	12	,	,	PUNCT
cuesj-183	203	13	2017	2017	NUM
cuesj-183	203	14	.	.	PUNCT
cuesj-183	204	1	27	27	NUM
cuesj-183	204	2	.	.	PUNCT
cuesj-183	205	1	world	world	PROPN
cuesj-183	205	2	health	health	PROPN
cuesj-183	205	3	organization	organization	NOUN
cuesj-183	205	4	.	.	PUNCT
cuesj-183	206	1	“	"	PUNCT
cuesj-183	206	2	global	global	ADJ
cuesj-183	206	3	health	health	NOUN
cuesj-183	206	4	sector	sector	NOUN
cuesj-183	206	5	strategy	strategy	NOUN
cuesj-183	206	6	on	on	ADP
cuesj-183	206	7	viral	viral	ADJ
cuesj-183	206	8	hepatitis	hepatitis	NOUN
cuesj-183	206	9	,	,	PUNCT
cuesj-183	206	10	2016	2016	NUM
cuesj-183	206	11	-	-	SYM
cuesj-183	206	12	2021	2021	NUM
cuesj-183	206	13	”	"	PUNCT
cuesj-183	206	14	.	.	PUNCT
cuesj-183	207	1	geneva	geneva	PROPN
cuesj-183	207	2	:	:	PUNCT
cuesj-183	207	3	world	world	PROPN
cuesj-183	207	4	health	health	PROPN
cuesj-183	207	5	organization	organization	NOUN
cuesj-183	207	6	,	,	PUNCT
cuesj-183	207	7	2016	2016	NUM
cuesj-183	207	8	.	.	PUNCT
cuesj-183	208	1	28	28	NUM
cuesj-183	208	2	.	.	PUNCT
cuesj-183	208	3	e.	e.	PROPN
cuesj-183	208	4	franco	franco	PROPN
cuesj-183	208	5	,	,	PUNCT
cuesj-183	208	6	b.	b.	PROPN
cuesj-183	208	7	bagnato	bagnato	PROPN
cuesj-183	208	8	,	,	PUNCT
cuesj-183	208	9	m.	m.	NOUN
cuesj-183	208	10	g.	g.	PROPN
cuesj-183	208	11	marino	marino	PROPN
cuesj-183	208	12	,	,	PUNCT
cuesj-183	208	13	c.	c.	PROPN
cuesj-183	208	14	meleleo	meleleo	PROPN
cuesj-183	208	15	,	,	PUNCT
cuesj-183	208	16	l.	l.	PROPN
cuesj-183	208	17	serino	serino	PROPN
cuesj-183	208	18	and	and	CCONJ
cuesj-183	208	19	l.	l.	PROPN
cuesj-183	208	20	zaratti	zaratti	PROPN
cuesj-183	208	21	.	.	PUNCT
cuesj-183	209	1	“	"	PUNCT
cuesj-183	209	2	hepatitis	hepatitis	PROPN
cuesj-183	209	3	b	b	NOUN
cuesj-183	209	4	:	:	PUNCT
cuesj-183	209	5	epidemiology	epidemiology	NOUN
cuesj-183	209	6	and	and	CCONJ
cuesj-183	209	7	prevention	prevention	NOUN
cuesj-183	209	8	in	in	ADP
cuesj-183	209	9	developing	develop	VERB
cuesj-183	209	10	countries	country	NOUN
cuesj-183	209	11	”	"	PUNCT
cuesj-183	209	12	.	.	PUNCT
cuesj-183	210	1	world	world	PROPN
cuesj-183	210	2	journal	journal	PROPN
cuesj-183	210	3	of	of	ADP
cuesj-183	210	4	hepatology	hepatology	NOUN
cuesj-183	210	5	,	,	PUNCT
cuesj-183	210	6	vol	vol	NOUN
cuesj-183	210	7	.	.	PROPN
cuesj-183	210	8	4	4	NUM
cuesj-183	210	9	,	,	PUNCT
cuesj-183	210	10	p.	p.	NOUN
cuesj-183	210	11	74	74	NUM
cuesj-183	210	12	,	,	PUNCT
cuesj-183	210	13	2012	2012	NUM
cuesj-183	210	14	.	.	PUNCT
cuesj-183	211	1	29	29	NUM
cuesj-183	211	2	.	.	PUNCT
cuesj-183	212	1	j.	j.	PROPN
cuesj-183	212	2	j.	j.	PROPN
cuesj-183	212	3	ott	ott	PROPN
cuesj-183	212	4	,	,	PUNCT
cuesj-183	212	5	g.	g.	PROPN
cuesj-183	212	6	a.	a.	PROPN
cuesj-183	212	7	stevens	stevens	PROPN
cuesj-183	212	8	,	,	PUNCT
cuesj-183	212	9	j.	j.	PROPN
cuesj-183	212	10	groeger	groeger	PROPN
cuesj-183	212	11	and	and	CCONJ
cuesj-183	212	12	s.	s.	PROPN
cuesj-183	212	13	wiersma	wiersma	PROPN
cuesj-183	212	14	.	.	PUNCT
cuesj-183	213	1	“	"	PUNCT
cuesj-183	213	2	global	global	ADJ
cuesj-183	213	3	epidemiology	epidemiology	NOUN
cuesj-183	213	4	of	of	ADP
cuesj-183	213	5	hepatitis	hepatitis	PROPN
cuesj-183	213	6	b	b	PROPN
cuesj-183	213	7	virus	virus	NOUN
cuesj-183	213	8	infection	infection	NOUN
cuesj-183	213	9	:	:	PUNCT
cuesj-183	213	10	new	new	ADJ
cuesj-183	213	11	estimates	estimate	NOUN
cuesj-183	213	12	of	of	ADP
cuesj-183	213	13	age	age	NOUN
cuesj-183	213	14	-	-	PUNCT
cuesj-183	213	15	specific	specific	ADJ
cuesj-183	213	16	hbsag	hbsag	ADJ
cuesj-183	213	17	seroprevalence	seroprevalence	NOUN
cuesj-183	213	18	and	and	CCONJ
cuesj-183	213	19	endemicity	endemicity	NOUN
cuesj-183	213	20	”	"	PUNCT
cuesj-183	213	21	.	.	PUNCT
cuesj-183	214	1	vaccine	vaccine	NOUN
cuesj-183	214	2	,	,	PUNCT
cuesj-183	214	3	vol	vol	NOUN
cuesj-183	214	4	.	.	PROPN
cuesj-183	214	5	30	30	NUM
cuesj-183	214	6	,	,	PUNCT
cuesj-183	214	7	pp	pp	ADJ
cuesj-183	214	8	.	.	PUNCT
cuesj-183	215	1	2212	2212	NUM
cuesj-183	215	2	-	-	SYM
cuesj-183	215	3	2219	2219	NUM
cuesj-183	215	4	,	,	PUNCT
cuesj-183	215	5	2012	2012	NUM
cuesj-183	215	6	.	.	PUNCT
cuesj-183	216	1	30	30	NUM
cuesj-183	216	2	.	.	PUNCT
cuesj-183	217	1	k.	k.	PROPN
cuesj-183	217	2	m.	m.	PROPN
cuesj-183	217	3	hanafiah	hanafiah	PROPN
cuesj-183	217	4	,	,	PUNCT
cuesj-183	217	5	j.	j.	PROPN
cuesj-183	217	6	groeger	groeger	PROPN
cuesj-183	217	7	,	,	PUNCT
cuesj-183	217	8	a.	a.	PROPN
cuesj-183	217	9	d.	d.	PROPN
cuesj-183	217	10	flaxman	flaxman	PROPN
cuesj-183	217	11	and	and	CCONJ
cuesj-183	217	12	s.	s.	PROPN
cuesj-183	217	13	t.	t.	PROPN
cuesj-183	217	14	wiersma	wiersma	PROPN
cuesj-183	217	15	.	.	PUNCT
cuesj-183	218	1	“	"	PUNCT
cuesj-183	218	2	global	global	ADJ
cuesj-183	218	3	epidemiology	epidemiology	NOUN
cuesj-183	218	4	of	of	ADP
cuesj-183	218	5	hepatitis	hepatitis	PROPN
cuesj-183	218	6	c	c	PROPN
cuesj-183	218	7	virus	virus	NOUN
cuesj-183	218	8	infection	infection	NOUN
cuesj-183	218	9	:	:	PUNCT
cuesj-183	218	10	new	new	ADJ
cuesj-183	218	11	estimates	estimate	NOUN
cuesj-183	218	12	of	of	ADP
cuesj-183	218	13	age	age	NOUN
cuesj-183	218	14	-	-	PUNCT
cuesj-183	218	15	specific	specific	ADJ
cuesj-183	218	16	antibody	antibody	NOUN
cuesj-183	218	17	to	to	PART
cuesj-183	218	18	hcv	hcv	VERB
cuesj-183	218	19	seroprevalence	seroprevalence	NOUN
cuesj-183	218	20	”	"	PUNCT
cuesj-183	218	21	.	.	PUNCT
cuesj-183	219	1	hepatology	hepatology	NOUN
cuesj-183	219	2	,	,	PUNCT
cuesj-183	219	3	vol	vol	NOUN
cuesj-183	219	4	.	.	PROPN
cuesj-183	219	5	57	57	NUM
cuesj-183	219	6	,	,	PUNCT
cuesj-183	219	7	pp	pp	ADJ
cuesj-183	219	8	.	.	PUNCT
cuesj-183	219	9	1333	1333	NUM
cuesj-183	219	10	-	-	SYM
cuesj-183	219	11	1342	1342	NUM
cuesj-183	219	12	,	,	PUNCT
cuesj-183	219	13	2013	2013	NUM
cuesj-183	219	14	.	.	PUNCT
cuesj-183	220	1	31	31	NUM
cuesj-183	220	2	.	.	PUNCT
cuesj-183	221	1	h.	h.	PROPN
cuesj-183	221	2	s.	s.	PROPN
cuesj-183	221	3	q.	q.	PROPN
cuesj-183	221	4	alhilfi	alhilfi	PROPN
cuesj-183	221	5	,	,	PUNCT
cuesj-183	221	6	r.	r.	PROPN
cuesj-183	221	7	a.	a.	PROPN
cuesj-183	221	8	h.	h.	PROPN
cuesj-183	221	9	alhashimi	alhashimi	PROPN
cuesj-183	221	10	and	and	CCONJ
cuesj-183	221	11	r.	r.	PROPN
cuesj-183	221	12	k.	k.	PROPN
cuesj-183	221	13	a.	a.	PROPN
cuesj-183	221	14	alsaad	alsaad	PROPN
cuesj-183	221	15	.	.	PUNCT
cuesj-183	222	1	“	"	PUNCT
cuesj-183	222	2	seroprevalence	seroprevalence	NOUN
cuesj-183	222	3	of	of	ADP
cuesj-183	222	4	hepatitis	hepatitis	PROPN
cuesj-183	222	5	b	b	PROPN
cuesj-183	222	6	and	and	CCONJ
cuesj-183	222	7	hepatitis	hepatitis	PROPN
cuesj-183	222	8	c	c	PROPN
cuesj-183	222	9	virus	virus	NOUN
cuesj-183	222	10	among	among	ADP
cuesj-183	222	11	blood	blood	NOUN
cuesj-183	222	12	donors	donor	NOUN
cuesj-183	222	13	in	in	ADP
cuesj-183	222	14	missan	missan	ADJ
cuesj-183	222	15	governorate	governorate	PROPN
cuesj-183	222	16	-	-	PUNCT
cuesj-183	222	17	iraq	iraq	PROPN
cuesj-183	222	18	”	"	PUNCT
cuesj-183	222	19	.	.	PUNCT
cuesj-183	223	1	international	international	ADJ
cuesj-183	223	2	journal	journal	PROPN
cuesj-183	223	3	of	of	ADP
cuesj-183	223	4	innovation	innovation	NOUN
cuesj-183	223	5	and	and	CCONJ
cuesj-183	223	6	applied	apply	VERB
cuesj-183	223	7	studies	study	NOUN
cuesj-183	223	8	,	,	PUNCT
cuesj-183	223	9	vol	vol	NOUN
cuesj-183	223	10	.	.	PROPN
cuesj-183	223	11	11	11	NUM
cuesj-183	223	12	,	,	PUNCT
cuesj-183	223	13	pp	pp	PROPN
cuesj-183	223	14	.	.	PUNCT
cuesj-183	223	15	816	816	NUM
cuesj-183	223	16	-	-	SYM
cuesj-183	223	17	820	820	NUM
cuesj-183	223	18	,	,	PUNCT
cuesj-183	223	19	2015	2015	NUM
cuesj-183	223	20	.	.	PUNCT
cuesj-183	224	1	32	32	NUM
cuesj-183	224	2	.	.	PUNCT
cuesj-183	225	1	h.	h.	PROPN
cuesj-183	225	2	boustani	boustani	PROPN
cuesj-183	225	3	,	,	PUNCT
cuesj-183	225	4	e.	e.	PROPN
cuesj-183	225	5	anvari	anvari	PROPN
cuesj-183	225	6	,	,	PUNCT
cuesj-183	225	7	s.	s.	PROPN
cuesj-183	225	8	saiadisartang	saiadisartang	PROPN
cuesj-183	225	9	,	,	PUNCT
cuesj-183	225	10	m.	m.	NOUN
cuesj-183	225	11	omidi	omidi	PROPN
cuesj-183	225	12	,	,	PUNCT
cuesj-183	225	13	e.	e.	PROPN
cuesj-183	225	14	rostami	rostami	PROPN
cuesj-183	225	15	and	and	CCONJ
cuesj-183	225	16	z.	z.	PROPN
cuesj-183	225	17	mohamadi	mohamadi	PROPN
cuesj-183	225	18	.	.	PUNCT
cuesj-183	226	1	“	"	PUNCT
cuesj-183	226	2	prevalence	prevalence	NOUN
cuesj-183	226	3	of	of	ADP
cuesj-183	226	4	hiv	hiv	PROPN
cuesj-183	226	5	,	,	PUNCT
cuesj-183	226	6	hepatitis	hepatitis	PROPN
cuesj-183	226	7	b	b	PROPN
cuesj-183	226	8	and	and	CCONJ
cuesj-183	226	9	c	c	NOUN
cuesj-183	226	10	infections	infection	NOUN
cuesj-183	226	11	among	among	ADP
cuesj-183	226	12	volunteer	volunteer	NOUN
cuesj-183	226	13	blood	blood	NOUN
cuesj-183	226	14	donors	donor	NOUN
cuesj-183	226	15	at	at	ADP
cuesj-183	226	16	the	the	DET
cuesj-183	226	17	blood	blood	NOUN
cuesj-183	226	18	transfusion	transfusion	NOUN
cuesj-183	226	19	center	center	NOUN
cuesj-183	226	20	of	of	ADP
cuesj-183	226	21	ilam	ilam	PROPN
cuesj-183	226	22	city	city	PROPN
cuesj-183	226	23	,	,	PUNCT
cuesj-183	226	24	iran	iran	PROPN
cuesj-183	226	25	”	"	PUNCT
cuesj-183	226	26	.	.	PUNCT
cuesj-183	227	1	journal	journal	PROPN
cuesj-183	227	2	of	of	ADP
cuesj-183	227	3	basic	basic	ADJ
cuesj-183	227	4	research	research	NOUN
cuesj-183	227	5	in	in	ADP
cuesj-183	227	6	medical	medical	ADJ
cuesj-183	227	7	sciences	science	NOUN
cuesj-183	227	8	,	,	PUNCT
cuesj-183	227	9	vol	vol	NOUN
cuesj-183	227	10	.	.	PROPN
cuesj-183	227	11	4	4	NUM
cuesj-183	227	12	,	,	PUNCT
cuesj-183	227	13	pp	pp	ADJ
cuesj-183	227	14	.	.	PUNCT
cuesj-183	228	1	4	4	NUM
cuesj-183	228	2	-	-	SYM
cuesj-183	228	3	8	8	NUM
cuesj-183	228	4	,	,	PUNCT
cuesj-183	228	5	2017	2017	NUM
cuesj-183	228	6	.	.	PUNCT
cuesj-183	229	1	33	33	NUM
cuesj-183	229	2	.	.	PUNCT
cuesj-183	230	1	s.	s.	PROPN
cuesj-183	230	2	m.	m.	PROPN
cuesj-183	230	3	sajjadi	sajjadi	PROPN
cuesj-183	230	4	,	,	PUNCT
cuesj-183	230	5	a.	a.	NOUN
cuesj-183	230	6	a.	a.	NOUN
cuesj-183	230	7	pourfathollah	pourfathollah	PROPN
cuesj-183	230	8	,	,	PUNCT
cuesj-183	230	9	s.	s.	PROPN
cuesj-183	230	10	mohammadi	mohammadi	PROPN
cuesj-183	230	11	,	,	PUNCT
cuesj-183	230	12	b.	b.	PROPN
cuesj-183	230	13	nouri	nouri	PROPN
cuesj-183	230	14	,	,	PUNCT
cuesj-183	230	15	r.	r.	PROPN
cuesj-183	230	16	hassanzadeh	hassanzadeh	PROPN
cuesj-183	230	17	and	and	CCONJ
cuesj-183	230	18	f.	f.	PROPN
cuesj-183	230	19	rad	rad	PROPN
cuesj-183	230	20	.	.	PUNCT
cuesj-183	231	1	“	"	PUNCT
cuesj-183	231	2	the	the	DET
cuesj-183	231	3	prevalence	prevalence	NOUN
cuesj-183	231	4	and	and	CCONJ
cuesj-183	231	5	trends	trend	NOUN
cuesj-183	231	6	of	of	ADP
cuesj-183	231	7	hepatitis	hepatitis	PROPN
cuesj-183	231	8	b	b	PROPN
cuesj-183	231	9	,	,	PUNCT
cuesj-183	231	10	hepatitis	hepatitis	NOUN
cuesj-183	231	11	c	c	NOUN
cuesj-183	231	12	,	,	PUNCT
cuesj-183	231	13	and	and	CCONJ
cuesj-183	231	14	hiv	hiv	PROPN
cuesj-183	231	15	among	among	ADP
cuesj-183	231	16	voluntary	voluntary	ADJ
cuesj-183	231	17	blood	blood	NOUN
cuesj-183	231	18	donors	donor	NOUN
cuesj-183	231	19	in	in	ADP
cuesj-183	231	20	kohgiluyeh	kohgiluyeh	PROPN
cuesj-183	231	21	and	and	CCONJ
cuesj-183	231	22	boyer	boyer	PROPN
cuesj-183	231	23	-	-	PUNCT
cuesj-183	231	24	ahmad	ahmad	PROPN
cuesj-183	231	25	transfusion	transfusion	NOUN
cuesj-183	231	26	center	center	NOUN
cuesj-183	231	27	,	,	PUNCT
cuesj-183	231	28	southwestern	southwestern	ADJ
cuesj-183	231	29	iran	iran	PROPN
cuesj-183	231	30	”	"	PUNCT
cuesj-183	231	31	.	.	PUNCT
cuesj-183	232	1	iranian	iranian	PROPN
cuesj-183	232	2	journal	journal	PROPN
cuesj-183	232	3	of	of	ADP
cuesj-183	232	4	public	public	ADJ
cuesj-183	232	5	health	health	NOUN
cuesj-183	232	6	,	,	PUNCT
cuesj-183	232	7	vol	vol	NOUN
cuesj-183	232	8	.	.	PROPN
cuesj-183	233	1	47	47	NUM
cuesj-183	233	2	,	,	PUNCT
cuesj-183	233	3	pp	pp	ADJ
cuesj-183	233	4	.	.	PUNCT
cuesj-183	234	1	944	944	NUM
cuesj-183	234	2	-	-	SYM
cuesj-183	234	3	951	951	NUM
cuesj-183	234	4	,	,	PUNCT
cuesj-183	234	5	2018	2018	NUM
cuesj-183	234	6	.	.	PUNCT
cuesj-183	235	1	34	34	NUM
cuesj-183	235	2	.	.	PUNCT
cuesj-183	236	1	s.	s.	PROPN
cuesj-183	236	2	p.	p.	PROPN
cuesj-183	236	3	s	s	PART
cuesj-183	236	4	gulia	gulia	PROPN
cuesj-183	236	5	.	.	PUNCT
cuesj-183	237	1	“	"	PUNCT
cuesj-183	237	2	seroprevalence	seroprevalence	NOUN
cuesj-183	237	3	of	of	ADP
cuesj-183	237	4	hepatitis	hepatitis	PROPN
cuesj-183	237	5	b	b	PROPN
cuesj-183	237	6	virus	virus	NOUN
cuesj-183	237	7	infection	infection	NOUN
cuesj-183	237	8	among	among	ADP
cuesj-183	237	9	blood	blood	NOUN
cuesj-183	237	10	donors	donor	NOUN
cuesj-183	237	11	in	in	ADP
cuesj-183	237	12	local	local	ADJ
cuesj-183	237	13	population	population	NOUN
cuesj-183	237	14	”	"	PUNCT
cuesj-183	237	15	.	.	PUNCT
cuesj-183	238	1	the	the	DET
cuesj-183	238	2	internet	internet	NOUN
cuesj-183	238	3	journal	journal	NOUN
cuesj-183	238	4	of	of	ADP
cuesj-183	238	5	pathology	pathology	PROPN
cuesj-183	238	6	,	,	PUNCT
cuesj-183	238	7	vol	vol	NOUN
cuesj-183	238	8	.	.	PROPN
cuesj-183	238	9	10	10	NUM
cuesj-183	238	10	,	,	PUNCT
cuesj-183	238	11	pp.29	pp.29	NOUN
cuesj-183	238	12	-	-	PUNCT
cuesj-183	238	13	33	33	NUM
cuesj-183	238	14	,	,	PUNCT
cuesj-183	238	15	2010	2010	NUM
cuesj-183	238	16	.	.	PUNCT
cuesj-183	238	17	35	35	NUM
cuesj-183	238	18	.	.	PUNCT
cuesj-183	239	1	s.	s.	PROPN
cuesj-183	239	2	r.	r.	PROPN
cuesj-183	239	3	qowaider	qowaider	PROPN
cuesj-183	239	4	,	,	PUNCT
cuesj-183	239	5	m.	m.	PROPN
cuesj-183	239	6	s.	s.	PROPN
cuesj-183	239	7	ali	ali	PROPN
cuesj-183	239	8	,	,	PUNCT
cuesj-183	239	9	s.	s.	PROPN
cuesj-183	239	10	a.	a.	PROPN
cuesj-183	239	11	moftah	moftah	PROPN
cuesj-183	239	12	and	and	CCONJ
cuesj-183	239	13	f.	f.	PROPN
cuesj-183	239	14	a.	a.	PROPN
cuesj-183	239	15	khaled	khaled	PROPN
cuesj-183	239	16	.	.	PUNCT
cuesj-183	240	1	“	"	PUNCT
cuesj-183	240	2	prevalence	prevalence	NOUN
cuesj-183	240	3	of	of	ADP
cuesj-183	240	4	hbv	hbv	NOUN
cuesj-183	240	5	and	and	CCONJ
cuesj-183	240	6	hcv	hcv	NOUN
cuesj-183	240	7	infections	infection	NOUN
cuesj-183	240	8	among	among	ADP
cuesj-183	240	9	blood	blood	NOUN
cuesj-183	240	10	donors	donor	NOUN
cuesj-183	240	11	in	in	ADP
cuesj-183	240	12	northeast	northeast	ADJ
cuesj-183	240	13	libya	libya	NOUN
cuesj-183	240	14	”	"	PUNCT
cuesj-183	240	15	.	.	PUNCT
cuesj-183	241	1	international	international	ADJ
cuesj-183	241	2	blood	blood	NOUN
cuesj-183	241	3	research	research	NOUN
cuesj-183	241	4	and	and	CCONJ
cuesj-183	241	5	reviews	review	NOUN
cuesj-183	241	6	,	,	PUNCT
cuesj-183	241	7	vol	vol	NOUN
cuesj-183	241	8	.	.	PROPN
cuesj-183	241	9	7	7	NUM
cuesj-183	241	10	,	,	PUNCT
cuesj-183	241	11	pp	pp	ADJ
cuesj-183	241	12	.	.	PUNCT
cuesj-183	242	1	1	1	NUM
cuesj-183	242	2	-	-	SYM
cuesj-183	242	3	5	5	NUM
cuesj-183	242	4	,	,	PUNCT
cuesj-183	242	5	2017	2017	NUM
cuesj-183	242	6	.	.	PUNCT
cuesj-183	243	1	36	36	NUM
cuesj-183	243	2	.	.	PUNCT
cuesj-183	244	1	v.	v.	PROPN
cuesj-183	244	2	d.	d.	PROPN
cuesj-183	244	3	hope	hope	PROPN
cuesj-183	244	4	,	,	PUNCT
cuesj-183	244	5	i.	i.	PROPN
cuesj-183	244	6	eramova	eramova	PROPN
cuesj-183	244	7	,	,	PUNCT
cuesj-183	244	8	d.	d.	PROPN
cuesj-183	244	9	capurro	capurro	PROPN
cuesj-183	244	10	and	and	CCONJ
cuesj-183	244	11	m.	m.	NOUN
cuesj-183	244	12	donoghoe	donoghoe	NOUN
cuesj-183	244	13	.	.	PUNCT
cuesj-183	245	1	“	"	PUNCT
cuesj-183	245	2	prevalence	prevalence	NOUN
cuesj-183	245	3	and	and	CCONJ
cuesj-183	245	4	estimation	estimation	NOUN
cuesj-183	245	5	of	of	ADP
cuesj-183	245	6	hepatitis	hepatitis	PROPN
cuesj-183	245	7	b	b	PROPN
cuesj-183	245	8	and	and	CCONJ
cuesj-183	245	9	c	c	NOUN
cuesj-183	245	10	infections	infection	NOUN
cuesj-183	245	11	in	in	ADP
cuesj-183	245	12	the	the	DET
cuesj-183	245	13	who	who	PRON
cuesj-183	245	14	european	european	PROPN
cuesj-183	245	15	region	region	PROPN
cuesj-183	245	16	:	:	PUNCT
cuesj-183	245	17	a	a	DET
cuesj-183	245	18	review	review	NOUN
cuesj-183	245	19	of	of	ADP
cuesj-183	245	20	data	datum	NOUN
cuesj-183	245	21	focusing	focus	VERB
cuesj-183	245	22	on	on	ADP
cuesj-183	245	23	the	the	DET
cuesj-183	245	24	countries	country	NOUN
cuesj-183	245	25	outside	outside	ADP
cuesj-183	245	26	the	the	DET
cuesj-183	245	27	european	european	PROPN
cuesj-183	245	28	union	union	PROPN
cuesj-183	245	29	and	and	CCONJ
cuesj-183	245	30	the	the	DET
cuesj-183	245	31	european	european	PROPN
cuesj-183	245	32	free	free	PROPN
cuesj-183	245	33	trade	trade	PROPN
cuesj-183	245	34	association	association	PROPN
cuesj-183	245	35	”	"	PUNCT
cuesj-183	245	36	.	.	PUNCT
cuesj-183	246	1	epidemiology	epidemiology	NOUN
cuesj-183	246	2	and	and	CCONJ
cuesj-183	246	3	infection	infection	NOUN
cuesj-183	246	4	,	,	PUNCT
cuesj-183	246	5	vol	vol	NOUN
cuesj-183	246	6	.	.	PROPN
cuesj-183	246	7	142	142	NUM
cuesj-183	246	8	,	,	PUNCT
cuesj-183	246	9	pp	pp	ADJ
cuesj-183	246	10	.	.	PUNCT
cuesj-183	247	1	270	270	NUM
cuesj-183	247	2	-	-	SYM
cuesj-183	247	3	286	286	NUM
cuesj-183	247	4	,	,	PUNCT
cuesj-183	247	5	2014	2014	NUM
cuesj-183	247	6	.	.	PUNCT
cuesj-183	248	1	37	37	NUM
cuesj-183	248	2	.	.	PUNCT
cuesj-183	248	3	m.	m.	PROPN
cuesj-183	248	4	s.	s.	PROPN
cuesj-183	248	5	kwak	kwak	PROPN
cuesj-183	248	6	and	and	CCONJ
cuesj-183	248	7	y.	y.	PROPN
cuesj-183	248	8	j.	j.	PROPN
cuesj-183	248	9	kim	kim	PROPN
cuesj-183	248	10	.	.	PUNCT
cuesj-183	249	1	“	"	PUNCT
cuesj-183	249	2	occult	occult	VERB
cuesj-183	249	3	hepatitis	hepatitis	PROPN
cuesj-183	249	4	b	b	PROPN
cuesj-183	249	5	virus	virus	NOUN
cuesj-183	249	6	infection	infection	NOUN
cuesj-183	249	7	”	"	PUNCT
cuesj-183	249	8	.	.	PUNCT
cuesj-183	250	1	world	world	PROPN
cuesj-183	250	2	journal	journal	PROPN
cuesj-183	250	3	of	of	ADP
cuesj-183	250	4	hepatology	hepatology	NOUN
cuesj-183	250	5	,	,	PUNCT
cuesj-183	250	6	vol	vol	NOUN
cuesj-183	250	7	.	.	PROPN
cuesj-183	250	8	6	6	NUM
cuesj-183	250	9	,	,	PUNCT
cuesj-183	250	10	pp	pp	ADJ
cuesj-183	250	11	.	.	PUNCT
cuesj-183	251	1	860	860	NUM
cuesj-183	251	2	-	-	SYM
cuesj-183	251	3	869	869	NUM
cuesj-183	251	4	,	,	PUNCT
cuesj-183	251	5	2014	2014	NUM
cuesj-183	251	6	.	.	PUNCT
cuesj-183	252	1	38	38	NUM
cuesj-183	252	2	.	.	PUNCT
cuesj-183	253	1	h.	h.	PROPN
cuesj-183	253	2	hennig	hennig	PROPN
cuesj-183	253	3	,	,	PUNCT
cuesj-183	253	4	i.	i.	PROPN
cuesj-183	253	5	puchta	puchta	PROPN
cuesj-183	253	6	,	,	PUNCT
cuesj-183	253	7	j.	j.	PROPN
cuesj-183	253	8	luhm	luhm	PROPN
cuesj-183	253	9	,	,	PUNCT
cuesj-183	253	10	p.	p.	PROPN
cuesj-183	253	11	schlenke	schlenke	NOUN
cuesj-183	253	12	,	,	PUNCT
cuesj-183	253	13	s.	s.	PROPN
cuesj-183	253	14	goerg	goerg	PROPN
cuesj-183	253	15	and	and	CCONJ
cuesj-183	253	16	h.	h.	PROPN
cuesj-183	253	17	kirchner	kirchner	PROPN
cuesj-183	253	18	.	.	PUNCT
cuesj-183	254	1	“	"	PUNCT
cuesj-183	254	2	frequency	frequency	NOUN
cuesj-183	254	3	and	and	CCONJ
cuesj-183	254	4	load	load	NOUN
cuesj-183	254	5	of	of	ADP
cuesj-183	254	6	hepatitis	hepatitis	PROPN
cuesj-183	254	7	b	b	PROPN
cuesj-183	254	8	virus	virus	NOUN
cuesj-183	254	9	dna	dna	PROPN
cuesj-183	254	10	in	in	ADP
cuesj-183	254	11	firsttime	firsttime	ADJ
cuesj-183	254	12	blood	blood	NOUN
cuesj-183	254	13	donors	donor	NOUN
cuesj-183	254	14	with	with	ADP
cuesj-183	254	15	antibodies	antibody	NOUN
cuesj-183	254	16	to	to	ADP
cuesj-183	254	17	hepatitis	hepatitis	PROPN
cuesj-183	254	18	b	b	PROPN
cuesj-183	254	19	core	core	NOUN
cuesj-183	254	20	antigen	antigen	PROPN
cuesj-183	254	21	”	"	PUNCT
cuesj-183	254	22	.	.	PUNCT
cuesj-183	255	1	blood	blood	NOUN
cuesj-183	255	2	,	,	PUNCT
cuesj-183	255	3	vol	vol	NOUN
cuesj-183	255	4	.	.	PROPN
cuesj-183	255	5	100	100	NUM
cuesj-183	255	6	,	,	PUNCT
cuesj-183	255	7	pp	pp	ADJ
cuesj-183	255	8	.	.	PUNCT
cuesj-183	255	9	2637	2637	NUM
cuesj-183	255	10	,	,	PUNCT
cuesj-183	255	11	2002	2002	NUM
cuesj-183	255	12	.	.	PUNCT
cuesj-183	255	13	39	39	NUM
cuesj-183	255	14	.	.	PUNCT
cuesj-183	256	1	s.	s.	PROPN
cuesj-183	256	2	h.	h.	PROPN
cuesj-183	256	3	kleinman	kleinman	PROPN
cuesj-183	256	4	,	,	PUNCT
cuesj-183	256	5	m.	m.	PROPN
cuesj-183	256	6	c.	c.	PROPN
cuesj-183	256	7	kuhns	kuhns	PROPN
cuesj-183	256	8	,	,	PUNCT
cuesj-183	256	9	d.	d.	PROPN
cuesj-183	256	10	s.	s.	PROPN
cuesj-183	256	11	todd	todd	PROPN
cuesj-183	256	12	,	,	PUNCT
cuesj-183	256	13	s.	s.	PROPN
cuesj-183	256	14	a.	a.	PROPN
cuesj-183	256	15	glynn	glynn	PROPN
cuesj-183	256	16	,	,	PUNCT
cuesj-183	256	17	a.	a.	PROPN
cuesj-183	256	18	mcnamara	mcnamara	PROPN
cuesj-183	256	19	,	,	PUNCT
cuesj-183	256	20	a.	a.	NOUN
cuesj-183	256	21	dimarco	dimarco	PROPN
cuesj-183	256	22	,	,	PUNCT
cuesj-183	256	23	m.	m.	NOUN
cuesj-183	256	24	p.	p.	NOUN
cuesj-183	256	25	busch	busch	PROPN
cuesj-183	256	26	and	and	CCONJ
cuesj-183	256	27	for	for	ADP
cuesj-183	256	28	the	the	DET
cuesj-183	256	29	retrovirus	retrovirus	NOUN
cuesj-183	256	30	epidemiology	epidemiology	NOUN
cuesj-183	256	31	donor	donor	NOUN
cuesj-183	256	32	study	study	NOUN
cuesj-183	256	33	.	.	PUNCT
cuesj-183	257	1	“	"	PUNCT
cuesj-183	257	2	frequency	frequency	NOUN
cuesj-183	257	3	of	of	ADP
cuesj-183	257	4	hbv	hbv	PROPN
cuesj-183	257	5	dna	dna	PROPN
cuesj-183	257	6	detection	detection	NOUN
cuesj-183	257	7	in	in	ADP
cuesj-183	257	8	us	we	PRON
cuesj-183	257	9	blood	blood	NOUN
cuesj-183	257	10	donors	donor	NOUN
cuesj-183	257	11	testing	test	VERB
cuesj-183	257	12	positive	positive	ADJ
cuesj-183	257	13	for	for	ADP
cuesj-183	257	14	the	the	DET
cuesj-183	257	15	presence	presence	NOUN
cuesj-183	257	16	of	of	ADP
cuesj-183	257	17	anti	anti	ADJ
cuesj-183	257	18	-	-	NOUN
cuesj-183	257	19	hbc	hbc	ADJ
cuesj-183	257	20	:	:	PUNCT
cuesj-183	257	21	implications	implication	NOUN
cuesj-183	257	22	for	for	ADP
cuesj-183	257	23	transfusion	transfusion	NOUN
cuesj-183	257	24	transmission	transmission	NOUN
cuesj-183	257	25	and	and	CCONJ
cuesj-183	257	26	donor	donor	NOUN
cuesj-183	257	27	screening	screening	NOUN
cuesj-183	257	28	”	"	PUNCT
cuesj-183	257	29	.	.	PUNCT
cuesj-183	258	1	transfusion	transfusion	NOUN
cuesj-183	258	2	,	,	PUNCT
cuesj-183	258	3	vol	vol	NOUN
cuesj-183	258	4	.	.	PROPN
cuesj-183	258	5	43	43	NUM
cuesj-183	258	6	,	,	PUNCT
cuesj-183	258	7	pp	pp	ADJ
cuesj-183	258	8	.	.	PUNCT
cuesj-183	259	1	696	696	NUM
cuesj-183	259	2	-	-	SYM
cuesj-183	259	3	704	704	NUM
cuesj-183	259	4	,	,	PUNCT
cuesj-183	259	5	2003	2003	NUM
cuesj-183	259	6	.	.	PUNCT
cuesj-183	260	1	40	40	NUM
cuesj-183	260	2	.	.	PUNCT
cuesj-183	260	3	m.	m.	NOUN
cuesj-183	260	4	sofian	sofian	PROPN
cuesj-183	260	5	,	,	PUNCT
cuesj-183	260	6	a.	a.	PROPN
cuesj-183	260	7	aghakhani	aghakhani	PROPN
cuesj-183	260	8	,	,	PUNCT
cuesj-183	260	9	n.	n.	NOUN
cuesj-183	260	10	izadi	izadi	NOUN
cuesj-183	260	11	,	,	PUNCT
cuesj-183	260	12	m.	m.	NOUN
cuesj-183	260	13	banifazl	banifazl	NOUN
cuesj-183	260	14	,	,	PUNCT
cuesj-183	260	15	e.	e.	PROPN
cuesj-183	260	16	kalantar	kalantar	PROPN
cuesj-183	260	17	,	,	PUNCT
cuesj-183	260	18	a.	a.	NOUN
cuesj-183	260	19	eslamifar	eslamifar	ADV
cuesj-183	260	20	and	and	CCONJ
cuesj-183	260	21	a.	a.	NOUN
cuesj-183	260	22	ramezani	ramezani	NOUN
cuesj-183	260	23	.	.	PUNCT
cuesj-183	261	1	“	"	PUNCT
cuesj-183	261	2	lack	lack	NOUN
cuesj-183	261	3	of	of	ADP
cuesj-183	261	4	occult	occult	NOUN
cuesj-183	261	5	hepatitis	hepatitis	PROPN
cuesj-183	261	6	b	b	PROPN
cuesj-183	261	7	virus	virus	NOUN
cuesj-183	261	8	infection	infection	NOUN
cuesj-183	261	9	among	among	ADP
cuesj-183	261	10	blood	blood	NOUN
cuesj-183	261	11	donors	donor	NOUN
cuesj-183	261	12	with	with	ADP
cuesj-183	261	13	isolated	isolated	ADJ
cuesj-183	261	14	hepatitis	hepatitis	PROPN
cuesj-183	261	15	b	b	PROPN
cuesj-183	261	16	core	core	NOUN
cuesj-183	261	17	antibody	antibody	NOUN
cuesj-183	261	18	living	live	VERB
cuesj-183	261	19	in	in	ADP
cuesj-183	261	20	an	an	DET
cuesj-183	261	21	hbv	hbv	NOUN
cuesj-183	261	22	low	low	ADJ
cuesj-183	261	23	prevalence	prevalence	NOUN
cuesj-183	261	24	region	region	NOUN
cuesj-183	261	25	of	of	ADP
cuesj-183	261	26	iran	iran	PROPN
cuesj-183	261	27	”	"	PUNCT
cuesj-183	261	28	.	.	PUNCT
cuesj-183	262	1	international	international	ADJ
cuesj-183	262	2	journal	journal	NOUN
cuesj-183	262	3	of	of	ADP
cuesj-183	262	4	infectious	infectious	ADJ
cuesj-183	262	5	diseases	disease	NOUN
cuesj-183	262	6	,	,	PUNCT
cuesj-183	262	7	vol	vol	NOUN
cuesj-183	262	8	.	.	PROPN
cuesj-183	262	9	14	14	NUM
cuesj-183	262	10	,	,	PUNCT
cuesj-183	262	11	pp	pp	ADJ
cuesj-183	262	12	.	.	PUNCT
cuesj-183	263	1	e308	e308	PROPN
cuesj-183	263	2	-	-	PUNCT
cuesj-183	263	3	e310	e310	PROPN
cuesj-183	263	4	,	,	PUNCT
cuesj-183	263	5	2010	2010	NUM
cuesj-183	263	6	.	.	PUNCT
cuesj-183	264	1	41	41	NUM
cuesj-183	264	2	.	.	PUNCT
cuesj-183	265	1	f.	f.	PROPN
cuesj-183	265	2	h.	h.	PROPN
cuesj-183	265	3	wolff	wolff	PROPN
cuesj-183	265	4	,	,	PUNCT
cuesj-183	265	5	s	s	PROPN
cuesj-183	265	6	..	..	PUNCT
cuesj-183	265	7	c.	c.	PROPN
cuesj-183	265	8	fuchs	fuchs	PROPN
cuesj-183	265	9	and	and	CCONJ
cuesj-183	265	10	a.	a.	PROPN
cuesj-183	265	11	b.	b.	PROPN
cuesj-183	265	12	m.	m.	PROPN
cuesj-183	265	13	brandão	brandão	PROPN
cuesj-183	265	14	.	.	PUNCT
cuesj-183	266	1	“	"	PUNCT
cuesj-183	266	2	absence	absence	NOUN
cuesj-183	266	3	of	of	ADP
cuesj-183	266	4	occult	occult	NOUN
cuesj-183	266	5	hepatitis	hepatitis	PROPN
cuesj-183	266	6	b	b	PROPN
cuesj-183	266	7	among	among	ADP
cuesj-183	266	8	blood	blood	NOUN
cuesj-183	266	9	donors	donor	NOUN
cuesj-183	266	10	in	in	ADP
cuesj-183	266	11	southern	southern	ADJ
cuesj-183	266	12	brazil	brazil	PROPN
cuesj-183	266	13	”	"	PUNCT
cuesj-183	266	14	.	.	PUNCT
cuesj-183	267	1	the	the	DET
cuesj-183	267	2	brazilian	brazilian	ADJ
cuesj-183	267	3	journal	journal	NOUN
cuesj-183	267	4	of	of	ADP
cuesj-183	267	5	infectious	infectious	ADJ
cuesj-183	267	6	diseases	disease	NOUN
cuesj-183	267	7	,	,	PUNCT
cuesj-183	267	8	vol	vol	NOUN
cuesj-183	267	9	.	.	PROPN
cuesj-183	267	10	15	15	NUM
cuesj-183	267	11	,	,	PUNCT
cuesj-183	267	12	pp	pp	ADJ
cuesj-183	267	13	.	.	PUNCT
cuesj-183	268	1	159	159	NUM
cuesj-183	268	2	-	-	SYM
cuesj-183	268	3	162	162	NUM
cuesj-183	268	4	,	,	PUNCT
cuesj-183	268	5	2011	2011	NUM
cuesj-183	268	6	.	.	PUNCT
cuesj-183	269	1	42	42	NUM
cuesj-183	269	2	.	.	PUNCT
cuesj-183	270	1	r.	r.	PROPN
cuesj-183	270	2	n.	n.	PROPN
cuesj-183	270	3	hassan	hassan	PROPN
cuesj-183	270	4	and	and	CCONJ
cuesj-183	270	5	a.	a.	PROPN
cuesj-183	270	6	h.	h.	PROPN
cuesj-183	270	7	hussain	hussain	PROPN
cuesj-183	270	8	.	.	PUNCT
cuesj-183	271	1	“	"	PUNCT
cuesj-183	271	2	hepatitis	hepatitis	PROPN
cuesj-183	271	3	b	b	PROPN
cuesj-183	271	4	virus	virus	NOUN
cuesj-183	271	5	dna	dna	PROPN
cuesj-183	271	6	in	in	ADP
cuesj-183	271	7	blood	blood	NOUN
cuesj-183	271	8	donors	donor	NOUN
cuesj-183	271	9	positive	positive	ADJ
cuesj-183	271	10	of	of	ADP
cuesj-183	271	11	anti	anti	ADJ
cuesj-183	271	12	-	-	ADJ
cuesj-183	271	13	hepatitis	hepatitis	ADJ
cuesj-183	271	14	b	b	NOUN
cuesj-183	271	15	core	core	NOUN
cuesj-183	271	16	antibodies	antibody	NOUN
cuesj-183	271	17	and	and	CCONJ
cuesj-183	271	18	negative	negative	ADJ
cuesj-183	271	19	for	for	ADP
cuesj-183	271	20	surface	surface	NOUN
cuesj-183	271	21	antigen	antigen	ADV
cuesj-183	271	22	in	in	ADP
cuesj-183	271	23	hawler	hawler	NOUN
cuesj-183	271	24	major	major	ADJ
cuesj-183	271	25	blood	blood	NOUN
cuesj-183	271	26	bank	bank	NOUN
cuesj-183	271	27	,	,	PUNCT
cuesj-183	271	28	kurdistan	kurdistan	PROPN
cuesj-183	271	29	region	region	NOUN
cuesj-183	271	30	,	,	PUNCT
cuesj-183	271	31	iraq	iraq	PROPN
cuesj-183	271	32	”	"	PUNCT
cuesj-183	271	33	.	.	PUNCT
cuesj-183	272	1	journal	journal	NOUN
cuesj-183	272	2	of	of	ADP
cuesj-183	272	3	the	the	DET
cuesj-183	272	4	faculty	faculty	NOUN
cuesj-183	272	5	of	of	ADP
cuesj-183	272	6	medicine	medicine	NOUN
cuesj-183	272	7	,	,	PUNCT
cuesj-183	272	8	baghdad	baghdad	PROPN
cuesj-183	272	9	,	,	PUNCT
cuesj-183	272	10	vol	vol	NOUN
cuesj-183	272	11	.	.	PROPN
cuesj-183	272	12	60	60	NUM
cuesj-183	272	13	,	,	PUNCT
cuesj-183	272	14	pp	pp	ADJ
cuesj-183	272	15	.	.	PUNCT
cuesj-183	273	1	57	57	NUM
cuesj-183	273	2	-	-	SYM
cuesj-183	273	3	61	61	NUM
cuesj-183	273	4	,	,	PUNCT
cuesj-183	273	5	2018	2018	NUM
cuesj-183	273	6	.	.	PUNCT
cuesj-183	274	1	43	43	NUM
cuesj-183	274	2	.	.	PUNCT
cuesj-183	275	1	d.	d.	PROPN
cuesj-183	275	2	h.	h.	PROPN
cuesj-183	275	3	seo	seo	PROPN
cuesj-183	275	4	,	,	PUNCT
cuesj-183	275	5	d.	d.	PROPN
cuesj-183	275	6	h.	h.	PROPN
cuesj-183	275	7	whang	whang	PROPN
cuesj-183	275	8	,	,	PUNCT
cuesj-183	275	9	e.	e.	PROPN
cuesj-183	275	10	y.	y.	PROPN
cuesj-183	275	11	song	song	PROPN
cuesj-183	275	12	,	,	PUNCT
cuesj-183	275	13	h.	h.	PROPN
cuesj-183	275	14	s.	s.	PROPN
cuesj-183	275	15	kim	kim	PROPN
cuesj-183	275	16	and	and	CCONJ
cuesj-183	275	17	q.	q.	PROPN
cuesj-183	275	18	park	park	PROPN
cuesj-183	275	19	.	.	PUNCT
cuesj-183	276	1	“	"	PUNCT
cuesj-183	276	2	prevalence	prevalence	NOUN
cuesj-183	276	3	of	of	ADP
cuesj-183	276	4	antibodies	antibody	NOUN
cuesj-183	276	5	to	to	ADP
cuesj-183	276	6	hepatitis	hepatitis	PROPN
cuesj-183	276	7	b	b	PROPN
cuesj-183	276	8	core	core	NOUN
cuesj-183	276	9	antigen	antigen	NOUN
cuesj-183	276	10	and	and	CCONJ
cuesj-183	276	11	occult	occult	VERB
cuesj-183	276	12	hepatitis	hepatitis	PROPN
cuesj-183	276	13	b	b	PROPN
cuesj-183	276	14	virus	virus	NOUN
cuesj-183	276	15	infections	infection	NOUN
cuesj-183	276	16	in	in	ADP
cuesj-183	276	17	korean	korean	ADJ
cuesj-183	276	18	blood	blood	NOUN
cuesj-183	276	19	donors	donor	NOUN
cuesj-183	276	20	”	"	PUNCT
cuesj-183	276	21	.	.	PUNCT
cuesj-183	277	1	transfusion	transfusion	NOUN
cuesj-183	277	2	,	,	PUNCT
cuesj-183	277	3	vol	vol	NOUN
cuesj-183	277	4	.	.	PROPN
cuesj-183	277	5	51	51	NUM
cuesj-183	277	6	,	,	PUNCT
cuesj-183	277	7	pp	pp	ADJ
cuesj-183	277	8	.	.	PUNCT
cuesj-183	278	1	1840	1840	NUM
cuesj-183	278	2	-	-	SYM
cuesj-183	278	3	1846	1846	NUM
cuesj-183	278	4	,	,	PUNCT
cuesj-183	278	5	2011	2011	NUM
cuesj-183	278	6	.	.	PUNCT
cuesj-183	279	1	44	44	NUM
cuesj-183	279	2	.	.	PUNCT
cuesj-183	280	1	e.	e.	PROPN
cuesj-183	280	2	zervou	zervou	PROPN
cuesj-183	280	3	,	,	PUNCT
cuesj-183	280	4	g.	g.	PROPN
cuesj-183	280	5	dalekos	dalekos	PROPN
cuesj-183	280	6	,	,	PUNCT
cuesj-183	280	7	d.	d.	PROPN
cuesj-183	280	8	boumba	boumba	PROPN
cuesj-183	280	9	and	and	CCONJ
cuesj-183	280	10	e.	e.	PROPN
cuesj-183	280	11	tsianos	tsianos	PROPN
cuesj-183	280	12	.	.	PUNCT
cuesj-183	281	1	“	"	PUNCT
cuesj-183	281	2	value	value	NOUN
cuesj-183	281	3	of	of	ADP
cuesj-183	281	4	antihbc	antihbc	PROPN
cuesj-183	281	5	screening	screening	NOUN
cuesj-183	281	6	of	of	ADP
cuesj-183	281	7	blood	blood	NOUN
cuesj-183	281	8	donors	donor	NOUN
cuesj-183	281	9	for	for	ADP
cuesj-183	281	10	prevention	prevention	NOUN
cuesj-183	281	11	of	of	ADP
cuesj-183	281	12	hbv	hbv	NOUN
cuesj-183	281	13	infection	infection	NOUN
cuesj-183	281	14	:	:	PUNCT
cuesj-183	281	15	results	result	NOUN
cuesj-183	281	16	of	of	ADP
cuesj-183	281	17	a	a	DET
cuesj-183	281	18	3	3	NUM
cuesj-183	281	19	-	-	PUNCT
cuesj-183	281	20	year	year	NOUN
cuesj-183	281	21	prospective	prospective	ADJ
cuesj-183	281	22	study	study	NOUN
cuesj-183	281	23	in	in	ADP
cuesj-183	281	24	northwestern	northwestern	PROPN
cuesj-183	281	25	greece	greece	PROPN
cuesj-183	281	26	”	"	PUNCT
cuesj-183	281	27	.	.	PUNCT
cuesj-183	282	1	transfusion	transfusion	NOUN
cuesj-183	282	2	,	,	PUNCT
cuesj-183	282	3	vol	vol	NOUN
cuesj-183	282	4	.	.	PROPN
cuesj-183	282	5	41	41	NUM
cuesj-183	282	6	,	,	PUNCT
cuesj-183	282	7	pp	pp	ADJ
cuesj-183	282	8	.	.	PUNCT
cuesj-183	283	1	652	652	NUM
cuesj-183	283	2	-	-	SYM
cuesj-183	283	3	658	658	NUM
cuesj-183	283	4	,	,	PUNCT
cuesj-183	283	5	2001	2001	NUM
cuesj-183	283	6	.	.	PUNCT
cuesj-183	284	1	45	45	NUM
cuesj-183	284	2	.	.	PUNCT
cuesj-183	284	3	s.	s.	PROPN
cuesj-183	284	4	a.	a.	PROPN
cuesj-183	284	5	awan	awan	PROPN
cuesj-183	284	6	,	,	PUNCT
cuesj-183	284	7	a.	a.	PROPN
cuesj-183	284	8	junaid	junaid	PROPN
cuesj-183	284	9	and	and	CCONJ
cuesj-183	284	10	s.	s.	PROPN
cuesj-183	284	11	sheikh	sheikh	PROPN
cuesj-183	284	12	.	.	PUNCT
cuesj-183	285	1	“	"	PUNCT
cuesj-183	285	2	transfusion	transfusion	VERB
cuesj-183	285	3	transmissible	transmissible	ADJ
cuesj-183	285	4	infections	infection	NOUN
cuesj-183	285	5	:	:	PUNCT
cuesj-183	285	6	maximizing	maximize	VERB
cuesj-183	285	7	donor	donor	NOUN
cuesj-183	285	8	surveillance	surveillance	NOUN
cuesj-183	285	9	”	"	PUNCT
cuesj-183	285	10	.	.	PUNCT
cuesj-183	286	1	cureus	cureus	NOUN
cuesj-183	286	2	,	,	PUNCT
cuesj-183	286	3	vol	vol	NOUN
cuesj-183	286	4	.	.	PROPN
cuesj-183	286	5	10	10	NUM
cuesj-183	286	6	,	,	PUNCT
cuesj-183	286	7	pp	pp	ADJ
cuesj-183	286	8	.	.	PUNCT
cuesj-183	287	1	e3787	e3787	NOUN
cuesj-183	287	2	-	-	PUNCT
cuesj-183	287	3	e3787	e3787	ADJ
cuesj-183	287	4	,	,	PUNCT
cuesj-183	287	5	2018	2018	NUM
cuesj-183	287	6	.	.	PUNCT
cuesj-183	288	1	46	46	NUM
cuesj-183	288	2	.	.	PUNCT
cuesj-183	289	1	s.	s.	PROPN
cuesj-183	289	2	l.	l.	PROPN
cuesj-183	289	3	stramer	stramer	PROPN
cuesj-183	289	4	,	,	PUNCT
cuesj-183	289	5	s.	s.	PROPN
cuesj-183	289	6	zou	zou	PROPN
cuesj-183	289	7	,	,	PUNCT
cuesj-183	289	8	e.	e.	PROPN
cuesj-183	289	9	p.	p.	PROPN
cuesj-183	289	10	notari	notari	PROPN
cuesj-183	289	11	,	,	PUNCT
cuesj-183	289	12	g.	g.	PROPN
cuesj-183	289	13	a.	a.	PROPN
cuesj-183	289	14	foster	foster	PROPN
cuesj-183	289	15	,	,	PUNCT
cuesj-183	289	16	d.	d.	PROPN
cuesj-183	289	17	e.	e.	PROPN
cuesj-183	289	18	krysztof	krysztof	PROPN
cuesj-183	289	19	,	,	PUNCT
cuesj-183	289	20	f.	f.	PROPN
cuesj-183	289	21	musavi	musavi	PROPN
cuesj-183	289	22	and	and	CCONJ
cuesj-183	289	23	r.	r.	PROPN
cuesj-183	289	24	y.	y.	PROPN
cuesj-183	289	25	dodd	dodd	PROPN
cuesj-183	289	26	.	.	PUNCT
cuesj-183	290	1	“	"	PUNCT
cuesj-183	290	2	blood	blood	NOUN
cuesj-183	290	3	donation	donation	NOUN
cuesj-183	290	4	screening	screen	VERB
cuesj-183	290	5	for	for	ADP
cuesj-183	290	6	hepatitis	hepatitis	PROPN
cuesj-183	290	7	b	b	PROPN
cuesj-183	290	8	virus	virus	NOUN
cuesj-183	290	9	markers	marker	NOUN
cuesj-183	290	10	in	in	ADP
cuesj-183	290	11	the	the	DET
cuesj-183	290	12	era	era	NOUN
cuesj-183	290	13	of	of	ADP
cuesj-183	290	14	nucleic	nucleic	ADJ
cuesj-183	290	15	acid	acid	NOUN
cuesj-183	290	16	testing	testing	NOUN
cuesj-183	290	17	:	:	PUNCT
cuesj-183	290	18	are	be	AUX
cuesj-183	290	19	all	all	PRON
cuesj-183	290	20	tests	test	NOUN
cuesj-183	290	21	of	of	ADP
cuesj-183	290	22	value	value	NOUN
cuesj-183	290	23	”	"	PUNCT
cuesj-183	290	24	?	?	PUNCT
cuesj-183	291	1	transfusion	transfusion	NOUN
cuesj-183	291	2	,	,	PUNCT
cuesj-183	291	3	vol	vol	NOUN
cuesj-183	291	4	.	.	PROPN
cuesj-183	291	5	52	52	NUM
cuesj-183	291	6	,	,	PUNCT
cuesj-183	291	7	pp	pp	ADJ
cuesj-183	291	8	.	.	PUNCT
cuesj-183	292	1	440	440	NUM
cuesj-183	292	2	-	-	SYM
cuesj-183	292	3	446	446	NUM
cuesj-183	292	4	,	,	PUNCT
cuesj-183	292	5	2012	2012	NUM
cuesj-183	292	6	.	.	PUNCT